🏷

Classifications

Harrison's Part

Mechanistic Nosology

ICIMD (Inherited Metabolic Disorders)

◈

Mechanistic Hypotheses

1

Postnatal glucose-to-fatty-acid fuel switch as the trigger for MRPL44 cardiomyopathy manifestation

nutrient_dependent_postnatal_manifestation EMERGING

Evidence balance 1 support

A single-patient preprint proposes that nutrient-dependent mitochondrial stress contributes to perinatal hypertrophy. One homozygous p.Leu156Arg iPSC line was compared with three healthy donor lines, without an isogenic correction. The 72-hour media comparison used 2 g/L glucose versus 1 g/L glucose with oleate 100 μM and palmitate 50 μM, not glucose-free fatty-acid conditions. In glucose-rich medium, mtDNA copy number, mitochondrial area and transcripts increased despite reduced complex I protein. Lipid-enriched medium induced mitochondrial and partial ER stress, with XBP1 expression but no splicing and no FGF21 induction. Transcript-based mTOR prediction and inferred lipid utilization do not measure mTOR activity or fatty-acid oxidation flux. The proposed contribution to hypertrophic growth remains provisional and does not justify dietary treatment.

Pathograph links

Impaired Mitochondrial Translation -> Failed Compensatory mtDNA Replication and Transcription INDIRECT UNKNOWN INTERMEDIATES Cardiomyocytes respond to the translation block by amplifying mtDNA and mitochondrial transcripts, a response that cannot restore protein output. Hypothesis-tagged: rests on a single unreviewed patient iPSC-cardiomyocyte study, and a mouse NIH3T3 knockdown study found no mtDNA copy-number effect.

Impaired Mitochondrial Translation -> Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes INDIRECT UNKNOWN INTERMEDIATES Provisional nutrient-dependent response to the translation defect in one patient iPSC-cardiomyocyte line. The initiating sensor and generalization to the intact heart remain unresolved.

Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes -> Hypertrophic Cardiomyopathy INDIRECT UNKNOWN INTERMEDIATES Provisional translation of the authors’ hypothesis that perinatal mitochondrial stress promotes hypertrophic growth. Evidence comes from one non-isogenic patient/control cell comparison; mTOR signaling was predicted and the intervening growth pathway is not established.

Show evidence (1 reference)

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT Other

"These observations provide a mechanistic basis for postnatal disease manifestation and highlight nutrient metabolism as a key driver in development of infantile-onset mitochondrial hypertrophic cardiomyopathy."

States the hypothesis directly. Preprint, one patient iPSC line, awaiting peer review and replication.

?

Discussions and Knowledge Gaps

9

Why is complex IV activity disproportionately reduced relative to complex I in MRPL44 deficiency, when the measured synthesis rates of complex I and complex IV mtDNA-encoded subunits are similarly depressed and complex I has more than twice as many mtDNA-encoded subunits?

KNOWLEDGE GAP OPEN gap_disproportionate_complex_iv_deficiency

Attached to

pathophysiology#Impaired Mitochondrial Translation pathophysiology#Combined Complex I and IV Deficiency

In most mitochondrial transcription and translation defects, complex I (seven mtDNA-encoded subunits) is more affected than complex IV (three) simply through subunit stoichiometry. MRPL44 deficiency inverts this, as do LRPPRC and TACO1 disease. The 2021 functional study excluded the obvious explanation by showing that the newly synthesized complex IV subunits (MT-CO1, MT-CO2, MT-CO3) were reduced to approximately the same degree as complex I subunits (average 30.1% versus 34.3% of controls, not significantly different). A difference in post-synthetic stability of the assembled subunits was proposed but could not be excluded or confirmed. Resolving this matters because a complex IV-selective post-translational bottleneck would be a different therapeutic target from generic mitoribosome insufficiency.

Proposed experiments

Pulse-chase stability assay of mtDNA-encoded complex IV versus complex I subunits

pulse-chase protein stability assay

exp_mrpl44_cox_subunit_pulse_chase

In MRPL44-patient and isogenic corrected cardiomyocytes, perform 35S pulse-chase labelling with quantification of the decay rate of newly synthesized MT-CO1/2/3 versus MT-ND subunits, to test whether the excess complex IV deficit arises from accelerated degradation of unassembled cytochrome c oxidase subunits rather than from unequal synthesis.

Model systems

Patient iPSC-derived cardiomyocyte

MRPL44-mutant patient iPSC-derived cardiomyocytes with isogenic corrected controls, providing the human cardiac context where the biochemical defect is most severe.

OTHER

Show evidence (1 reference)

PMID:34140213 SUPPORT Other

"The reason for this more pronounced defect in complex IV is not clear."

The authors explicitly state that this mechanistic question is unresolved.

Can the yeast MrpL3/mL44 homolog or a mouse Mrpl44 knockout serve as a valid model for human MRPL44 disease alleles, given that the human disease mutation modelled at the equivalent yeast residue does not impair function and that mouse null loss is embryonically lethal?

HUMAN MODEL MISMATCH OPEN mismatch_yeast_mrpl3_l156r_equivalent

Attached to

pathophysiology#Biallelic MRPL44 Loss of Function and mL44 Protein Depletion pathophysiology#Large Mitoribosomal Subunit Assembly Defect

Yeast MrpL3/mL44 is the tractable genetic model for mL44 function, and mutagenesis of its conserved hydrophobic pocket does identify residues critical for assembling translationally active mitoribosomes. However, the exact human disease substitution modelled at the equivalent yeast residue (A186) had no major functional impact, and the authors concluded the two orthologs have diverged in evolution. Mouse Mrpl44 loss is a different kind of mismatch: knockout is embryonically lethal, whereas human patients carry hypomorphic alleles with residual protein and survive with tissue-restricted disease. Neither model therefore reproduces the human hypomorphic, cardiac-selective genotype-phenotype relationship, and both should be treated as tools for general mitoribosome biology rather than as MRPL44 disease models. Patient-derived iPSC cardiomyocytes are the emerging replacement, but the only published line covers a single genotype and the work remains a preprint.

Proposed experiments

Isogenic MRPL44 iPSC-derived cardiomyocyte allelic series

isogenic iPSC-derived cardiomyocyte allelic series

exp_mrpl44_isogenic_ipsc_cardiomyocyte

Engineer an allelic series (p.Leu156Arg, p.Leu156Pro, p.Thr161Serfs*2, and corrected wild type) in a common human iPSC background, differentiate to cardiomyocytes, and quantify mL44 abundance, 39S assembly, mitochondrial translation, complex I and IV activity, and contractile function, testing whether the human cardiac context reproduces the allele-severity gradient that neither yeast nor mouse captures.

Model systems

Human iPSC-derived cardiomyocyte

Cardiomyocytes differentiated from gene-edited human iPSCs carrying the reported MRPL44 disease alleles, preserving the human sequence context that diverges from yeast MrpL3.

OTHER

Show evidence (3 references)

PMID:38950860 SUPPORT Model Organism

"the introduction of the disease-related mutation into the equivalent position in the yeast protein (residue A186) was found to not have a major impact on function"

Directly demonstrates that the yeast ortholog does not phenocopy the human disease allele.

PMID:38950860 SUPPORT Other

"The human and yeast mL44 proteins share many similarities in sequence and structure; however results presented here indicate that these two proteins have diverged somewhat in evolution."

The authors themselves flag the evolutionary divergence limiting model validity.

PMID:34140213 SUPPORT Model Organism

"In mice, it is expressed widely throughout multiple tissues during development and its absence is embryonically lethal"

Mouse null lethality contrasts with the survivable, tissue-restricted human hypomorphic phenotype, the second arm of the model mismatch.

What determines the striking tissue gradient of MRPL44 deficiency, in which heart muscle shows profound respiratory chain deficiency, skeletal muscle intermediate, and fibroblasts only borderline changes, despite comparable reduction of mL44 protein in all three tissues?

KNOWLEDGE GAP OPEN gap_cardiac_tissue_selectivity

Attached to

pathophysiology#Cardiomyocyte Contractile Element Loss

mL44 protein levels are reduced in heart, skeletal muscle, and fibroblasts alike, yet the enzymatic and clinical consequences are overwhelmingly cardiac. Candidate explanations include the higher OXPHOS flux demand and mitochondrial density of the myocardium, the postnatal switch to fatty-acid oxidation (the nutrient-dependent hypothesis), tissue-specific differences in mitoribosome assembly-factor buffering, and a possible transcript hierarchy in mitochondrial translation - the yeast work showed that MrpL3/mL44 mutation does not affect all mtDNA-encoded transcripts equally. Distinguishing a threshold effect from a genuinely cardiac-specific mechanism is required before extrapolating any therapy tested in fibroblasts to the heart.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"There are tissue specific differences. The enzyme deficiency was most pronounced in cardiac muscle tissue, where there was massive proliferation of mitochondria on electron microscopy displacing contractile elements."

Documents the tissue gradient that this gap seeks to explain.

PMID:38950860 SUPPORT Model Organism

"we observed that mutation of the MrpL3/mL44 does not impact the translation of all mitochondrial encoded proteins equally, suggesting the mitochondrial translation system may exhibit a transcript hierarchy and prioritization."

Offers a candidate mechanism (transcript hierarchy) for differential consequences, though demonstrated in yeast rather than human tissue.

Does the postnatal glucose-to-fatty-acid fuel switch causally trigger MRPL44 hypertrophic cardiomyopathy in vivo, and does the ISRmt/lipid-handling arm represent a tractable therapeutic target distinct from OXPHOS repletion?

KNOWLEDGE GAP OPEN gap_nutrient_dependent_hypothesis_validation

Attached to

pathophysiology#Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes

The nutrient-dependent model is currently supported by a single unreviewed preprint using one patient iPSC line in short-term culture, with immature in-vitro cardiomyocyte physiology. It is mechanistically attractive because it would explain the otherwise puzzling perinatal timing of disease onset, and because it points to a stress-signalling rather than purely bioenergetic target. It must not, however, be translated into fat restriction, ketogenic diet, or any other dietary manipulation: no clinical evidence supports this, and fasting/catabolic stress is itself a recognized hazard in mitochondrial disease. Replication across genotypes, in matured or engineered heart tissue, and ideally in vivo is required.

Proposed experiments

Multi-genotype nutrient-switch replication in matured cardiac tissue

engineered heart tissue nutrient-switch assay

exp_mrpl44_fuel_switch_replication

Replicate the glucose-versus-lipid comparison across at least three MRPL44 genotypes plus isogenic controls in maturation-promoted engineered heart tissue, with longitudinal transcriptomics, lipidomics, contractile force, and ISRmt readouts, and test whether pharmacological ISRmt attenuation rescues the lipid-condition phenotype.

Model systems

Engineered human heart tissue

Maturation-promoted 3D engineered heart tissue from MRPL44-mutant and isogenic control iPSCs, addressing the immaturity limitation of monolayer iPSC cardiomyocytes.

OTHER

Show evidence (1 reference)

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT In Vitro

"Our findings indicate that glucose and lipids, the latter being the postnatally favored cardiac fuel, exert remarkably different consequences in MRPL44 deficient cardiomyocytes."

States the finding whose in-vivo validity and therapeutic tractability are the open question. Preprint, single patient line.

Which mechanisms account for early metabolic and feeding findings?

KNOWLEDGE GAP OPEN mrpl44_metabolic_and_feeding_attribution

Attached to

phenotypes#Lactic Acidosis phenotypes#Hypoglycemia phenotypes#Hypothermia phenotypes#Hyperammonemia phenotypes#Feeding Difficulties in Infancy phenotypes#Failure to Thrive

The infant report establishes neonatal acidosis, hypoglycemia and feeding difficulty, with transient hyperammonemia in Patient 2 and hypothermia in Patient 1. A qualified OXPHOS-to-lactic-acidosis route is represented using established pyruvate/redox physiology and the MRPL44 clinical measurements; missing tissue-level reconstruction does not negate that relation. The precise tissue contribution and possible cardiac/illness amplification remain unresolved. Intrinsic hypoglycemia, hypothermia, hyperammonemia and feeding difficulty are less causally localized by these sources. Hypoglycemia preceded cardiac shock; the shock link concerns its acute exacerbation only. Feeding insufficiency has a supported nutritional route to poor growth. Patient 1 also carried a 16q23.3 deletion. No blanket ATP-depletion fanout is asserted.

Show evidence (3 references)

PMID:34140213 SUPPORT Human Clinical

"She presented on the second day of life with Kussmaul breathing due to metabolic acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2 mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM)."

Patient 2’s neonatal metabolic episode defines the acidosis, breathing and ammonia findings; the source does not resolve the intrinsic metabolic pathway.

PMID:34140213 SUPPORT Human Clinical

"We describe two infants who presented with cardiomyopathy from the neonatal period, failure to thrive, hypoglycemia and in one infant lactic acidosis."

The two-infant clinical summary establishes the recurring metabolic/growth presentation, not its separate tissue mechanisms.

PMID:34140213 SUPPORT Human Clinical

"Chromosomal microarray revealed a deletion of 16q23.3"

The first infant’s additional chromosome deletion limits exclusive attribution of every isolated finding to MRPL44.

What distinguishes chronic hepatorenal involvement from acute circulatory complications?

KNOWLEDGE GAP OPEN mrpl44_chronic_hepatorenal_attribution

Attached to

phenotypes#Hepatic Steatosis phenotypes#Elevated Hepatic Transaminases phenotypes#Renal Insufficiency phenotypes#Hepatic Failure

Chronic renal insufficiency and hepatopathy occur in the multisystem literature; the Orphanet definition specifies steatosis and elevated transaminases. These sources do not establish a renal cell compartment or demonstrate a liver-specific lipid/ATP pathway. The infant’s renal dysfunction and hepatic failure during shock support separately qualified secondary circulatory routes, which must not be transferred to the chronic organ findings. Cardiac iPSC lipid droplets are not evidence for a hepatocyte steatosis mechanism.

Show evidence (2 references)

ORPHA:352563 SUPPORT Other

"A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases, exercise intolerance and muscle weakness."

Orphanet's expert clinical definition includes hepatic steatosis with elevated liver transaminases as a characteristic feature.

PMID:25797485 SUPPORT Human Clinical

"However, we observed several additional clinical signs and symptoms including pigmentary retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."

Reports renal insufficiency among the additional features of the two patients in this series. No frequency band is assigned: the source enumerates features without per-patient attribution or any count, so any band would be unsupported.

Does MRPL44 deficiency directly cause respiratory failure?

KNOWLEDGE GAP OPEN mrpl44_respiratory_infection_scope

Attached to

phenotypes#Respiratory Failure phenotypes#Hypoxemia

The source reports respiratory failure during RSV infection with recovery to baseline, followed by a separate cardiac shock admission. A direct MRPL44 pulmonary or respiratory-muscle mechanism was not established. The source-supported acidosis-to-Kussmaul route and qualified shock-to-hypoxia route explain those particular components without explaining the infection itself.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"At nine months of age during a respiratory syncytial viral infection, she was admitted for hypoxia and had respiratory failure for ten days after which she recovered back to baseline."

The acute respiratory failure was infection-associated. It does not establish primary chronic pulmonary involvement from MRPL44.

Which tissue mechanisms mediate the clinically attributed multisystem syndrome?

KNOWLEDGE GAP OPEN mrpl44_multisystem_intermediates

Attached to

pathophysiology#Impaired Mitochondrial Translation phenotypes#Myopathy phenotypes#Muscle Weakness phenotypes#Exercise Intolerance phenotypes#Fatigue phenotypes#Hemiplegic Migraine phenotypes#Pigmentary Retinopathy phenotypes#Ataxia phenotypes#Spasticity phenotypes#Cognitive Impairment phenotypes#Hemiparesis phenotypes#Confusion phenotypes#Impaired Executive Functioning

The clinical reports explicitly attribute the multisystem disorder to MRPL44-related mitochondrial dysfunction, and Horga links the adult phenotype to a demonstrable translation defect. Those qualified causal attributions are represented even though intervening tissue mechanisms are unknown. No measured chronic ATP deficit is claimed in kidney, liver, retina or brain, and MRI distribution alone is not taken as proof that a particular lesion causes ataxia, spasticity or migraine. Case-specific modifiers remain possible, particularly in the chromosome 2 isodisomy case.

Show evidence (2 references)

PMID:33742325 SUPPORT INDIRECT Other

"confirms that MRLP44 mutations cause a mitochondrial translation defect that may present as a multisystem disorder with neurological involvement."

The authors’ causal interpretation supports the broad syndrome attribution while leaving tissue intermediates unresolved.

PMID:25797485 SUPPORT INDIRECT Other

"Our findings expand the clinical spectrum associated with MRPL44 mutations and indicate that MRPL44-associated mitochondrial dysfunction can also manifest as a progressive multisystem disease with central nervous system involvement."

The independent clinical report supports a multisystem mitochondrial interpretation, without identifying specific downstream cellular mediators.

How were the sparse clinical sources and phenotype terms scoped?

INTERPRETATION OPEN mrpl44_source_and_phenotype_scope

Attached to

phenotypes#Cognitive Impairment phenotypes#Hemiplegic Migraine

The 2013, 2015 and adult-2021 primary abstracts were read, and detailed case observations were checked against the full 2021 infant paper, which explicitly summarizes the earlier cases. Accessible DOI fetches did not provide full text of the 2015 or adult-2021 reports; no inaccessible table was treated as read. GeneReviews PMID20301403 is an umbrella overview, not an MRPL44-specific chapter or phenotype baseline. Cognitive impairment replaces a specific-learning-disability term because the source does not identify a particular academic skill deficit. Migraine is retained as the broader binding because the current Migraine with aura HPO definition excludes motor weakness and a dedicated hemiplegic term was not retrieved. Regional Leigh-like MRI findings remain in imaging_findings; central cores and hypercontracted fibers are preserved as biopsy observations, not invented causal nodes.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic migraines, learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in thalami, basal ganglia and cerebellum on brain MRI"

The report names learning difficulties without identifying a specific academic-skill deficit or excluding general cognitive impairment in that individual; the broader cognitive term avoids an unsupported specific-learning-disability claim.

PMID:25797485 SUPPORT Human Clinical

"However, we observed several additional clinical signs and symptoms including pigmentary retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."

The two-case report includes hemiplegic migraine. The generic Migraine binding retains the motor subtype in the name: the current HPO Migraine with aura definition explicitly excludes motor weakness, and no dedicated hemiplegic-migraine HP term was retrieved. No frequency is inferred.

⚙

Pathophysiology

7

Biallelic MRPL44 Loss of Function and mL44 Protein Depletion

Pathogenic MRPL44 genotypes reduce steady-state mL44 abundance in examined patient tissues and fibroblasts. The recurrent p.Leu156Arg allele is associated with protein instability. The p.Thr161Serfs*2 allele is predicted to be null; p.Leu156Pro was observed in trans with p.Leu156Arg, so residual protein cannot be assigned specifically to the proline allele. These functional observations are not extended to the p.Arg78Gln or 2025 delins alleles. mL44 is a mitochondrial large-subunit protein; murine-expression experiments support matrix localization and multimer formation.

MRPL44 hgnc:16650

mitochondrial large ribosomal subunit GO:0005762

Downstream

Large Mitoribosomal Subunit Assembly Defect Depletion of mL44 removes a structural component of the 39S subunit and compromises its assembly and stability.

Show evidence (3 references)

PMID:23315540 SUPPORT Human Clinical

"We found severely reduced MRPL44 levels in the patient's heart, skeletal muscle and fibroblasts suggesting that the missense mutation affected the protein stability."

Patient tissue and fibroblast protein measurements show reduced mL44 abundance; altered stability is the authors’ interpretation, not a directly measured degradation rate in every tissue.

PMID:26221731 SUPPORT In Vitro

"We found that it can form multimers, and confirm that it is part of the large subunit of the mitochondrial ribosome."

Confirms mL44 is a bona fide constituent of the large mitoribosomal subunit that oligomerizes.

PMID:26221731 SUPPORT In Vitro

"we show by immunofluorescence microscopy and subcellular fractionation that Mrpl44 is localized to the matrix of the mitochondria."

Establishes the mitochondrial matrix localization of mL44.

Large Mitoribosomal Subunit Assembly Defect

Loss of mL44 reduces the amount of assembled large (39S) mitoribosomal subunit and destabilizes the mtDNA-encoded 16S rRNA that forms its scaffold, while leaving the small (28S) subunit largely intact. Retroviral re-expression of wild-type MRPL44 in patient fibroblasts restores the large subunit assembly defect, establishing the causal direction.

mitochondrial large ribosomal subunit assembly GO:1902775 ↓ DECREASED

mitochondrial large ribosomal subunit GO:0005762

Downstream

Impaired Mitochondrial Translation Fewer translationally competent mitoribosomes reduce the rate of synthesis of mtDNA-encoded polypeptides.

Show evidence (3 references)

PMID:23315540 SUPPORT In Vitro

"In patient fibroblasts, decreased MRPL44 affected assembly of the large ribosomal subunit and stability of 16S rRNA leading to complex IV deficiency."

Directly demonstrates the 39S assembly and 16S rRNA stability defect in patient cells.

PMID:23315540 SUPPORT In Vitro

"Retroviral expression of wild-type MRPL44 in patient fibroblasts rescued the large ribosome assembly defect and COX deficiency."

Genetic complementation establishes that MRPL44 loss is causal for the assembly and cytochrome c oxidase defects.

PMID:33742325 SUPPORT In Vitro

"These studies confirmed that c.467 T > G affects the stability or assembly of the large subunit of the mitochondrial ribosome, leading to impaired mitochondrial protein synthesis and decreased levels of multiple OXPHOS components."

Independent replication in a second laboratory of the 39S assembly defect caused by the recurrent allele.

Impaired Mitochondrial Translation

Patient fibroblast assays demonstrate reduced mtDNA-encoded protein synthesis, with variation by genotype and assay. In the 2021 series, Patient 1 retained 33% of control incorporation (p<0.01) and Patient 2 56% (p=0.08). This two-patient comparison suggests residual-function differences but does not validate clinical severity prediction; both infants died. The original family had a milder fibroblast translation defect despite impaired large-subunit assembly, raising an additional nascent-polypeptide stability hypothesis.

Postnatal glucose-to-fatty-acid fuel switch as the trigger for MRPL44 cardiomyopathy manifestation

fibroblast CL:0000057

mitochondrial translation GO:0032543 ↓ DECREASED

Downstream

Failed Compensatory mtDNA Replication and Transcription Cardiomyocytes respond to the translation block by amplifying mtDNA and mitochondrial transcripts, a response that cannot restore protein output. Hypothesis-tagged: rests on a single unreviewed patient iPSC-cardiomyocyte study, and a mouse NIH3T3 knockdown study found no mtDNA copy-number effect.

Combined Complex I and IV Deficiency Reduced supply of mtDNA-encoded subunits prevents assembly of the respiratory chain complexes that contain them.

Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes Provisional nutrient-dependent response to the translation defect in one patient iPSC-cardiomyocyte line. The initiating sensor and generalization to the intact heart remain unresolved.

Hypertrophic Cardiomyopathy Mitoribosomal dysfunction is causally implicated in MRPL44 cardiomyopathy by patient genetics and complementation of the cell defect. The route from impaired translation to cardiac hypertrophic remodeling remains incompletely resolved.

Myopathy Qualified attribution of myopathy to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The paired endpoint summarizes multiple earlier cases. Complete maternal chromosome 2 isodisomy applied only to the separately described adult case, not to this entire historical group. No across-variant inevitability is asserted.

Muscle Weakness Qualified attribution of muscle weakness to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The paired endpoint summarizes multiple earlier cases. Complete maternal chromosome 2 isodisomy applied only to the separately described adult case, not to this entire historical group. No across-variant inevitability is asserted.

Exercise Intolerance Qualified attribution of exercise intolerance to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability is asserted.

Fatigue Qualified attribution of fatigue to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The paired endpoint summarizes multiple earlier cases. Complete maternal chromosome 2 isodisomy applied only to the separately described adult case, not to this entire historical group. No across-variant inevitability is asserted.

Hemiplegic Migraine Qualified attribution of hemiplegic migraine to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. This endpoint comes from the 2015 multisystem report; the adolescent phenotype is summarized separately in the 2021 infant paper. The adult Horga isodisomy case is not its source. No across-variant inevitability is asserted.

Pigmentary Retinopathy Qualified attribution of pigmentary retinopathy to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. This endpoint comes from the 2015 multisystem report; the adolescent phenotype is summarized separately in the 2021 infant paper. The adult Horga isodisomy case is not its source. No across-variant inevitability is asserted.

Ataxia Qualified attribution of ataxia to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability is asserted.

Spasticity Qualified attribution of spasticity to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability is asserted.

Cognitive Impairment Qualified attribution of cognitive impairment to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The paired endpoint quote concerns the adolescent’s learning difficulties. The phenotype also separately records slower processing in the adult isodisomy case, but the two patients are not pooled into one cognitive trajectory or frequency.

Hemiparesis Qualified attribution of hemiparesis to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability is asserted.

Confusion Qualified attribution of confusion to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability is asserted.

Impaired Executive Functioning Qualified attribution of impaired executive functioning to the MRPL44 mitochondrial translation disorder, supported by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability is asserted.

Left Ventricular Hypertrophy Qualified mitochondrial etiology of the left ventricular hypertrophy component documented in MRPL44 cardiomyopathy. The route to cardiac enlargement is not reconstructed, and no anatomical-identity arrow from the cardiomyopathy phenotype is used.

Cardiomegaly Qualified mitochondrial etiology of the cardiomegaly component documented in MRPL44 cardiomyopathy. The route to cardiac enlargement is not reconstructed, and no anatomical-identity arrow from the cardiomyopathy phenotype is used.

Show evidence (3 references)

PMID:34140213 SUPPORT In Vitro

"We show this to be caused by reduced mitochondrial DNA encoded protein synthesis affecting all subunits, and resulting in dysfunction of complex I and IV assembly."

Establishes globally reduced mtDNA-encoded protein synthesis as the proximate cause of the OXPHOS assembly defects.

PMID:34140213 SUPPORT In Vitro

"The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial protein synthesis due to different pathogenic variants."

The authors report a relation between translation and OXPHOS impairment across two patient genotypes. The second translation result was not conventionally significant (p=0.08), and both clinical outcomes were fatal; this is not a validated allele-severity scale.

PMID:23315540 SUPPORT In Vitro

"Despite this assembly defect, de novo mitochondrial translation was only mildly affected in fibroblasts suggesting that MRPL44 may have a function in the assembly/stability of nascent mitochondrial polypeptides exiting the ribosome."

Qualifies the translation defect - in fibroblasts of the index family the de novo translation deficit was mild, raising an additional peptide-exit chaperoning role for mL44.

Failed Compensatory mtDNA Replication and Transcription

In glucose-rich medium, a single p.Leu156Arg patient iPSC-cardiomyocyte line showed about 2.5-fold higher mtDNA copy number, elevated mitochondrial transcripts and increased mitochondrial content, despite reduced complex I protein. Compensation is the authors’ interpretation of these readouts. The observations do not demonstrate that increased DNA replication itself causes the stress response seen under a different nutrient condition, or that all patient tissues share this response.

cardiac muscle cell CL:0000746

mitochondrial DNA replication GO:0006264 ↑ INCREASED mitochondrial transcription GO:0006390 ↑ INCREASED

Show evidence (3 references)

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT In Vitro

"The patient CMs showed an increase of 2.5-fold in mtDNA copy number compared to controls"

Quantifies the compensatory mtDNA amplification in patient cardiomyocytes. Preprint evidence from a single patient iPSC line.

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT In Vitro

"Despite this transcriptional upregulation, steady-state complex I protein level was markedly reduced"

Shows the compensatory response fails to restore OXPHOS subunit protein. Preprint evidence.

PMID:26221731 SUPPORT INDIRECT In Vitro

"qRT-PCR analysis for mitochondrial versus nuclear DNA found that altered Mrpl44 expres- sion had no impact on the mitochondrial DNA content of cells ( S4 Fig)."

Murine NIH3T3 knockdown/overexpression did not alter mtDNA content. This system-specific counterpoint limits generalization of the human cardiomyocyte result, without asserting absence of the response in MRPL44 patients.

Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes

Lipid-enriched medium induced mitochondrial stress-response and partial ER-stress transcripts in the p.Leu156Arg iPSC-cardiomyocyte line, with lipid droplets and altered lipid-uptake/cholesterol genes. ATF5 targets increased; FGF21 induction and XBP1 splicing were absent. Fatty-acid utilization was inferred from these data rather than directly measured as oxidation flux. Ingenuity pathway analysis predicted mTOR changes; direct mTORC1 activation was not measured. The authors propose that nutrient-dependent stress promotes hypertrophic growth, a preprint hypothesis requiring replication and in-vivo testing.

Postnatal glucose-to-fatty-acid fuel switch as the trigger for MRPL44 cardiomyopathy manifestation

cardiac muscle cell CL:0000746

Downstream

Hypertrophic Cardiomyopathy Provisional translation of the authors’ hypothesis that perinatal mitochondrial stress promotes hypertrophic growth. Evidence comes from one non-isogenic patient/control cell comparison; mTOR signaling was predicted and the intervening growth pathway is not established.

Show evidence (2 references)

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT In Vitro

"In contrast the lipid-enriched medium triggered both mitochondrial and endoplasmic reticulum -related stress responses, disrupted lipid and cholesterol homeostasis, accompanied by remodeling of the central biosynthetic pathway of one carbon metabolism."

Documents the nutrient-conditional stress response. Preprint, in vitro, single patient line.

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT In Vitro

"The cells accumulated lipids while also inducing lipid uptake and synthesis genes, suggesting maladaptive metabolic rewiring."

Documents the maladaptive lipid handling in mutant cardiomyocytes.

Combined Complex I and IV Deficiency

Combined respiratory-chain deficiency emphasizes complexes I and IV but varies by patient, tissue and preparation. Patient 1 had profound cardiac complex IV and strong complex I deficiency, milder muscle deficits and borderline fibroblast complex IV activity, with abnormal complex I/V assembly. Patient 2 had multiple muscle deficiencies but normal fibroblast complex I/V assembly and complex IV holocomplex; complex IV activity was low only in the mitochondrial isolate. Reduced synthesis of mtDNA-encoded subunits supports the OXPHOS defect, but does not fully explain disproportionate complex IV involvement.

mitochondrial respiratory chain complex I assembly GO:0032981 ↓ DECREASED mitochondrial respiratory chain complex IV assembly GO:0033617 ↓ DECREASED oxidative phosphorylation GO:0006119 ↓ DECREASED

Downstream

Cardiomyocyte Contractile Element Loss The profound cardiac enzyme defect is associated with mitochondrial proliferation and loss of contractile elements in the infant biopsy. An injury route from deficient mitochondrial function is supported, while the steps producing the structural lesion were not experimentally separated.

Lactic Acidosis Established respiratory-chain physiology supports a qualified contribution of the MRPL44 OXPHOS defect to lactic acidosis. Impaired pyruvate oxidation and altered redox balance favor lactate formation. The MRPL44 infant had severe lactic metabolic acidosis and a reported elevated lactate/pyruvate ratio; the dominant tissue contribution and effects of cardiac dysfunction or illness were not experimentally separated. The murine unchanged-ECAR result is not evidence of increased lactate flux.

Show evidence (3 references)

PMID:23315540 SUPPORT Human Clinical

"Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and IV in the heart and skeletal muscle."

The defining biochemical signature of MRPL44 deficiency in patient tissue.

PMID:34140213 SUPPORT Human Clinical

"We document a combined respiratory chain enzyme deficiency with emphasis on complex I and IV, affecting heart muscle tissue more than skeletal muscle or fibroblasts."

Replicates the combined CI/CIV deficiency and establishes its tissue gradient.

PMID:26221731 SUPPORT In Vitro

"This ultimately impacted ATP synthesis capability and respiratory capacity of cells."

Independent experimental manipulation of Mrpl44 expression reproduces the OXPHOS capacity defect.

Cardiomyocyte Contractile Element Loss

The first 2021 infant’s myocardial biopsy showed areas of contractile element loss and diffuse proliferation of enlarged mitochondria with abnormal cristae. This provides a cellular substrate for contractile dysfunction. Compensation and displacement are proposed interpretations of the morphology; the biopsy does not directly quantify ATP depletion or prove the cause of hypertrophic growth.

cardiac muscle cell CL:0000746

heart UBERON:0000948

Downstream

Congestive Heart Failure Loss of contractile elements provides a plausible structural contribution to ventricular pump failure in the biopsied infant; the relation is indirect and the relative contribution of metabolic dysfunction versus structural injury is unresolved.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"The enzyme deficiency was most pronounced in cardiac muscle tissue, where there was massive proliferation of mitochondria on electron microscopy displacing contractile elements."

Links the tissue-graded biochemical defect to the cardiac structural pathology.

PMID:23315540 SUPPORT Other

"These findings indicate that mitochondrial ribosomal subunit defects can generate tissue-specific manifestations, such as cardiomyopathy."

Frames the cardiac-selective manifestation as the central conceptual finding of MRPL44 deficiency.

✶

Histopathology

3

Mitochondrial Proliferation with Aberrant Cristae in Cardiomyocytes

Electron microscopy of myocardial biopsy shows a diffuse proliferation of enlarged, atypically shaped mitochondria with aberrant cristae together with areas of contractile element loss - the classic ultrastructural picture of a mitochondrial cardiomyopathy.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"In Patient 1, on electron microscopy, the heart showed areas of contractile element loss within the cardiomyocytes and a diffuse proliferation of enlarged, atypically shaped mitochondria with aberrant cristae, typical for a mitochondrial cardiomyopathy"

Direct ultrastructural description of the cardiac histopathology.

Abnormal Skeletal Muscle Mitochondria without Ragged Red Fibers

Skeletal muscle shows abnormal mitochondria with granular content and abnormal cristae, and enlarged mitochondria in some fibers. Notably, Gomori trichrome staining did not reveal ragged blue fibers and there were no cytochrome c oxidase-negative fibers, so routine mitochondrial muscle histochemistry can be unrevealing in MRPL44 deficiency.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"In Patient 2, on light microscopy skeletal muscle showed abnormal mitochondria with granular content and abnormal cristae, and in some fibers enlarged mitochondria were noted."

Describes the skeletal muscle mitochondrial abnormalities.

PMID:34140213 SUPPORT Human Clinical

"Gomori trichrome staining did not reveal ragged blue fibers, and there were no cytochrome c oxidase negative fibers."

Establishes that the standard mitochondrial myopathy histochemical markers may be absent, an important diagnostic caveat.

Central Cores in Skeletal Muscle Fibers

Patient 2 had some fibers with central cores and some hypercontracted fibers at three months. Ragged blue and COX-negative fibers were absent. This isolated observation is not evidence for a second primary central-core myopathy.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"Histology showed some fibers with central cores and some hypercontracted fibers."

Documents the additional muscle biopsy finding in Patient 2; it is not a separate causal mechanism.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

32

Cardiovascular 6

Hypertrophic Cardiomyopathy HP:0001639

Show evidence (2 references)

PMID:25797485 SUPPORT Human Clinical

"Both patients presented with childhood-onset hypertrophic cardiomyopathy, which seems to be the core clinical feature associated with MRPL44 deficiency."

Both patients in this report had childhood-onset HCM, described as the core clinical feature. No disease-wide numerical band is inferred from these few reported cases.

PMID:34140213 SUPPORT Human Clinical

"All patients presented as children with hypertrophic cardiomyopathy, had mild lactic acidosis, and easy fatigue and muscle weakness."

The introduction summarizes HCM in the five previously reported patients. Five of five is not an 80–99% estimate, and the candidate 2025 VUS siblings are not added to this denominator. The same paragraph records recognition at age 21 in one individual, qualifying the general childhood wording.

Left Ventricular Hypertrophy HP:0001712

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"an echocardiogram revealed an ejection fraction of 25% (normal 55–70%) with left ventricular dysfunction and hypertrophy"

Documents echocardiographic left ventricular dysfunction and hypertrophy in an affected infant.

Congestive Heart Failure HP:0001635

Course: PROGRESSIVE

Sequelae: Cardiogenic Shock

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She had cardiomegaly on chest X-ray, and echocardiography showed a very restrictive right ventricle and a ballooned left ventricle with barely any unmeasurable contraction and blood flow, and she died in cardiac failure shortly after."

Documents fatal congestive cardiac failure in an infant with MRPL44 deficiency.

Cardiomegaly HP:0001640

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She had cardiomegaly on chest X-ray, and echocardiography showed a very restrictive right ventricle and a ballooned left ventricle with barely any unmeasurable contraction and blood flow, and she died in cardiac failure shortly after."

Patient 2 had radiographic cardiomegaly during terminal cardiac decompensation.

Cardiogenic Shock HP:0030149

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Sequelae: Hypotension Lethargy Hypoxemia Renal Insufficiency Hepatic Failure Hypoglycemia

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"However, three days after discharge at ten months of age, she was readmitted in cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right ventricular failure."

Documents cardiogenic shock in the acute decompensation episode. The proposed cardiac cause is qualified by the authors as likely.

Hypotension HP:0002615

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"However, three days after discharge at ten months of age, she was readmitted in cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right ventricular failure."

Documents hypotension in the acute decompensation episode. The proposed cardiac cause is qualified by the authors as likely.

Digestive 3

Hepatic Steatosis HP:0001397

Show evidence (1 reference)

ORPHA:352563 SUPPORT Other

"A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases, exercise intolerance and muscle weakness."

Orphanet's expert clinical definition includes hepatic steatosis with elevated liver transaminases as a characteristic feature.

Feeding Difficulties in Infancy HP:0008872

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Sequelae: Failure to Thrive

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She had feeding difficulties taking only 10 to 30% of her feeds orally with the remainder provided by nasogastric tube feeding."

Only 10–30% of feeds were taken orally in Patient 1.

Hepatic Failure HP:0001399

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She remained in cardiogenic shock and hepatic failure, and ultimately developed disseminated Candida lusitanease infection which resulted in her death two days after her first birthday."

Patient 1 had hepatic failure during severe circulatory decompensation; this is distinct from chronic hepatopathy or steatosis.

Eye 1

Pigmentary Retinopathy HP:0000580

Show evidence (1 reference)

PMID:25797485 SUPPORT Human Clinical

"However, we observed several additional clinical signs and symptoms including pigmentary retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."

Reports pigmentary retinopathy among the late features observed in this two-patient series. No frequency band is assigned - the source gives no count or qualitative frequency term.

Genitourinary 1

Renal Insufficiency HP:0000083

Show evidence (1 reference)

PMID:25797485 SUPPORT Human Clinical

"However, we observed several additional clinical signs and symptoms including pigmentary retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."

Reports renal insufficiency among the additional features of the two patients in this series. No frequency band is assigned: the source enumerates features without per-patient attribution or any count, so any band would be unsupported.

Metabolism 5

Lactic Acidosis HP:0003128

Sequelae: Hyperventilation

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological symptoms."

The abstract mentions mild lactate elevation in three historical infant presentations but does not score the other two as negative. Its body summarizes mild lactate elevation in all five earlier cases. Therefore neither four of seven nor a disease-wide frequency band is derived from this sentence.

PMID:34140213 SUPPORT Human Clinical

"She presented on the second day of life with Kussmaul breathing due to metabolic acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2 mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM)."

Patient 2 had severe neonatal lactic metabolic acidosis. This is a directly described occurrence with its own measurements, independent of the incomplete historical summary.

Hypoglycemia HP:0001943

Temporal: RECURRENT

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"We describe two infants who presented with cardiomyopathy from the neonatal period, failure to thrive, hypoglycemia and in one infant lactic acidosis."

Documents hypoglycemia as part of the infantile presentation.

Elevated Hepatic Transaminases Elevated circulating hepatic transaminase concentration HP:0002910

Show evidence (1 reference)

ORPHA:352563 SUPPORT Other

"hepatic steatosis with elevated liver transaminases"

Orphanet clinical definition lists elevated liver transaminases.

Hypothermia HP:0002045

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"Following vaginal delivery at 396/7 weeks gestation, during the neonatal period the girl had an episode of hypothermia and was persistently hypoglycemic (lowest 16 mg/dL), which was treated with continuous intravenous glucose."

Documents hypothermia in Patient 1; its relationship to hypoglycemia or mitochondrial dysfunction was not separately established.

Hyperammonemia HP:0001987

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She presented on the second day of life with Kussmaul breathing due to metabolic acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2 mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM)."

Documents the transient early ammonia elevation, not sustained hyperammonemia.

Musculoskeletal 3

Muscle Weakness HP:0001324

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"All patients presented as children with hypertrophic cardiomyopathy, had mild lactic acidosis, and easy fatigue and muscle weakness."

The introduction describes weakness in the five earlier cases. The newly reported infants were not separately scored, so no 80–99% disease-wide band is derived from five of five historical reports.

Myopathy HP:0003198

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological symptoms."

Documents myopathy as the presenting feature of the two later-onset patients, distinguishing the adolescent/adult phenotype from the infantile cardiac-dominant one.

Spasticity HP:0001257

This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant paper summarizes the original Horga report.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia, and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and cerebellar white matter"

Documents spasticity in the adult multisystem presentation.

Nervous System 7

Hemiplegic Migraine HP:0002076

Show evidence (1 reference)

PMID:25797485 SUPPORT Human Clinical

"However, we observed several additional clinical signs and symptoms including pigmentary retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."

The two-case report includes hemiplegic migraine. The generic Migraine binding retains the motor subtype in the name: the current HPO Migraine with aura definition explicitly excludes motor weakness, and no dedicated hemiplegic-migraine HP term was retrieved. No frequency is inferred.

Ataxia HP:0001251

This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant paper summarizes the original Horga report.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia, and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and cerebellar white matter"

The clinical summary records ataxia in the adult with maternal chromosome 2 isodisomy and homozygous p.Leu156Arg. It supplies occurrence, not a disease-wide frequency.

Cognitive Impairment HP:0100543

Learning difficulties refer to the adolescent case; slower processing and impaired executive function refer to the adult with maternal chromosome 2 isodisomy. These are different clinical observations, not a combined frequency denominator.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic migraines, learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in thalami, basal ganglia and cerebellum on brain MRI"

The report names learning difficulties without identifying a specific academic-skill deficit or excluding general cognitive impairment in that individual; the broader cognitive term avoids an unsupported specific-learning-disability claim.

PMID:34140213 SUPPORT Human Clinical

"She had normal cognitive function, but as a young adult started to have reduced processing speed and executive function."

The adult case developed slower processing after previously normal cognition; this supports acquired cognitive impairment, without an IQ or dementia claim.

Lethargy HP:0001254

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"However, three days after discharge at ten months of age, she was readmitted in cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right ventricular failure."

Documents lethargy in the acute decompensation episode. The proposed cardiac cause is qualified by the authors as likely.

Hemiparesis HP:0001269

This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant paper summarizes the original Horga report.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"A fifth patient presented as a young adult with skeletal myopathy and exercise intolerance, subclinical cardiac hypertrophy recognized at age 21 years, migraine, transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia, and on brain MRI lesions in basal..."

The source specifically records hemiparesis among the transient neurological episodes.

Confusion HP:0001289

This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant paper summarizes the original Horga report.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"A fifth patient presented as a young adult with skeletal myopathy and exercise intolerance, subclinical cardiac hypertrophy recognized at age 21 years, migraine, transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia, and on brain MRI lesions in basal..."

The source specifically records confusion among the transient neurological episodes.

Impaired Executive Functioning HP:0033051

This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant paper summarizes the original Horga report.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She had normal cognitive function, but as a young adult started to have reduced processing speed and executive function."

The adult clinical summary explicitly describes diminished executive function.

Respiratory 3

Hyperventilation HP:0002883

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"She presented on the second day of life with Kussmaul breathing due to metabolic acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2 mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM)."

The authors explicitly attribute the Kussmaul breathing to metabolic acidosis; no primary pulmonary disorder is asserted.

Hypoxemia HP:0012418

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"However, three days after discharge at ten months of age, she was readmitted in cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right ventricular failure."

Documents hypoxemia in the acute decompensation episode. The proposed cardiac cause is qualified by the authors as likely.

Respiratory Failure HP:0002878

This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is case-scoped and not solely attributed to MRPL44.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"At nine months of age during a respiratory syncytial viral infection, she was admitted for hypoxia and had respiratory failure for ten days after which she recovered back to baseline."

The acute respiratory failure was infection-associated. It does not establish primary chronic pulmonary involvement from MRPL44.

Constitutional 2

Exercise Intolerance HP:0003546

Show evidence (2 references)

ORPHA:352563 SUPPORT Other

"hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases, exercise intolerance and muscle weakness"

The Orphanet clinical definition of COXPD16 lists exercise intolerance as a characteristic feature.

PMID:34140213 SUPPORT Human Clinical

"A fifth patient presented as a young adult with skeletal myopathy and exercise intolerance, subclinical cardiac hypertrophy recognized at age 21 years"

Documents exercise intolerance as a presenting adult feature.

Fatigue HP:0012378

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"All patients presented as children with hypertrophic cardiomyopathy, had mild lactic acidosis, and easy fatigue and muscle weakness."

The historical five-case summary records easy fatigue; it does not establish a representative frequency band.

Growth 1

Failure to Thrive HP:0001508

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"We describe two infants who presented with cardiomyopathy from the neonatal period, failure to thrive, hypoglycemia and in one infant lactic acidosis."

Documents failure to thrive in the infantile presentation.

🧬

Genetic Associations

1

MRPL44 biallelic pathogenic variants

Gene: MRPL44 hgnc:16650 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal recessive

Show evidence (1 reference)

PMID:30384889 SUPPORT Human Clinical

"The disease genes converge on metabolic causes (PRKAG2, MRPL44, AARS2, HADHB, DNAJC19, PPA2, TAZ, BAG3), MAPK pathways (HRAS, PTPN11, RAF1, TAB2), development (NEK8 and TBX20), calcium signaling (JPH2, CALM1, CACNA1C), and the sarcomeric contraction cycle (TNNC1, TNNI3, ACTC1, MYH7, NRAP)."

A countrywide severe childhood cardiomyopathy cohort places MRPL44 among the established metabolic cardiomyopathy genes.

Variants (5)

MRPL44 c.467T>G, p.(Leu156Arg) Pathogenic

Gene: MRPL44 hgnc:16650

The recurrent missense allele, present in 9 of the first 10 published disease alleles. It is located in the conserved hydrophobic pocket of the RNase III-like domain and strongly reduces mL44 protein levels while leaving some residual protein and activity. Homozygotes have been reported with both fatal infantile cardiomyopathy and with later-onset multisystem disease, so genotype alone does not predict the clinical course.

Show evidence (2 references)

PMID:23315540 SUPPORT Human Clinical

"Exome sequencing uncovered a homozygous mutation (L156R) in MRPL44 of both siblings."

First identification of the recurrent p.Leu156Arg allele.

PMID:34140213 SUPPORT Human Clinical

"The variant c.467T>G; p.(Leu156Arg) is a commonly recurring causal pathogenic variant present in 9 of 10 alleles published"

Quantifies the dominance of this allele in the published cohort.

MRPL44 c.233G>A, p.(Arg78Gln)

Gene: MRPL44 hgnc:16650

A missense allele identified in compound heterozygosity with the recurrent p.Leu156Arg variant in a patient with childhood-onset hypertrophic cardiomyopathy plus late multisystem features. No clinical_significance is recorded here deliberately: unlike the other four alleles, p.Arg78Gln has never been assigned a formal ACMG classification in the literature and has not been functionally assayed (no protein-abundance, mitoribosome-assembly, or translation data exist for it), so any classification would be curator invention rather than a sourced claim.

Show evidence (1 reference)

PMID:25797485 SUPPORT Human Clinical

"we identified two further unrelated patients harboring the previously reported mutation c.467T > G, p.Leu156Arg in MRPL44 in the homozygous state and compound heterozygous with a novel missense mutation c.233G > A, p.Arg78Gln, respectively."

Reports the p.Arg78Gln allele in trans with p.Leu156Arg.

MRPL44 c.481_484delinsTC, p.(Thr161Serfs*2) Pathogenic

Gene: MRPL44 hgnc:16650

A frameshift allele predicted to trigger nonsense-mediated decay or produce a premature stop codon, i.e. a true null. In trans with p.Leu156Arg it produced the most severe biochemical phenotype in the published series - mitochondrial protein synthesis at roughly a third of controls - and fatal infantile cardiomyopathy.

Show evidence (1 reference)

PMID:34140213 SUPPORT Other

"The variant in Patient 1 c.481_484delinsTC p.Thr161Serfs*2 is predicted to cause either nonsense-mediated mRNA decay or a premature stop codon."

Defines this allele as a predicted null.

MRPL44 c.467T>C, p.(Leu156Pro) Pathogenic

Gene: MRPL44 hgnc:16650

A second substitution at Leu156, observed in trans with p.Leu156Arg. The authors predict a disruptive proline substitution. Reduced mL44 abundance was measured in the compound-heterozygous cells, without assigning residual protein specifically to the proline allele.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The additional variant in Patient 2 affected the same amino acid Leu156, but the change was to proline instead of arginine."

Documents a second pathogenic substitution at the Leu156 hotspot.

MRPL44 c.198_205delinsTA, p.(Trp66_His69delinsCysAsn) Uncertain Significance

Gene: MRPL44 hgnc:16650

A homozygous delins allele reported in a Tunisian family with severe hypertrophic cardiomyopathy affecting two siblings. It shortens the protein and was absent from ClinVar and HGMD at the time of reporting; formal ACMG classification was VUS, with pathogenicity supported by co-segregation and in silico structural modelling rather than by functional assays.

Show evidence (3 references)

PMID:40402202 SUPPORT Human Clinical

"The proband harboured a homozygous variant, NM_022915.5: c.198_205delinsTA; p.(Trp66_His69 delinsCysAsn), in the MRPL44 gene, leading to a shorter protein."

Reports the novel Tunisian allele.

PMID:40402202 SUPPORT Computational

"In silico analysis showed significant structural differences in the mutated mL44 protein, disrupting its interaction with ribosomal complex components and impairing translation and protein synthesis."

Pathogenicity rests on in silico modelling rather than functional assay, so the mechanistic claim remains an untested computational prediction.

PMID:40402202 SUPPORT Human Clinical

"This variant is novel, being absent in ClinVar and Human Gene Mutation Database (HGMD) and classified as VUS according to American College of Medical Genetics and Genomics (ACMG) criteria."

Records the formal ACMG classification as VUS.

💊

Medical Actions

6

Supportive Heart Failure Management

Action: supportive care Ontology label: Supportive Care NCIT:C15747

No disease-modifying therapy exists. Care is supportive and cardiac-directed: beta blockade and standard anti-failure pharmacotherapy, nutritional support via nasogastric or gastrostomy feeding, avoidance of catabolic stress, and surveillance echocardiography. Intercurrent infection is a recognized trigger of fatal cardiac decompensation.

Target Phenotypes: Congestive heart failure HP:0001635

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The patient responded well to treatment and was discharged at 71 days of life while being treated with beta blockers and receiving feeding mainly via gastrostomy tube."

Documents beta blockade and enteral nutritional support as the initial management, with initial clinical response.

Beta Blocker Therapy

Action: Pharmacotherapy NCIT:C15986

Agent: beta-adrenergic antagonist NCIT:C29576

Platform: Small molecule

Beta blockade is the specific anti-failure pharmacotherapy documented in MRPL44 deficiency; an affected infant was discharged on beta blockers with gastrostomy feeding after an initial clinical response, although the cardiomyopathy later decompensated fatally.

Target Phenotypes: Congestive heart failure HP:0001635

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The patient responded well to treatment and was discharged at 71 days of life while being treated with beta blockers and receiving feeding mainly via gastrostomy tube."

Documents beta blockade in an affected infant with an initial response. This is single-case, uncontrolled use extrapolated from general pediatric heart failure practice, not MRPL44-specific efficacy data.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Autosomal recessive counselling with a specific caveat: one reported patient was homozygous through complete maternal uniparental isodisomy of chromosome 2 rather than biparental transmission. A homozygous MRPL44 result with only one carrier parent should therefore prompt uniparental disomy testing, since the recurrence risk differs substantially from the standard 25%.

Show evidence (1 reference)

PMID:33742325 SUPPORT Human Clinical

"Short-tandem repeat and genome-wide SNP microarray analyses of the family trio confirmed complete maternal uniparental isodisomy of chromosome 2."

Establishes uniparental isodisomy as a documented route to homozygosity in MRPL44 disease, which directly changes recurrence-risk counselling.

Mechanical Circulatory Support

Action: ventricular assist device placement Ontology label: Ventricular Assist Device Placement NCIT:C80452

Platform: Device

Ventricular assist device placement and venoarterial extracorporeal membrane oxygenation have been used aggressively in infants with MRPL44-related cardiogenic shock, on the rationale that some patients stabilize after the first year. In the published case this did not prevent death from multiorgan failure and opportunistic infection, so the benefit is unproven.

Mechanism Target:

INHIBITS Congestive Heart Failure — Mechanical unloading substitutes for the failing bioenergetically depleted myocardium; it does not correct the underlying translation defect.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"aggressive management including left ventricle assist device was performed in the case presented here."

Documents the use of mechanical circulatory support and its rationale.

PMID:34140213 SUPPORT Human Clinical

"She remained in cardiogenic shock and hepatic failure, and ultimately developed disseminated Candida lusitanease infection which resulted in her death two days after her first birthday."

Shows that mechanical support did not rescue the reported infant, so efficacy is unestablished.

Cardiac Transplantation

Action: heart transplantation Ontology label: Heart Transplantation NCIT:C15246

Platform: Surgery

The clinical authors considered cardiac transplantation for infantile MRPL44 cardiomyopathy. Their stated caveat is that progressive neurological and other extra-cardiac involvement may emerge later. This is a proposed clinical option, not a reported transplant outcome, and does not imply that OXPHOS deficiency was measured in every organ.

Show evidence (1 reference)

PMID:34140213 SUPPORT Other

"We were considering cardiac transplantation as an option in this condition in infancy, bearing in mind that in adolescence a progressive clinical involvement including neurological symptoms may still occur."

States both the rationale for and the principal caveat against cardiac transplantation in MRPL44 deficiency.

Mitochondrial Biogenesis Induction (Investigational)

Action: investigational pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986

The authors propose increasing mL44 abundance with mitochondrial-biogenesis approaches such as NRF2, PGC-1-alpha or PPAR-delta activation. This is untested in MRPL44 deficiency and is not established by the two-patient residual-translation comparison. The cardiomyocyte preprint shows increased mtDNA/transcripts despite reduced complex I protein, limiting the assumption that more biogenesis alone restores function.

Mechanism Target:

INHIBITS Biallelic MRPL44 Loss of Function and mL44 Protein Depletion — Raising MRPL44 transcription is proposed to partially compensate for the reduced steady-state abundance of the destabilized mL44 protein.

Show evidence (2 references)

PMID:34140213 SUPPORT Other

"Since the amount of residual activity is related to translational efficiency, to improve the function and perhaps allow infants to recover from the cardiac dysfunction, increasing the amount of ml44 should be considered."

States the therapeutic hypothesis. Indirect support because the paper proposes but does not test this strategy.

DOI:10.1101/2025.09.24.678132 Preprint · not peer-reviewed SUPPORT In Vitro

"MRPL44 deficiency impairs mitochondrial translation but induces mtDNA replication and transcription in iPSC-derived cardiomyocytes."

Tempers the biogenesis-induction rationale - patient cardiomyocytes already mount a biogenesis response that fails to correct the translation block. Preprint, in vitro.

🔬

Biochemical Markers

5

Increased circulating lactate concentration (INCREASED)

Context: Elevated blood lactate, generally mild but occasionally severe. One neonate had persistent lactic acidemia of 3.3 to 15 mmol/L unrelated to feeding, with an elevated lactate/pyruvate ratio indicating a respiratory chain rather than a pyruvate dehydrogenase defect.

Pathograph Readouts

Readout Of Lactic Acidosis

Blood lactate measures the lactate component; acidosis additionally requires acid-base assessment, as documented in the severe neonatal episode.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The persistent lactic acidemia (3.3 to 15 mmol/L, normal < 2 mM) did not change in relation to feeding"

Blood lactate measures the lactate component; acidosis additionally requires acid-base assessment, as documented in the severe neonatal episode.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The persistent lactic acidemia (3.3 to 15 mmol/L, normal < 2 mM) did not change in relation to feeding"

Quantifies the persistent elevation of blood lactate.

Reduced cytochrome c oxidase (complex IV) enzyme activity (DECREASED)

Context: The most consistently and most severely reduced respiratory chain activity. In cardiac tissue complex IV activity is profoundly decreased; in skeletal muscle it is severely to mildly decreased; in fibroblasts it is only borderline low, and may only be detectable in a mitochondrial isolate rather than a whole-cell homogenate.

Pathograph Readouts

Readout Of Combined Complex I and IV Deficiency

The complex IV enzyme assay reports this component of the respiratory-chain defect; tissue and homogenate preparation affect sensitivity.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"in Patient 1 respiratory chain enzyme activities showed a combined deficiency of the activities of respiratory chain enzyme complexes in heart tissue, with a profound decrease in complex IV and a strong decrease in complex I, and a mild decrease of complex II-III"

The complex IV enzyme assay reports this component of the respiratory-chain defect; tissue and homogenate preparation affect sensitivity.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"in Patient 1 respiratory chain enzyme activities showed a combined deficiency of the activities of respiratory chain enzyme complexes in heart tissue, with a profound decrease in complex IV and a strong decrease in complex I, and a mild decrease of complex II-III"

Quantifies the tissue-specific respiratory chain enzyme deficiencies.

PMID:34140213 SUPPORT In Vitro

"In fibroblasts the respiratory chain enzyme activities were normal in the 600 × g homogenate, but showed low complex IV activity in a mitochondrial isolate."

Important diagnostic caveat - fibroblast whole-homogenate assays can miss the complex IV defect.

Reduced NADH:ubiquinone oxidoreductase (complex I) enzyme activity (DECREASED)

Context: Complex I activity is strongly reduced in cardiac tissue and mildly to moderately reduced in skeletal muscle, completing the combined complex I and IV deficiency signature.

Pathograph Readouts

Readout Of Combined Complex I and IV Deficiency

The complex I activity assay reports this component of the combined respiratory-chain defect in the sampled tissue.

Show evidence (1 reference)

PMID:23315540 SUPPORT Human Clinical

"Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and IV in the heart and skeletal muscle."

The complex I activity assay reports this component of the combined respiratory-chain defect in the sampled tissue.

Show evidence (1 reference)

PMID:23315540 SUPPORT Human Clinical

"Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and IV in the heart and skeletal muscle."

Documents combined complex I and IV deficiency in patient heart and muscle.

Reduced mitochondrial protein synthesis in fibroblasts (DECREASED)

Context: Quantitative 35S-amino-acid incorporation into mtDNA-encoded polypeptides is reduced to approximately one third of control values in fibroblasts from a patient with a missense/frameshift genotype, and to approximately half in a patient with a missense/missense genotype - a functional assay that both confirms the translation defect and grades allele severity.

Pathograph Readouts

Readout Of Impaired Mitochondrial Translation

Radiolabeled amino-acid incorporation reports mitochondrial protein synthesis in cultured fibroblasts, without a validated clinical severity cutoff.

Show evidence (1 reference)

PMID:34140213 SUPPORT In Vitro

"clearly decreased synthesis of mitochondrial proteins at 2.23 ± 0.48 fmol AA/μg protein, 33% of the average incorporation (p<0.01)"

Radiolabeled amino-acid incorporation reports mitochondrial protein synthesis in cultured fibroblasts, without a validated clinical severity cutoff.

Show evidence (2 references)

PMID:34140213 SUPPORT In Vitro

"clearly decreased synthesis of mitochondrial proteins at 2.23 ± 0.48 fmol AA/μg protein, 33% of the average incorporation (p<0.01)"

Quantifies the translation deficit in the missense/frameshift patient's fibroblasts at 33% of control incorporation.

PMID:34140213 SUPPORT In Vitro

"The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial protein synthesis due to different pathogenic variants."

The authors relate the two genotypes to differing residual translation and OXPHOS dysfunction. Patient 2 retained 56% with p=0.08; no validated clinical severity prediction follows.

Reduced MT-CO1 protein with preserved nuclear-encoded ATP5F1B (DECREASED)

Context: Western blotting shows reduced MT-CO1 (a mtDNA-encoded complex IV subunit) in all tissues examined while the nuclear-encoded ATP synthase subunit ATP5F1B is normal - a discriminating pattern that localizes the defect to mitochondrial rather than cytosolic translation.

Pathograph Readouts

Readout Of Combined Complex I and IV Deficiency

Reduced MT-CO1 is a protein-abundance readout supporting the OXPHOS defect; it is not itself an activity assay. Preserved ATP5F1B is an internal nuclear-encoded comparator.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The amount of MT-CO1 was decreased in all tissues, but the amount of ATP5FB1 was normal"

Patient 1 measurements include heart and skeletal muscle biopsies as well as fibroblasts (Figure 2A–C), showing reduced MT-CO1 with preserved nuclear-encoded ATP5F1B. The snippet retains the source spelling ATP5FB1. This is protein abundance, not an enzyme-activity measurement; a separately cited Patient 2 fibroblast-only assay would be IN_VITRO.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"The amount of MT-CO1 was decreased in all tissues, but the amount of ATP5FB1 was normal"

Patient 1 measurements include heart and skeletal muscle biopsies as well as fibroblasts (Figure 2A–C), showing reduced MT-CO1 with preserved nuclear-encoded ATP5F1B. The snippet retains the source spelling ATP5FB1. This is protein abundance, not an enzyme-activity measurement; a separately cited Patient 2 fibroblast-only assay would be IN_VITRO.

🔬

Diagnosis

5

Molecular genetic testing of MRPL44

Diagnosis is molecular. Every reported case was solved by exome sequencing or a nuclear mitochondrial-disease/cardiomyopathy panel that includes MRPL44; notably, a targeted comprehensive cardiomyopathy panel was non-diagnostic in one infant, so a mitochondrial-inclusive panel or trio exome is preferred. When a homozygous variant appears with only one carrier parent, add short-tandem-repeat and SNP-microarray testing for uniparental disomy.

genetic testing NCIT:C15709

Results: Biallelic (homozygous or compound heterozygous) pathogenic MRPL44 variants confirm the diagnosis.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"Clinical exome sequencing demonstrated compound heterozygosity for pathogenic variants in the MRPL44 gene"

Documents exome sequencing as the confirmatory diagnostic test.

PMID:34140213 SUPPORT Human Clinical

"a comprehensive cardiomyopathy sequencing panel did not report any variants."

Important diagnostic caveat - a standard cardiomyopathy gene panel missed the diagnosis, arguing for exome or a mitochondrial-inclusive panel.

Respiratory chain enzymology of heart and skeletal muscle

Respiratory-chain enzyme activity measurements can support the diagnosis, but yield varies by tissue, patient and preparation. In the extensively studied first 2021 infant, the cardiac defect was profound, muscle involvement milder and fibroblast complex IV activity borderline. The second infant had normal fibroblast whole-homogenate activities but low complex IV activity in a mitochondrial isolate, so a normal whole-homogenate result does not exclude the disorder.

respiratory chain enzyme assay

Results: Combined deficiency of complexes I and IV, most marked in cardiac tissue.

Show evidence (2 references)

PMID:23315540 SUPPORT Human Clinical

"Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and IV in the heart and skeletal muscle."

Establishes the diagnostic biochemical signature.

PMID:34140213 SUPPORT In Vitro

"In fibroblasts the respiratory chain enzyme activities were normal in the 600 × g homogenate, but showed low complex IV activity in a mitochondrial isolate."

Documents the false-negative risk of fibroblast whole-homogenate enzymology.

Skeletal muscle biopsy with mitochondrial histochemistry

Muscle biopsy shows ultrastructurally abnormal mitochondria, but the routine mitochondrial-myopathy histochemical markers can be entirely absent, so a normal Gomori trichrome and COX stain does not exclude the diagnosis.

muscle biopsy NCIT:C51895

Results: Abnormal mitochondria with granular content and abnormal cristae, without ragged red/blue fibers and without COX-negative fibers.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"Gomori trichrome staining did not reveal ragged blue fibers, and there were no cytochrome c oxidase negative fibers."

Establishes that the standard mitochondrial myopathy histochemical markers may be absent in MRPL44 deficiency.

Mitochondrial protein synthesis (translation) assay

Specialist 35S-amino-acid incorporation assays can demonstrate impaired mitochondrial translation in patient fibroblasts. The two 2021 patients differed in residual incorporation and OXPHOS assays, but this does not establish a validated clinical-severity or novel-variant classification test.

mitochondrial translation assay

Results: Reduced incorporation of labelled amino acids into mtDNA-encoded polypeptides, proportional to the severity of the genotype.

Show evidence (1 reference)

PMID:34140213 SUPPORT In Vitro

"The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial protein synthesis due to different pathogenic variants."

The two-patient functional comparison supports measuring residual translation, not a validated prognostic or variant-classification threshold.

Echocardiography

Echocardiography establishes and monitors the defining cardiac phenotype and is the basis for surveillance in at-risk siblings and in survivors of the infantile presentation.

echocardiography NCIT:C16525

Results: Left ventricular hypertrophy with variably depressed ejection fraction.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"an echocardiogram revealed an ejection fraction of 25% (normal 55–70%) with left ventricular dysfunction and hypertrophy"

Documents the echocardiographic findings that define the cardiac phenotype.

🩻

Imaging Findings

2

Leigh-Like Lesions on Brain MRI

Symmetric signal abnormalities of the thalami, basal ganglia, midbrain, and cerebellar and subcortical white matter resembling Leigh syndrome have been documented in older MRPL44-deficient patients. No brain MRI abnormality has been reported in the infantile cardiac-dominant presentation, but infant neuroimaging is sparse - one neonate had a normal cranial ultrasound and no infant brain MRI has been published, so the apparent sparing is unconfirmed.

Mri

Abnormal basal ganglia MRI signal intensity HP:0012751

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"Five patients have been described with compound heterozygous or homozygous pathogenic variants in MRPL44 ... The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic migraines, learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in thalami, basal..."

Restores MRPL44 attribution and the older patients' ages, including the explicitly Leigh-like case before the more detailed regional MRI findings. The excerpt does not establish an absence of infant CNS disease from sparse imaging.

ORPHA:352563 SUPPORT Other

"Neuro-opthalmological features (hemiplegic migraine, Leigh-like lesions on brain MRI, pigmentary retinopathy) have been reported later in life."

Orphanet's clinical definition lists Leigh-like brain MRI lesions as a late-onset feature.

Cardiomegaly on Chest Radiograph

Cardiomegaly on plain chest radiography was the first objective sign of cardiac involvement in one infant, prompting the echocardiogram that revealed left ventricular hypertrophy and a depressed ejection fraction.

Xray

Cardiomegaly HP:0001640

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"a chest radiograph identified cardiomegaly and an echocardiogram revealed an ejection fraction of 25%"

Documents radiographic cardiomegaly with echocardiographic confirmation.

📈

Progression

1

Variable course. Infantile-onset disease is dominated by rapidly progressive hypertrophic cardiomyopathy; cardiac decompensation within the first year of life has been fatal in several reported infants despite inotropes, ventricular assist devices, and ECMO. Children who stabilize after the first year may remain well with asymptomatic cardiomyopathy into adolescence, and at least one case of spontaneous resolution of the cardiomyopathy has been described. Some individuals homozygous for the recurrent p.Leu156Arg allele subsequently developed a slowly progressive multisystem phenotype in the second and third decades, with myopathy, exercise intolerance, hepatopathy, renal insufficiency, hemiplegic migraine, pigmentary retinopathy, and Leigh-like brain MRI lesions. This age-dependent emergence of neurological involvement is prognostically important when cardiac transplantation is being considered in infancy. No prospective natural-history study, survival estimate, or validated prognostic biomarker exists.

Show evidence (3 references)

PMID:25797485 SUPPORT Human Clinical

"Of note, neurological and neuro-ophthalmological impairment seems to be a disease feature of the second and third decades of life, which should be taken into account in patient management and counseling."

Documents the delayed, age-dependent onset of neurological and neuro-ophthalmological involvement in survivors.

PMID:34140213 SUPPORT Human Clinical

"A decompensation of the cardiac function in the first year resulted in demise."

Documents fatal first-year cardiac decompensation in the infantile presentation.

PMID:34140213 SUPPORT Human Clinical

"The first child died in infancy of cardiac failure following an acute infection, whereas in her sister the cardiomyopathy stabilized, and she remained well with only asymptomatic cardiomyopathy at the time of publication at age 14 years"

Illustrates the marked intrafamilial variability in course between siblings carrying the same genotype.

📊

Prevalence

1

Worldwide

Cases In Literature Ultra Rare

Seven patients were described through the two 2021 clinical reports. A Tunisian sibling pair with hypertrophic cardiomyopathy was reported in 2025, but their shared delins allele remained formally a VUS; they are not counted as two additional molecularly established cases. No population prevalence or carrier-frequency estimate is supplied by these case reports.

Show evidence (2 references)

PMID:34140213 SUPPORT Human Clinical

"To date, five patients have been described with pathogenic variants in MRPL44, encoding the ml44 protein which is part of the large subunit of the mitochondrial ribosome (mitoribosome)."

Establishes that only five patients had been published before this 2021 report added two more, confirming ultra-rare status.

PMID:40402202 SUPPORT Human Clinical

"This study reports a novel MRPL44 variant associated with HCM in a Tunisian family."

Reports another family with HCM and a segregating MRPL44 variant, formally classified as a VUS. This is a candidate family, not a confirmed-case prevalence denominator.

🔀

Differential Diagnoses

5

Conditions with similar clinical presentations that must be differentiated from MRPL44 Deficiency:

MTO1 deficiency (mitochondrial hypertrophic cardiomyopathy with lactic acidosis) MONDO:0013865

Overlapping Features A mitochondrial tRNA-modification (rather than mitoribosomal structural) translation defect presenting with infantile hypertrophic cardiomyopathy and lactic acidosis. Clinically near-indistinguishable from MRPL44 deficiency at presentation, and a documented source of named-entity confusion in the literature and in automated curation.

Distinguishing Features

Molecular. MTO1 acts on mt-tRNA taurinomethyl modification, not on the 39S subunit; lactic acidosis is typically more severe and more consistently present in MTO1 deficiency, and MTO1 patients more often show early encephalopathy.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"Of these, cardiomyopathy has for instance been described in the following genes: AARS2, YARS2, GARS, KARS, MRPL3, MRPS22, MRPS14, MRPL44, TSFM, RMND1, MTO1, HSD17B10, ELAC2, TRMT5, GTPBP3 [3]."

Lists MTO1 among the mitochondrial translation cardiomyopathy genes.

Other mitochondrial translation-defect cardiomyopathies

Overlapping Features A broader group of nuclear mitochondrial translation genes causes biochemically indistinguishable infantile cardiomyopathy with combined respiratory chain deficiency: aminoacyl-tRNA synthetases (AARS2, YARS2, GARS, KARS), other mitoribosomal proteins (MRPS22, MRPS14), elongation and assembly factors (TSFM, RMND1), and tRNA-modifying enzymes (ELAC2, TRMT5, GTPBP3, HSD17B10).

Distinguishing Features

Not separable on respiratory chain enzymology or muscle histology; requires a nuclear mitochondrial gene panel, exome, or genome. This is the practical argument for not stopping at a targeted cardiomyopathy panel.

Show evidence (1 reference)

PMID:34140213 SUPPORT Human Clinical

"Of these, cardiomyopathy has for instance been described in the following genes: AARS2, YARS2, GARS, KARS, MRPL3, MRPS22, MRPS14, MRPL44, TSFM, RMND1, MTO1, HSD17B10, ELAC2, TRMT5, GTPBP3 [3]."

Enumerates the mitochondrial translation genes in which cardiomyopathy has been described, defining this differential group.

Non-mitochondrial metabolic and sarcomeric infantile cardiomyopathies

Overlapping Features Pompe disease (glycogen storage disease II), Barth syndrome (TAZ), fatty-acid-oxidation defects, and primary sarcomeric hypertrophic cardiomyopathy all present with infantile or childhood hypertrophic cardiomyopathy.

Distinguishing Features

These are separable without sequencing: Pompe by acid alpha-glucosidase enzyme assay and marked creatine kinase elevation; Barth by cyclic 3-methylglutaconic aciduria, neutropenia and X-linked inheritance; fatty-acid-oxidation defects by a diagnostic acylcarnitine profile; sarcomeric HCM by dominant inheritance, later onset, and the absence of lactic acidosis or combined respiratory chain deficiency.

{ }

Source YAML

click to show

name: MRPL44 Deficiency
category: Genetic
creation_date: "2026-08-01T00:00:00Z"
synonyms:
- COXPD16
- Combined oxidative phosphorylation deficiency 16
- Combined oxidative phosphorylation defect type 16
- Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency
- MRPL44-related mitochondrial disease
description: >-
  MRPL44 deficiency (COXPD16; OMIM #615395; ORPHA:352563) is an autosomal recessive mitochondrial translation
  disorder caused by biallelic pathogenic MRPL44 variants. MRPL44 encodes mL44 in the large mitoribosomal
  subunit. Reduced mL44 abundance and impaired subunit assembly or stability compromise mitochondrial
  protein synthesis and oxidative phosphorylation, particularly complexes I and IV. Tissue and assay effects
  vary: cardiac muscle was most severely affected in the extensively studied infant, whereas fibroblast
  enzymology could be borderline or normal. The clinical spectrum includes rapidly progressive infantile
  hypertrophic cardiomyopathy with hypoglycemia and poor growth, and later cardiac and skeletal myopathy
  with neurological, retinal, renal and hepatic involvement. Cardiac hypertrophy was recognized only at
  age 21 years in one adult. Some children stabilize; later multisystem progression is possible rather
  than inevitable. Supportive cardiac and nutritional treatment is documented. A single-patient iPSC-cardiomyocyte
  preprint proposes nutrient-dependent stress as a contributor to hypertrophy; it does not establish a
  dietary treatment.
disease_term:
  preferred_term: Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency
  term:
    id: MONDO:0014162
    label: infantile hypertrophic cardiomyopathy due to MRPL44 deficiency
parents:
- MONDO:0000732
references:
- reference: PMID:23315540
  title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to
    underlie mitochondrial infantile cardiomyopathy."
- reference: PMID:25797485
  title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic
    cardiomyopathy."
- reference: PMID:34140213
  title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial translation
    defect."
- reference: PMID:33742325
  title: "Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem mitochondrial disease."
- reference: PMID:40402202
  title: "A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44) associated
    with hypertrophic cardiomyopathy in Tunisian patients."
- reference: DOI:10.1101/2025.09.24.678132
  title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
- reference: PMID:20301403
  title: "Primary Mitochondrial Disorders Overview."
  tags:
  - GeneReviews
- reference: PMID:35806492
  title: The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders.
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
  mechanistic_category:
  - classification_value: mitochondrial disease
  icimd_category:
  - classification_value: mitoribosome
    notes: >-
      ICIMD category for disorders of the mitoribosome. MRPL44 encodes mL44, a
      structural protein of the large (39S) subunit of the mitochondrial
      ribosome, so COXPD16 is a mitoribosomal translation defect rather than a
      primary respiratory-chain subunit or assembly-factor disorder.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Seven patients were described through the two 2021 clinical reports. A Tunisian sibling pair with
    hypertrophic cardiomyopathy was reported in 2025, but their shared delins allele remained formally
    a VUS; they are not counted as two additional molecularly established cases. No population prevalence
    or carrier-frequency estimate is supplied by these case reports.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, five patients have been described with pathogenic variants in MRPL44, encoding
      the ml44 protein which is part of the large subunit of the mitochondrial ribosome (mitoribosome)."
    explanation: >-
      Establishes that only five patients had been published before this 2021 report added two more, confirming
      ultra-rare status.
  - reference: PMID:40402202
    reference_title: "A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44)
      associated with hypertrophic cardiomyopathy in Tunisian patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This study reports a novel MRPL44 variant associated with HCM in a Tunisian family."
    explanation: >-
      Reports another family with HCM and a segregating MRPL44 variant, formally classified as a VUS.
      This is a candidate family, not a confirmed-case prevalence denominator.
progression:
- notes: >
    Variable course. Infantile-onset disease is dominated by rapidly progressive hypertrophic cardiomyopathy;
    cardiac decompensation within the first year of life has been fatal in several reported infants despite
    inotropes, ventricular assist devices, and ECMO. Children who stabilize after the first year may remain
    well with asymptomatic cardiomyopathy into adolescence, and at least one case of spontaneous resolution
    of the cardiomyopathy has been described. Some individuals homozygous for the recurrent p.Leu156Arg
    allele subsequently developed a slowly progressive multisystem phenotype in the second and third decades,
    with myopathy, exercise intolerance, hepatopathy, renal insufficiency, hemiplegic migraine, pigmentary
    retinopathy, and Leigh-like brain MRI lesions. This age-dependent emergence of neurological involvement
    is prognostically important when cardiac transplantation is being considered in infancy. No prospective
    natural-history study, survival estimate, or validated prognostic biomarker exists.
  evidence:
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of note, neurological and neuro-ophthalmological impairment seems to be a disease feature
      of the second and third decades of life, which should be taken into account in patient management
      and counseling."
    explanation: >-
      Documents the delayed, age-dependent onset of neurological and neuro-ophthalmological involvement
      in survivors.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A decompensation of the cardiac function in the first year resulted in demise."
    explanation: >-
      Documents fatal first-year cardiac decompensation in the infantile presentation.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The first child died in infancy of cardiac failure following an acute infection, whereas
      in her sister the cardiomyopathy stabilized, and she remained well with only asymptomatic cardiomyopathy
      at the time of publication at age 14 years"
    explanation: >-
      Illustrates the marked intrafamilial variability in course between siblings carrying the same genotype.
mechanistic_hypotheses:
- hypothesis_group_id: nutrient_dependent_postnatal_manifestation
  hypothesis_label: >-
    Postnatal glucose-to-fatty-acid fuel switch as the trigger for
    MRPL44 cardiomyopathy manifestation
  status: EMERGING
  description: >-
    A single-patient preprint proposes that nutrient-dependent mitochondrial stress contributes to perinatal
    hypertrophy. One homozygous p.Leu156Arg iPSC line was compared with three healthy donor lines, without
    an isogenic correction. The 72-hour media comparison used 2 g/L glucose versus 1 g/L glucose with
    oleate 100 μM and palmitate 50 μM, not glucose-free fatty-acid conditions. In glucose-rich medium,
    mtDNA copy number, mitochondrial area and transcripts increased despite reduced complex I protein.
    Lipid-enriched medium induced mitochondrial and partial ER stress, with XBP1 expression but no splicing
    and no FGF21 induction. Transcript-based mTOR prediction and inferred lipid utilization do not measure
    mTOR activity or fatty-acid oxidation flux. The proposed contribution to hypertrophic growth remains
    provisional and does not justify dietary treatment.
  evidence:
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "These observations provide a mechanistic basis for postnatal disease manifestation and highlight
      nutrient metabolism as a key driver in development of infantile-onset mitochondrial hypertrophic
      cardiomyopathy."
    explanation: >-
      States the hypothesis directly. Preprint, one patient iPSC line, awaiting peer review and replication.
pathophysiology:
- name: Biallelic MRPL44 Loss of Function and mL44 Protein Depletion
  biological_scale: MOLECULAR
  description: >-
    Pathogenic MRPL44 genotypes reduce steady-state mL44 abundance in examined patient tissues and fibroblasts.
    The recurrent p.Leu156Arg allele is associated with protein instability. The p.Thr161Serfs*2 allele
    is predicted to be null; p.Leu156Pro was observed in trans with p.Leu156Arg, so residual protein cannot
    be assigned specifically to the proline allele. These functional observations are not extended to
    the p.Arg78Gln or 2025 delins alleles. mL44 is a mitochondrial large-subunit protein; murine-expression
    experiments support matrix localization and multimer formation.
  gene:
    preferred_term: MRPL44
    term:
      id: hgnc:16650
      label: MRPL44
  cellular_components:
  - preferred_term: mitochondrial large ribosomal subunit
    term:
      id: GO:0005762
      label: mitochondrial large ribosomal subunit
  evidence:
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found severely reduced MRPL44 levels in the patient's heart, skeletal muscle and fibroblasts
      suggesting that the missense mutation affected the protein stability."
    explanation: >-
      Patient tissue and fibroblast protein measurements show reduced mL44 abundance; altered stability
      is the authors’ interpretation, not a directly measured degradation rate in every tissue.
  - reference: PMID:26221731
    reference_title: "A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We found that it can form multimers, and confirm that it is part of the large subunit of
      the mitochondrial ribosome."
    explanation: >-
      Confirms mL44 is a bona fide constituent of the large mitoribosomal subunit that oligomerizes.
  - reference: PMID:26221731
    reference_title: "A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we show by immunofluorescence microscopy and subcellular fractionation that Mrpl44 is localized
      to the matrix of the mitochondria."
    explanation: >-
      Establishes the mitochondrial matrix localization of mL44.
  downstream:
  - target: Large Mitoribosomal Subunit Assembly Defect
    causal_link_type: DIRECT
    description: >-
      Depletion of mL44 removes a structural component of the 39S subunit and
      compromises its assembly and stability.
- name: Large Mitoribosomal Subunit Assembly Defect
  biological_scale: MOLECULAR
  description: >
    Loss of mL44 reduces the amount of assembled large (39S) mitoribosomal
    subunit and destabilizes the mtDNA-encoded 16S rRNA that forms its scaffold,
    while leaving the small (28S) subunit largely intact. Retroviral
    re-expression of wild-type MRPL44 in patient fibroblasts restores the large
    subunit assembly defect, establishing the causal direction.
  cellular_components:
  - preferred_term: mitochondrial large ribosomal subunit
    term:
      id: GO:0005762
      label: mitochondrial large ribosomal subunit
  biological_processes:
  - preferred_term: mitochondrial large ribosomal subunit assembly
    term:
      id: GO:1902775
      label: mitochondrial large ribosomal subunit assembly
    modifier: DECREASED
  evidence:
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In patient fibroblasts, decreased MRPL44 affected assembly of the large ribosomal subunit
      and stability of 16S rRNA leading to complex IV deficiency."
    explanation: >-
      Directly demonstrates the 39S assembly and 16S rRNA stability defect in patient cells.
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Retroviral expression of wild-type MRPL44 in patient fibroblasts rescued the large ribosome
      assembly defect and COX deficiency."
    explanation: >-
      Genetic complementation establishes that MRPL44 loss is causal for the assembly and cytochrome c
      oxidase defects.
  - reference: PMID:33742325
    reference_title: "Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem mitochondrial
      disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "These studies confirmed that c.467 T > G affects the stability or assembly of the large
      subunit of the mitochondrial ribosome, leading to impaired mitochondrial protein synthesis and decreased
      levels of multiple OXPHOS components."
    explanation: >-
      Independent replication in a second laboratory of the 39S assembly defect caused by the recurrent
      allele.
  downstream:
  - target: Impaired Mitochondrial Translation
    causal_link_type: DIRECT
    description: >-
      Fewer translationally competent mitoribosomes reduce the rate of synthesis
      of mtDNA-encoded polypeptides.
- name: Impaired Mitochondrial Translation
  biological_scale: CELLULAR
  description: >-
    Patient fibroblast assays demonstrate reduced mtDNA-encoded protein synthesis, with variation by genotype
    and assay. In the 2021 series, Patient 1 retained 33% of control incorporation (p<0.01) and Patient
    2 56% (p=0.08). This two-patient comparison suggests residual-function differences but does not validate
    clinical severity prediction; both infants died. The original family had a milder fibroblast translation
    defect despite impaired large-subunit assembly, raising an additional nascent-polypeptide stability
    hypothesis.
  biological_processes:
  - preferred_term: mitochondrial translation
    term:
      id: GO:0032543
      label: mitochondrial translation
    modifier: DECREASED
  cell_types:
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We show this to be caused by reduced mitochondrial DNA encoded protein synthesis affecting
      all subunits, and resulting in dysfunction of complex I and IV assembly."
    explanation: >-
      Establishes globally reduced mtDNA-encoded protein synthesis as the proximate cause of the OXPHOS
      assembly defects.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial
      protein synthesis due to different pathogenic variants."
    explanation: >-
      The authors report a relation between translation and OXPHOS impairment across two patient genotypes.
      The second translation result was not conventionally significant (p=0.08), and both clinical outcomes
      were fatal; this is not a validated allele-severity scale.
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Despite this assembly defect, de novo mitochondrial translation was only mildly affected
      in fibroblasts suggesting that MRPL44 may have a function in the assembly/stability of nascent mitochondrial
      polypeptides exiting the ribosome."
    explanation: >-
      Qualifies the translation defect - in fibroblasts of the index family the de novo translation deficit
      was mild, raising an additional peptide-exit chaperoning role for mL44.
  downstream:
  - target: Failed Compensatory mtDNA Replication and Transcription
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - nutrient_dependent_postnatal_manifestation
    description: >-
      Cardiomyocytes respond to the translation block by amplifying mtDNA and
      mitochondrial transcripts, a response that cannot restore protein output.
      Hypothesis-tagged: rests on a single unreviewed patient iPSC-cardiomyocyte
      study, and a mouse NIH3T3 knockdown study found no mtDNA copy-number effect.
    evidence:
    - reference: DOI:10.1101/2025.09.24.678132
      reference_title: Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy
        model
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: The patient CMs showed an increase of 2.5-fold in mtDNA copy number compared to
        controls
      explanation: >-
        The mutant-cell comparison supports a proposed compensatory response in one p.Leu156Arg iPSC line;
        it does not identify the intervening sensor or establish this response in all tissues.
      directness: INDIRECT
  - target: Combined Complex I and IV Deficiency
    causal_link_type: DIRECT
    description: >-
      Reduced supply of mtDNA-encoded subunits prevents assembly of the
      respiratory chain complexes that contain them.
  - target: Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Provisional nutrient-dependent response to the translation defect in one patient iPSC-cardiomyocyte
      line. The initiating sensor and generalization to the intact heart remain unresolved.
    evidence:
    - reference: DOI:10.1101/2025.09.24.678132
      reference_title: Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy
        model
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: In contrast the lipid-enriched medium triggered both mitochondrial and endoplasmic
        reticulum -related stress responses, disrupted lipid and cholesterol homeostasis,
        accompanied by remodeling of the central biosynthetic pathway of one carbon metabolism.
      explanation: >-
        The nutrient comparison measured stress-related expression changes in mutant cardiomyocytes; it
        is not an in-vivo perinatal challenge.
      directness: INDIRECT
    hypothesis_groups:
    - nutrient_dependent_postnatal_manifestation
  - target: Hypertrophic Cardiomyopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Mitoribosomal dysfunction is causally implicated in MRPL44 cardiomyopathy by patient genetics and
      complementation of the cell defect. The route from impaired translation to cardiac hypertrophic
      remodeling remains incompletely resolved.
    evidence:
    - reference: PMID:23315540
      reference_title: Whole-exome sequencing identifies a mutation in the mitochondrial ribosome
        protein MRPL44 to underlie mitochondrial infantile cardiomyopathy.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: These findings indicate that mitochondrial ribosomal subunit defects can generate
        tissue-specific manifestations, such as cardiomyopathy.
      explanation: >-
        The original authors infer cardiac disease from the genetic and functional findings; this is an
        etiologic interpretation, not a fully reconstructed cardiac pathway.
      directness: INDIRECT
  - target: Myopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of myopathy to the MRPL44 mitochondrial translation disorder, supported by
      the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The paired endpoint summarizes multiple earlier cases. Complete maternal chromosome
      2 isodisomy applied only to the separately described adult case, not to this entire historical group.
      No across-variant inevitability is asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to myopathy, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and
        easy fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological
        symptoms."
      explanation: >-
        This human clinical observation identifies myopathy within the reported MRPL44 spectrum. It supplies
        the endpoint paired with the source’s etiologic interpretation; it does not independently prove
        a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Muscle Weakness
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of muscle weakness to the MRPL44 mitochondrial translation disorder, supported
      by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The paired endpoint summarizes multiple earlier cases. Complete maternal chromosome
      2 isodisomy applied only to the separately described adult case, not to this entire historical group.
      No across-variant inevitability is asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to muscle weakness, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All patients presented as children with hypertrophic cardiomyopathy, had mild lactic acidosis,
        and easy fatigue and muscle weakness."
      explanation: >-
        This human clinical observation identifies muscle weakness within the reported MRPL44 spectrum.
        It supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Exercise Intolerance
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of exercise intolerance to the MRPL44 mitochondrial translation disorder,
      supported by the clinical authors’ multisystem interpretation and the specific reported finding.
      Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome
      2 isodisomy, which limits exclusive attribution of individual components. No across-variant inevitability
      is asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to exercise intolerance, this supports a qualified etiologic route with unresolved tissue
        intermediates, not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "A fifth patient presented as a young adult with skeletal myopathy and exercise intolerance,
        subclinical cardiac hypertrophy recognized at age 21 years"
      explanation: >-
        This human clinical observation identifies exercise intolerance within the reported MRPL44 spectrum.
        It supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Fatigue
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of fatigue to the MRPL44 mitochondrial translation disorder, supported by
      the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The paired endpoint summarizes multiple earlier cases. Complete maternal chromosome
      2 isodisomy applied only to the separately described adult case, not to this entire historical group.
      No across-variant inevitability is asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to fatigue, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: All patients presented as children with hypertrophic cardiomyopathy, had mild lactic
        acidosis, and easy fatigue and muscle weakness.
      explanation: >-
        This human clinical observation identifies fatigue within the reported MRPL44 spectrum. It supplies
        the endpoint paired with the source’s etiologic interpretation; it does not independently prove
        a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Hemiplegic Migraine
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of hemiplegic migraine to the MRPL44 mitochondrial translation disorder, supported
      by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. This endpoint comes from the 2015 multisystem report; the adolescent phenotype
      is summarized separately in the 2021 infant paper. The adult Horga isodisomy case is not its source.
      No across-variant inevitability is asserted.
    evidence:
    - reference: PMID:25797485
      reference_title: MRPL44 mutations cause a slowly progressive multisystem disease with
        childhood-onset hypertrophic cardiomyopathy.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Our findings expand the clinical spectrum associated with MRPL44 mutations and
        indicate that MRPL44-associated mitochondrial dysfunction can also manifest as a progressive
        multisystem disease with central nervous system involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to hemiplegic migraine, this supports a qualified etiologic route with unresolved tissue
        intermediates, not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:25797485
      reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
        hypertrophic cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
        retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
      explanation: >-
        This human clinical observation identifies hemiplegic migraine within the reported MRPL44 spectrum.
        It supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Pigmentary Retinopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of pigmentary retinopathy to the MRPL44 mitochondrial translation disorder,
      supported by the clinical authors’ multisystem interpretation and the specific reported finding.
      Tissue intermediates remain unresolved. This endpoint comes from the 2015 multisystem report; the
      adolescent phenotype is summarized separately in the 2021 infant paper. The adult Horga isodisomy
      case is not its source. No across-variant inevitability is asserted.
    evidence:
    - reference: PMID:25797485
      reference_title: MRPL44 mutations cause a slowly progressive multisystem disease with
        childhood-onset hypertrophic cardiomyopathy.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Our findings expand the clinical spectrum associated with MRPL44 mutations and
        indicate that MRPL44-associated mitochondrial dysfunction can also manifest as a progressive
        multisystem disease with central nervous system involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to pigmentary retinopathy, this supports a qualified etiologic route with unresolved tissue
        intermediates, not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:25797485
      reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
        hypertrophic cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
        retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
      explanation: >-
        This human clinical observation identifies pigmentary retinopathy within the reported MRPL44 spectrum.
        It supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Ataxia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of ataxia to the MRPL44 mitochondrial translation disorder, supported by the
      clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy,
      which limits exclusive attribution of individual components. No across-variant inevitability is
      asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to ataxia, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity
        and ataxia, and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and
        cerebellar white matter"
      explanation: >-
        This human clinical observation identifies ataxia within the reported MRPL44 spectrum. It supplies
        the endpoint paired with the source’s etiologic interpretation; it does not independently prove
        a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Spasticity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of spasticity to the MRPL44 mitochondrial translation disorder, supported
      by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy,
      which limits exclusive attribution of individual components. No across-variant inevitability is
      asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to spasticity, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity
        and ataxia, and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and
        cerebellar white matter"
      explanation: >-
        This human clinical observation identifies spasticity within the reported MRPL44 spectrum. It
        supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Cognitive Impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of cognitive impairment to the MRPL44 mitochondrial translation disorder,
      supported by the clinical authors’ multisystem interpretation and the specific reported finding.
      Tissue intermediates remain unresolved. The paired endpoint quote concerns the adolescent’s learning
      difficulties. The phenotype also separately records slower processing in the adult isodisomy case,
      but the two patients are not pooled into one cognitive trajectory or frequency.
    evidence:
    - reference: PMID:25797485
      reference_title: MRPL44 mutations cause a slowly progressive multisystem disease with
        childhood-onset hypertrophic cardiomyopathy.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Our findings expand the clinical spectrum associated with MRPL44 mutations and
        indicate that MRPL44-associated mitochondrial dysfunction can also manifest as a progressive
        multisystem disease with central nervous system involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to cognitive impairment, this supports a qualified etiologic route with unresolved tissue
        intermediates, not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic migraines,
        learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in thalami, basal
        ganglia and cerebellum on brain MRI"
      explanation: >-
        This human clinical observation identifies cognitive impairment within the reported MRPL44 spectrum.
        It supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Hemiparesis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of hemiparesis to the MRPL44 mitochondrial translation disorder, supported
      by the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy,
      which limits exclusive attribution of individual components. No across-variant inevitability is
      asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to hemiparesis, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: A fifth patient presented as a young adult with skeletal myopathy and exercise
        intolerance, subclinical cardiac hypertrophy recognized at age 21 years, migraine, transient
        episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia,
        and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and
        cerebellar white matter [6].
      explanation: >-
        This human clinical observation identifies hemiparesis within the reported MRPL44 spectrum. It
        supplies the endpoint paired with the source’s etiologic interpretation; it does not independently
        prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Confusion
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of confusion to the MRPL44 mitochondrial translation disorder, supported by
      the clinical authors’ multisystem interpretation and the specific reported finding. Tissue intermediates
      remain unresolved. The adult p.Leu156Arg case carried complete maternal chromosome 2 isodisomy,
      which limits exclusive attribution of individual components. No across-variant inevitability is
      asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to confusion, this supports a qualified etiologic route with unresolved tissue intermediates,
        not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: A fifth patient presented as a young adult with skeletal myopathy and exercise
        intolerance, subclinical cardiac hypertrophy recognized at age 21 years, migraine, transient
        episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia,
        and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and
        cerebellar white matter [6].
      explanation: >-
        This human clinical observation identifies confusion within the reported MRPL44 spectrum. It supplies
        the endpoint paired with the source’s etiologic interpretation; it does not independently prove
        a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Impaired Executive Functioning
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified attribution of impaired executive functioning to the MRPL44 mitochondrial translation
      disorder, supported by the clinical authors’ multisystem interpretation and the specific reported
      finding. Tissue intermediates remain unresolved. The adult p.Leu156Arg case carried complete maternal
      chromosome 2 isodisomy, which limits exclusive attribution of individual components. No across-variant
      inevitability is asserted.
    evidence:
    - reference: PMID:33742325
      reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
        mitochondrial disease.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
        present as a multisystem disorder with neurological involvement.
      explanation: >-
        The authors attribute the multisystem presentation to MRPL44-related mitochondrial dysfunction.
        Applied to impaired executive functioning, this supports a qualified etiologic route with unresolved
        tissue intermediates, not a measured ATP deficit or an identified neural circuit.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She had normal cognitive function, but as a young adult started to have reduced
        processing speed and executive function.
      explanation: >-
        This human clinical observation identifies impaired executive functioning within the reported
        MRPL44 spectrum. It supplies the endpoint paired with the source’s etiologic interpretation; it
        does not independently prove a specific downstream cellular mechanism.
      directness: INDIRECT
  - target: Left Ventricular Hypertrophy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified mitochondrial etiology of the left ventricular hypertrophy component documented in MRPL44
      cardiomyopathy. The route to cardiac enlargement is not reconstructed, and no anatomical-identity
      arrow from the cardiomyopathy phenotype is used.
    evidence:
    - reference: PMID:23315540
      reference_title: Whole-exome sequencing identifies a mutation in the mitochondrial ribosome
        protein MRPL44 to underlie mitochondrial infantile cardiomyopathy.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: These findings indicate that mitochondrial ribosomal subunit defects can generate
        tissue-specific manifestations, such as cardiomyopathy.
      explanation: >-
        The authors’ cardiac etiologic interpretation supports this case-documented morphological component,
        with unknown intermediates.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "an echocardiogram revealed an ejection fraction of 25% (normal 55–70%) with left ventricular
        dysfunction and hypertrophy"
      explanation: >-
        Documents echocardiographic left ventricular dysfunction and hypertrophy in an affected infant.
  - target: Cardiomegaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Qualified mitochondrial etiology of the cardiomegaly component documented in MRPL44 cardiomyopathy.
      The route to cardiac enlargement is not reconstructed, and no anatomical-identity arrow from the
      cardiomyopathy phenotype is used.
    evidence:
    - reference: PMID:23315540
      reference_title: Whole-exome sequencing identifies a mutation in the mitochondrial ribosome
        protein MRPL44 to underlie mitochondrial infantile cardiomyopathy.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: These findings indicate that mitochondrial ribosomal subunit defects can generate
        tissue-specific manifestations, such as cardiomyopathy.
      explanation: >-
        The authors’ cardiac etiologic interpretation supports this case-documented morphological component,
        with unknown intermediates.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She had cardiomegaly on chest X-ray, and echocardiography showed a very restrictive
        right ventricle and a ballooned left ventricle with barely any unmeasurable contraction and
        blood flow, and she died in cardiac failure shortly after.
      explanation: >-
        Patient 2 had radiographic cardiomegaly during terminal cardiac decompensation.
- name: Failed Compensatory mtDNA Replication and Transcription
  biological_scale: CELLULAR
  description: >-
    In glucose-rich medium, a single p.Leu156Arg patient iPSC-cardiomyocyte line showed about 2.5-fold
    higher mtDNA copy number, elevated mitochondrial transcripts and increased mitochondrial content,
    despite reduced complex I protein. Compensation is the authors’ interpretation of these readouts.
    The observations do not demonstrate that increased DNA replication itself causes the stress response
    seen under a different nutrient condition, or that all patient tissues share this response.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  biological_processes:
  - preferred_term: mitochondrial DNA replication
    term:
      id: GO:0006264
      label: mitochondrial DNA replication
    modifier: INCREASED
  - preferred_term: mitochondrial transcription
    term:
      id: GO:0006390
      label: mitochondrial transcription
    modifier: INCREASED
  evidence:
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The patient CMs showed an increase of 2.5-fold in mtDNA copy number compared to controls"
    explanation: >-
      Quantifies the compensatory mtDNA amplification in patient cardiomyocytes. Preprint evidence from
      a single patient iPSC line.
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Despite this transcriptional upregulation, steady-state complex I protein level was markedly
      reduced"
    explanation: >-
      Shows the compensatory response fails to restore OXPHOS subunit protein. Preprint evidence.
  - reference: PMID:26221731
    reference_title: A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: |-
      qRT-PCR analysis for mitochondrial versus nuclear DNA found that altered Mrpl44 expres-
      sion had no impact on the mitochondrial DNA content of cells ( S4 Fig).
    explanation: >-
      Murine NIH3T3 knockdown/overexpression did not alter mtDNA content. This system-specific counterpoint
      limits generalization of the human cardiomyocyte result, without asserting absence of the response
      in MRPL44 patients.
    directness: INDIRECT
- name: Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes
  biological_scale: CELLULAR
  description: >-
    Lipid-enriched medium induced mitochondrial stress-response and partial ER-stress transcripts in the
    p.Leu156Arg iPSC-cardiomyocyte line, with lipid droplets and altered lipid-uptake/cholesterol genes.
    ATF5 targets increased; FGF21 induction and XBP1 splicing were absent. Fatty-acid utilization was
    inferred from these data rather than directly measured as oxidation flux. Ingenuity pathway analysis
    predicted mTOR changes; direct mTORC1 activation was not measured. The authors propose that nutrient-dependent
    stress promotes hypertrophic growth, a preprint hypothesis requiring replication and in-vivo testing.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  evidence:
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In contrast the lipid-enriched medium triggered both mitochondrial and endoplasmic reticulum
      -related stress responses, disrupted lipid and cholesterol homeostasis, accompanied by remodeling
      of the central biosynthetic pathway of one carbon metabolism."
    explanation: >-
      Documents the nutrient-conditional stress response. Preprint, in vitro, single patient line.
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The cells accumulated lipids while also inducing lipid uptake and synthesis genes, suggesting
      maladaptive metabolic rewiring."
    explanation: >-
      Documents the maladaptive lipid handling in mutant cardiomyocytes.
  downstream:
  - target: Hypertrophic Cardiomyopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Provisional translation of the authors’ hypothesis that perinatal mitochondrial stress promotes
      hypertrophic growth. Evidence comes from one non-isogenic patient/control cell comparison; mTOR
      signaling was predicted and the intervening growth pathway is not established.
    evidence:
    - reference: DOI:10.1101/2025.09.24.678132
      reference_title: Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy
        model
      supports: SUPPORT
      evidence_source: OTHER
      snippet: |-
        Together, the data suggest that perinatal ISRmt
        activation is maladaptive, promoting growth and hypertrophy.
      explanation: >-
        This is the preprint authors’ causal interpretation of the cell data, not a measured clinical
        effect or a direct assay of mTOR activity.
      directness: INDIRECT
    hypothesis_groups:
    - nutrient_dependent_postnatal_manifestation
- name: Combined Complex I and IV Deficiency
  biological_scale: CELLULAR
  description: >-
    Combined respiratory-chain deficiency emphasizes complexes I and IV but varies by patient, tissue
    and preparation. Patient 1 had profound cardiac complex IV and strong complex I deficiency, milder
    muscle deficits and borderline fibroblast complex IV activity, with abnormal complex I/V assembly.
    Patient 2 had multiple muscle deficiencies but normal fibroblast complex I/V assembly and complex
    IV holocomplex; complex IV activity was low only in the mitochondrial isolate. Reduced synthesis of
    mtDNA-encoded subunits supports the OXPHOS defect, but does not fully explain disproportionate complex
    IV involvement.
  biological_processes:
  - preferred_term: mitochondrial respiratory chain complex I assembly
    term:
      id: GO:0032981
      label: mitochondrial respiratory chain complex I assembly
    modifier: DECREASED
  - preferred_term: mitochondrial respiratory chain complex IV assembly
    term:
      id: GO:0033617
      label: mitochondrial respiratory chain complex IV assembly
    modifier: DECREASED
  - preferred_term: oxidative phosphorylation
    term:
      id: GO:0006119
      label: oxidative phosphorylation
    modifier: DECREASED
  evidence:
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and
      IV in the heart and skeletal muscle."
    explanation: >-
      The defining biochemical signature of MRPL44 deficiency in patient tissue.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We document a combined respiratory chain enzyme deficiency with emphasis on complex I and
      IV, affecting heart muscle tissue more than skeletal muscle or fibroblasts."
    explanation: >-
      Replicates the combined CI/CIV deficiency and establishes its tissue gradient.
  - reference: PMID:26221731
    reference_title: "A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "This ultimately impacted ATP synthesis capability and respiratory capacity of cells."
    explanation: >-
      Independent experimental manipulation of Mrpl44 expression reproduces the OXPHOS capacity defect.
  downstream:
  - target: Cardiomyocyte Contractile Element Loss
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The profound cardiac enzyme defect is associated with mitochondrial proliferation and loss of contractile
      elements in the infant biopsy. An injury route from deficient mitochondrial function is supported,
      while the steps producing the structural lesion were not experimentally separated.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: In Patient 1, on electron microscopy, the heart showed areas of contractile element
        loss within the cardiomyocytes and a diffuse proliferation of enlarged, atypically shaped
        mitochondria with aberrant cristae, typical for a mitochondrial cardiomyopathy (Figure
        1A,B).
      explanation: >-
        The cardiac biopsy provides the cellular lesion underlying the proposed indirect contractile-injury
        route; this does not measure myocardial ATP concentration.
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "We document a combined respiratory chain enzyme deficiency with emphasis on complex I
        and IV, affecting heart muscle tissue more than skeletal muscle or fibroblasts."
      explanation: >-
        Replicates the combined CI/CIV deficiency and establishes its tissue gradient.
  - target: Lactic Acidosis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Impaired pyruvate oxidation and altered cytosolic redox balance
    - Reduction of pyruvate to lactate
    description: >-
      Established respiratory-chain physiology supports a qualified contribution of the MRPL44 OXPHOS
      defect to lactic acidosis. Impaired pyruvate oxidation and altered redox balance favor lactate formation.
      The MRPL44 infant had severe lactic metabolic acidosis and a reported elevated lactate/pyruvate
      ratio; the dominant tissue contribution and effects of cardiac dysfunction or illness were not experimentally
      separated. The murine unchanged-ECAR result is not evidence of increased lactate flux.
    evidence:
    - reference: PMID:35806492
      reference_title: The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders.
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: However, when mitochondria are impaired, the resultant inability to fully oxidise
        pyruvate to drive ATP production causes pyruvate to be reduced into lactate.
      explanation: >-
        This biochemical review explains the causal respiratory-chain/pyruvate route. It is general mechanistic
        synthesis, applied indirectly to the clinically established MRPL44 OXPHOS defect, not a new patient
        experiment.
    - reference: PMID:35806492
      reference_title: The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders.
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: When oxidative phosphorylation is impaired, the cytosolic NADH:NAD ratio is
        typically, but not exclusively, raised, which, in turn, reflects the molar ratio of lactate
        to pyruvate (L:P) [6].
      explanation: >-
        The review explains the redox basis of an elevated lactate/pyruvate ratio while noting it is not
        exclusive to OXPHOS disease. It supports the omitted biochemical intermediates, not a MRPL44-specific
        tissue measurement.
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She presented on the second day of life with Kussmaul breathing due to metabolic
        acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2
        mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM).
      explanation: >-
        Patient 2 had severe neonatal lactic metabolic acidosis. This is a directly described occurrence
        with its own measurements, independent of the incomplete historical summary.
- name: Cardiomyocyte Contractile Element Loss
  biological_scale: CELLULAR
  conforms_to: "cardiomyopathy_maladaptive_remodeling#Primary Cardiomyocyte Insult"
  description: >-
    The first 2021 infant’s myocardial biopsy showed areas of contractile element loss and diffuse proliferation
    of enlarged mitochondria with abnormal cristae. This provides a cellular substrate for contractile
    dysfunction. Compensation and displacement are proposed interpretations of the morphology; the biopsy
    does not directly quantify ATP depletion or prove the cause of hypertrophic growth.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  locations:
  - preferred_term: heart
    term:
      id: UBERON:0000948
      label: heart
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The enzyme deficiency was most pronounced in cardiac muscle tissue, where there was massive
      proliferation of mitochondria on electron microscopy displacing contractile elements."
    explanation: >-
      Links the tissue-graded biochemical defect to the cardiac structural pathology.
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "These findings indicate that mitochondrial ribosomal subunit defects can generate tissue-specific
      manifestations, such as cardiomyopathy."
    explanation: >-
      Frames the cardiac-selective manifestation as the central conceptual finding of MRPL44 deficiency.
  downstream:
  - target: Congestive Heart Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Loss of contractile elements provides a plausible structural contribution to ventricular pump failure
      in the biopsied infant; the relation is indirect and the relative contribution of metabolic dysfunction
      versus structural injury is unresolved.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: In Patient 1, on electron microscopy, the heart showed areas of contractile element
        loss within the cardiomyocytes and a diffuse proliferation of enlarged, atypically shaped
        mitochondria with aberrant cristae, typical for a mitochondrial cardiomyopathy (Figure
        1A,B).
      explanation: >-
        Documents myocardial loss of contractile elements in the infant with severe ventricular dysfunction;
        paired clinical evidence identifies the pump-failure phenotype.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: At 51 days of age, a chest radiograph identified cardiomegaly and an echocardiogram
        revealed an ejection fraction of 25% (normal 55–70%) with left ventricular dysfunction and
        hypertrophy.
      explanation: >-
        Documents impaired ventricular function in the same biopsied infant.
      directness: INDIRECT
phenotypes:
- category: Cardiovascular
  name: Hypertrophic Cardiomyopathy
  description: >-
    Hypertrophic cardiomyopathy is the core reported cardiac presentation. Recognition ranges from infancy
    to age 21 years; some children stabilize or improve, whereas severe infantile cases progress to failure.
  phenotype_term:
    preferred_term: Hypertrophic cardiomyopathy
    term:
      id: HP:0001639
      label: Hypertrophic cardiomyopathy
  diagnostic: true
  evidence:
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both patients presented with childhood-onset hypertrophic cardiomyopathy, which seems to
      be the core clinical feature associated with MRPL44 deficiency."
    explanation: >-
      Both patients in this report had childhood-onset HCM, described as the core clinical feature. No
      disease-wide numerical band is inferred from these few reported cases.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients presented as children with hypertrophic cardiomyopathy, had mild lactic acidosis,
      and easy fatigue and muscle weakness."
    explanation: >-
      The introduction summarizes HCM in the five previously reported patients. Five of five is not an
      80–99% estimate, and the candidate 2025 VUS siblings are not added to this denominator. The same
      paragraph records recognition at age 21 in one individual, qualifying the general childhood wording.
- category: Cardiovascular
  name: Left Ventricular Hypertrophy
  description: >-
    Left ventricular hypertrophy with reduced ejection fraction was documented in the first 2021 infant.
    Ventricular function and morphology vary with age and between cases; the second infant initially had
    a prominent left ventricle with normal function.
  phenotype_term:
    preferred_term: Left ventricular hypertrophy
    term:
      id: HP:0001712
      label: Left ventricular hypertrophy
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an echocardiogram revealed an ejection fraction of 25% (normal 55–70%) with left ventricular
      dysfunction and hypertrophy"
    explanation: >-
      Documents echocardiographic left ventricular dysfunction and hypertrophy in an affected infant.
- category: Cardiovascular
  name: Congestive Heart Failure
  description: >-
    Cardiac decompensation with reduced ejection fraction and severe ventricular dysfunction can require
    mechanical circulatory support. Both infants in the 2021 series died: Patient 2 at six months and
    Patient 1 two days after her first birthday following persistent shock, hepatic failure and disseminated
    Candida infection.
  phenotype_term:
    preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She had cardiomegaly on chest X-ray, and echocardiography showed a very restrictive right
      ventricle and a ballooned left ventricle with barely any unmeasurable contraction and blood flow,
      and she died in cardiac failure shortly after."
    explanation: >-
      Documents fatal congestive cardiac failure in an infant with MRPL44 deficiency.
  sequelae:
  - target: Cardiogenic Shock
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The first 2021 infant’s shock was attributed to likely right ventricular failure; this is a case-specific
      clinical causal assessment.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: However, three days after discharge at ten months of age, she was readmitted in
        cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
        ventricular failure.
      explanation: >-
        The authors explicitly propose right ventricular failure as the cause of the shock episode.
      directness: INDIRECT
- category: Metabolic
  name: Lactic Acidosis
  description: >-
    Lactic acidosis ranges from mild historical elevations to severe neonatal metabolic acidosis. Patient
    2 presented on day two with Kussmaul breathing, pH below 7.0, lactate 19 mmol/L and an elevated lactate/pyruvate
    ratio. A respiratory-chain contribution is supported by established mitochondrial pyruvate/redox physiology
    and the documented OXPHOS defect; the relative tissue and illness-related contributions remain unresolved.
  phenotype_term:
    preferred_term: Lactic acidosis
    term:
      id: HP:0003128
      label: Lactic acidosis
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy
      fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological
      symptoms."
    explanation: >-
      The abstract mentions mild lactate elevation in three historical infant presentations but does not
      score the other two as negative. Its body summarizes mild lactate elevation in all five earlier
      cases. Therefore neither four of seven nor a disease-wide frequency band is derived from this sentence.
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She presented on the second day of life with Kussmaul breathing due to metabolic
      acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2
      mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM).
    explanation: >-
      Patient 2 had severe neonatal lactic metabolic acidosis. This is a directly described occurrence
      with its own measurements, independent of the incomplete historical summary.
  sequelae:
  - target: Hyperventilation
    causal_link_type: DIRECT
    description: >-
      The source explicitly attributes neonatal Kussmaul breathing to severe metabolic acidosis with lactate
      elevation.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She presented on the second day of life with Kussmaul breathing due to metabolic
        acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2
        mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM).
      explanation: >-
        Direct clinical attribution of the breathing pattern to metabolic acidosis in Patient 2.
- category: Metabolic
  name: Hypoglycemia
  description: >
    Recurrent, often asymptomatic hypoglycemia was documented in both infants of
    the 2021 series, in one requiring continuous intravenous glucose in the
    neonatal period. Insulin, cortisol, and growth hormone responses during
    hypoglycemia were appropriate, excluding hyperinsulinism.
  phenotype_term:
    preferred_term: Hypoglycemia
    term:
      id: HP:0001943
      label: Hypoglycemia
    temporality: RECURRENT
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe two infants who presented with cardiomyopathy from the neonatal period, failure
      to thrive, hypoglycemia and in one infant lactic acidosis."
    explanation: >-
      Documents hypoglycemia as part of the infantile presentation.
- category: Growth
  name: Failure to Thrive
  description: >
    Poor growth with feeding difficulties requiring nasogastric or gastrostomy
    feeding was prominent in the infantile presentation.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe two infants who presented with cardiomyopathy from the neonatal period, failure
      to thrive, hypoglycemia and in one infant lactic acidosis."
    explanation: >-
      Documents failure to thrive in the infantile presentation.
- category: Musculoskeletal
  name: Muscle Weakness
  description: >-
    Muscle weakness and easy fatigue occur in the reported cardiac and multisystem spectrum. The accessible
    clinical summaries do not establish proximal localization or inevitable progression in every survivor.
  phenotype_term:
    preferred_term: Muscle weakness
    term:
      id: HP:0001324
      label: Muscle weakness
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients presented as children with hypertrophic cardiomyopathy, had mild lactic acidosis,
      and easy fatigue and muscle weakness."
    explanation: >-
      The introduction describes weakness in the five earlier cases. The newly reported infants were not
      separately scored, so no 80–99% disease-wide band is derived from five of five historical reports.
- category: Musculoskeletal
  name: Myopathy
  description: >-
    Skeletal myopathy was reported in a child with mild liver involvement and in the two later multisystem
    presentations. It is distinct from cardiac myopathy and does not imply that every infant develops
    progressive skeletal disease.
  phenotype_term:
    preferred_term: Myopathy
    term:
      id: HP:0003198
      label: Myopathy
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy
      fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological
      symptoms."
    explanation: >-
      Documents myopathy as the presenting feature of the two later-onset patients, distinguishing the
      adolescent/adult phenotype from the infantile cardiac-dominant one.
- category: Musculoskeletal
  name: Exercise Intolerance
  description: >
    Exercise intolerance is a defining feature of the skeletal-muscle arm of the
    disease and was the presenting complaint of the young adult reported with
    subclinical cardiac hypertrophy.
  phenotype_term:
    preferred_term: Exercise intolerance
    term:
      id: HP:0003546
      label: Exercise intolerance
  evidence:
  - reference: ORPHA:352563
    reference_title: "Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases, exercise
      intolerance and muscle weakness"
    explanation: >-
      The Orphanet clinical definition of COXPD16 lists exercise intolerance as a characteristic feature.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A fifth patient presented as a young adult with skeletal myopathy and exercise intolerance,
      subclinical cardiac hypertrophy recognized at age 21 years"
    explanation: >-
      Documents exercise intolerance as a presenting adult feature.
- category: Hepatic
  name: Hepatic Steatosis
  description: >-
    Hepatic steatosis is included in the Orphanet disease definition. The primary abstract reports hepatopathy
    without specifying steatosis; acute hepatic failure during infantile shock is curated separately.
  phenotype_term:
    preferred_term: Hepatic steatosis
    term:
      id: HP:0001397
      label: Hepatic steatosis
  evidence:
  - reference: ORPHA:352563
    reference_title: "Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency
      characterized by hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases,
      exercise intolerance and muscle weakness."
    explanation: >-
      Orphanet's expert clinical definition includes hepatic steatosis with elevated liver transaminases
      as a characteristic feature.
- category: Hepatic
  name: Elevated Hepatic Transaminases
  description: >
    Elevated serum liver transaminases accompany the hepatic involvement of
    MRPL44 deficiency.
  phenotype_term:
    preferred_term: Elevated circulating hepatic transaminase concentration
    term:
      id: HP:0002910
      label: Elevated circulating hepatic transaminase concentration
  evidence:
  - reference: ORPHA:352563
    reference_title: "Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "hepatic steatosis with elevated liver transaminases"
    explanation: >-
      Orphanet clinical definition lists elevated liver transaminases.
- category: Renal
  name: Renal Insufficiency
  description: >
    Renal insufficiency has been reported as part of the late multisystem
    phenotype; acute renal dysfunction also occurs secondary to cardiogenic shock.
  phenotype_term:
    preferred_term: Renal insufficiency
    term:
      id: HP:0000083
      label: Renal insufficiency
  evidence:
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
      retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
    explanation: >-
      Reports renal insufficiency among the additional features of the two patients in this series. No
      frequency band is assigned: the source enumerates features without per-patient attribution or any
      count, so any band would be unsupported.
- category: Ophthalmological
  name: Pigmentary Retinopathy
  description: >-
    Pigmentary retinopathy, also described as tapetoretinal dystrophy, was reported in the adolescent
    multisystem presentation. It is a possible later manifestation, not an inevitable consequence of surviving
    infancy.
  phenotype_term:
    preferred_term: Pigmentary retinopathy
    term:
      id: HP:0000580
      label: Pigmentary retinopathy
  evidence:
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
      retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
    explanation: >-
      Reports pigmentary retinopathy among the late features observed in this two-patient series. No frequency
      band is assigned - the source gives no count or qualitative frequency term.
- category: Neurological
  name: Hemiplegic Migraine
  description: >
    Hemiplegic migraine with transient episodes of hemiparesis and confusion has
    been reported in older MRPL44-deficient patients, typically alongside
    Leigh-like brain MRI lesions.
  phenotype_term:
    preferred_term: Hemiplegic migraine
    term:
      id: HP:0002076
      label: Migraine
  evidence:
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
      retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
    explanation: >-
      The two-case report includes hemiplegic migraine. The generic Migraine binding retains the motor
      subtype in the name: the current HPO Migraine with aura definition explicitly excludes motor weakness,
      and no dedicated hemiplegic-migraine HP term was retrieved. No frequency is inferred.
- category: Neurological
  name: Ataxia
  description: >
    Ataxia and spasticity were described in the young adult with cerebellar and
    subcortical white matter lesions on brain MRI.
  phenotype_term:
    preferred_term: Ataxia
    term:
      id: HP:0001251
      label: Ataxia
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity
      and ataxia, and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and
      cerebellar white matter"
    explanation: >-
      The clinical summary records ataxia in the adult with maternal chromosome 2 isodisomy and homozygous
      p.Leu156Arg. It supplies occurrence, not a disease-wide frequency.
  notes: >-
    This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant
    paper summarizes the original Horga report.
- category: Neurological
  name: Spasticity
  description: >
    Spasticity accompanied the ataxia and Leigh-like MRI changes in the adult
    multisystem presentation.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "transient episodes of neurological dysfunction of hemiparesis and confusion, spasticity
      and ataxia, and on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and
      cerebellar white matter"
    explanation: >-
      Documents spasticity in the adult multisystem presentation.
  notes: >-
    This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant
    paper summarizes the original Horga report.
- category: Neurodevelopmental
  name: Cognitive Impairment
  description: >-
    Learning difficulties were reported in the adolescent case; reduced processing speed emerged in the
    young adult who previously had normal cognition. No particular academic skill deficit, IQ range or
    global developmental delay is established by these descriptions. Executive dysfunction is recorded
    separately.
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic migraines,
      learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in thalami, basal
      ganglia and cerebellum on brain MRI"
    explanation: >-
      The report names learning difficulties without identifying a specific academic-skill deficit or
      excluding general cognitive impairment in that individual; the broader cognitive term avoids an
      unsupported specific-learning-disability claim.
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She had normal cognitive function, but as a young adult started to have reduced
      processing speed and executive function.
    explanation: >-
      The adult case developed slower processing after previously normal cognition; this supports acquired
      cognitive impairment, without an IQ or dementia claim.
  notes: >-
    Learning difficulties refer to the adolescent case; slower processing and impaired executive function
    refer to the adult with maternal chromosome 2 isodisomy. These are different clinical observations,
    not a combined frequency denominator.
- name: Feeding Difficulties in Infancy
  category: Gastrointestinal
  description: >-
    Severe oral feeding difficulty required nasogastric and later gastrostomy support in the first 2021
    infant.
  phenotype_term:
    preferred_term: Feeding difficulties in infancy
    term:
      id: HP:0008872
      label: Feeding difficulties in infancy
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She had feeding difficulties taking only 10 to 30% of her feeds orally with the
      remainder provided by nasogastric tube feeding.
    explanation: >-
      Only 10–30% of feeds were taken orally in Patient 1.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
  sequelae:
  - target: Failure to Thrive
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Inadequate oral intake plausibly contributed to poor growth in Patient 1; adequate weight gain on
      gastrostomy feeding supports a nutritional component, without excluding cardiac/metabolic contributors.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She had feeding difficulties taking only 10 to 30% of her feeds orally with the
        remainder provided by nasogastric tube feeding.
      explanation: >-
        Documents substantially inadequate oral intake in Patient 1.
      directness: INDIRECT
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Over the next months, the child showed adequate weight gain using gastrostomy
        feedings but remained unable to take adequate oral feedings.
      explanation: >-
        Weight gain improved with tube feeding despite persistent oral difficulty, supporting a qualified
        nutritional contribution.
      directness: INDIRECT
- name: Hypothermia
  category: Metabolic
  description: >-
    A neonatal episode of hypothermia preceded recognition of cardiac disease.
  phenotype_term:
    preferred_term: Hypothermia
    term:
      id: HP:0002045
      label: Hypothermia
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Following vaginal delivery at 396/7 weeks gestation, during the neonatal period the
      girl had an episode of hypothermia and was persistently hypoglycemic (lowest 16 mg/dL), which
      was treated with continuous intravenous glucose.
    explanation: >-
      Documents hypothermia in Patient 1; its relationship to hypoglycemia or mitochondrial dysfunction
      was not separately established.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
- name: Hyperventilation
  category: Respiratory
  description: >-
    Kussmaul breathing accompanied severe neonatal lactic metabolic acidosis in Patient 2.
  phenotype_term:
    preferred_term: Hyperventilation
    term:
      id: HP:0002883
      label: Hyperventilation
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She presented on the second day of life with Kussmaul breathing due to metabolic
      acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2
      mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM).
    explanation: >-
      The authors explicitly attribute the Kussmaul breathing to metabolic acidosis; no primary pulmonary
      disorder is asserted.
- name: Hyperammonemia
  category: Metabolic
  description: >-
    Mild hyperammonemia (180 μM) occurred with neonatal acidosis in Patient 2; subsequent ammonia values
    were normal.
  phenotype_term:
    preferred_term: Hyperammonemia
    term:
      id: HP:0001987
      label: Hyperammonemia
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She presented on the second day of life with Kussmaul breathing due to metabolic
      acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2
      mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM).
    explanation: >-
      Documents the transient early ammonia elevation, not sustained hyperammonemia.
- name: Cardiomegaly
  category: Cardiovascular
  description: >-
    Cardiomegaly was observed radiographically in both severely affected 2021 infants.
  phenotype_term:
    preferred_term: Cardiomegaly
    term:
      id: HP:0001640
      label: Cardiomegaly
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She had cardiomegaly on chest X-ray, and echocardiography showed a very restrictive
      right ventricle and a ballooned left ventricle with barely any unmeasurable contraction and
      blood flow, and she died in cardiac failure shortly after.
    explanation: >-
      Patient 2 had radiographic cardiomegaly during terminal cardiac decompensation.
- name: Cardiogenic Shock
  category: Cardiovascular
  description: >-
    Cardiogenic shock at ten months was attributed to probable right ventricular failure.
  phenotype_term:
    preferred_term: Cardiogenic shock
    term:
      id: HP:0030149
      label: Cardiogenic shock
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: However, three days after discharge at ten months of age, she was readmitted in
      cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
      ventricular failure.
    explanation: >-
      Documents cardiogenic shock in the acute decompensation episode. The proposed cardiac cause is qualified
      by the authors as likely.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
  sequelae:
  - target: Hypotension
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The hypotension component belongs to the same acute episode attributed to probable ventricular failure.
      This qualified circulatory attribution does not extend to chronic symptoms or the earlier RSV episode.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: However, three days after discharge at ten months of age, she was readmitted in
        cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
        ventricular failure.
      explanation: >-
        The sentence places hypotension within the acute clinically attributed shock episode; no separate
        tissue mechanism was measured.
      directness: INDIRECT
  - target: Lethargy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The lethargy component belongs to the same acute episode attributed to probable ventricular failure.
      This qualified circulatory attribution does not extend to chronic symptoms or the earlier RSV episode.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: However, three days after discharge at ten months of age, she was readmitted in
        cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
        ventricular failure.
      explanation: >-
        The sentence places lethargy within the acute clinically attributed shock episode; no separate
        tissue mechanism was measured.
      directness: INDIRECT
  - target: Hypoxemia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The hypoxemia component belongs to the same acute episode attributed to probable ventricular failure.
      This qualified circulatory attribution does not extend to chronic symptoms or the earlier RSV episode.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: However, three days after discharge at ten months of age, she was readmitted in
        cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
        ventricular failure.
      explanation: >-
        The sentence places hypoxemia within the acute clinically attributed shock episode; no separate
        tissue mechanism was measured.
      directness: INDIRECT
  - target: Renal Insufficiency
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Renal dysfunction developed despite inotropic and mechanical circulatory support during shock. A
      secondary low-output contribution is plausible in this episode, without explaining the separately
      reported chronic renal involvement.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She required multiple inotropic medication, and placement of a Berlin heart left
        ventricular assist device, but still developed liver and renal dysfunction.
      explanation: >-
        Documents renal dysfunction during persistent circulatory failure; secondary causation is a qualified
        clinical inference.
      directness: INDIRECT
  - target: Hepatic Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Hepatic failure persisted during severe cardiogenic shock. The clinical course supports a secondary
      circulatory contribution, without proving that all hepatic injury was ischemic.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: She remained in cardiogenic shock and hepatic failure, and ultimately developed
        disseminated Candida lusitanease infection which resulted in her death two days after her
        first birthday.
      explanation: >-
        Records persistent hepatic failure during shock; infection and underlying mitochondrial disease
        also limit exclusive causal attribution.
      directness: INDIRECT
  - target: Hypoglycemia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The authors include hypoglycemia in the acute episode attributed to probable right ventricular failure.
      This qualified exacerbation route applies to that episode; hypoglycemia was already present neonatally,
      so it does not explain the intrinsic recurrent phenotype.
    evidence:
    - reference: PMID:34140213
      reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
        mitochondrial translation defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: However, three days after discharge at ten months of age, she was readmitted in
        cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
        ventricular failure.
      explanation: >-
        The acute clinical causal assessment includes hypoglycemia, while earlier independent neonatal
        episodes establish that shock is not its sole cause.
      directness: INDIRECT
- name: Hypotension
  category: Cardiovascular
  description: >-
    Hypotension accompanied the cardiogenic shock episode.
  phenotype_term:
    preferred_term: Hypotension
    term:
      id: HP:0002615
      label: Hypotension
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: However, three days after discharge at ten months of age, she was readmitted in
      cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
      ventricular failure.
    explanation: >-
      Documents hypotension in the acute decompensation episode. The proposed cardiac cause is qualified
      by the authors as likely.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
- name: Lethargy
  category: Neurological
  description: >-
    Lethargy occurred during acute cardiogenic shock; chronic neurological impairment is not implied.
  phenotype_term:
    preferred_term: Lethargy
    term:
      id: HP:0001254
      label: Lethargy
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: However, three days after discharge at ten months of age, she was readmitted in
      cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
      ventricular failure.
    explanation: >-
      Documents lethargy in the acute decompensation episode. The proposed cardiac cause is qualified
      by the authors as likely.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
- name: Hypoxemia
  category: Respiratory
  description: >-
    Hypoxia occurred during cardiogenic shock and during a separate respiratory viral infection; no measured
    arterial oxygen value was supplied.
  phenotype_term:
    preferred_term: Hypoxemia
    term:
      id: HP:0012418
      label: Hypoxemia
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: However, three days after discharge at ten months of age, she was readmitted in
      cardiogenic shock, hypotensive, hypoglycemic, lethargic and hypoxic, likely due to right
      ventricular failure.
    explanation: >-
      Documents hypoxemia in the acute decompensation episode. The proposed cardiac cause is qualified
      by the authors as likely.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
- name: Hepatic Failure
  category: Hepatic
  description: >-
    Persistent hepatic failure developed during the infantile shock course despite circulatory support.
  phenotype_term:
    preferred_term: Hepatic failure
    term:
      id: HP:0001399
      label: Hepatic failure
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She remained in cardiogenic shock and hepatic failure, and ultimately developed
      disseminated Candida lusitanease infection which resulted in her death two days after her
      first birthday.
    explanation: >-
      Patient 1 had hepatic failure during severe circulatory decompensation; this is distinct from chronic
      hepatopathy or steatosis.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
- name: Respiratory Failure
  category: Respiratory
  description: >-
    Respiratory failure lasting ten days accompanied RSV infection at nine months and resolved to baseline
    before the later shock admission.
  phenotype_term:
    preferred_term: Respiratory failure
    term:
      id: HP:0002878
      label: Respiratory failure
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: At nine months of age during a respiratory syncytial viral infection, she was admitted
      for hypoxia and had respiratory failure for ten days after which she recovered back to
      baseline.
    explanation: >-
      The acute respiratory failure was infection-associated. It does not establish primary chronic pulmonary
      involvement from MRPL44.
  notes: >-
    This was Patient 1 (p.Leu156Arg/p.Thr161Serfs*2), who also had a 16q23.3 deletion; the finding is
    case-scoped and not solely attributed to MRPL44.
- name: Hemiparesis
  category: Neurological
  description: >-
    Transient hemiparesis episodes occurred in the adult multisystem presentation.
  phenotype_term:
    preferred_term: Hemiparesis
    term:
      id: HP:0001269
      label: Hemiparesis
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: A fifth patient presented as a young adult with skeletal myopathy and exercise
      intolerance, subclinical cardiac hypertrophy recognized at age 21 years, migraine, transient
      episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia, and
      on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and cerebellar
      white matter [6].
    explanation: >-
      The source specifically records hemiparesis among the transient neurological episodes.
  notes: >-
    This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant
    paper summarizes the original Horga report.
- name: Confusion
  category: Neurological
  description: >-
    Transient confusion episodes occurred in the adult multisystem presentation.
  phenotype_term:
    preferred_term: Confusion
    term:
      id: HP:0001289
      label: Confusion
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: A fifth patient presented as a young adult with skeletal myopathy and exercise
      intolerance, subclinical cardiac hypertrophy recognized at age 21 years, migraine, transient
      episodes of neurological dysfunction of hemiparesis and confusion, spasticity and ataxia, and
      on brain MRI lesions in basal ganglia, thalami and midbrain and subcortical and cerebellar
      white matter [6].
    explanation: >-
      The source specifically records confusion among the transient neurological episodes.
  notes: >-
    This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant
    paper summarizes the original Horga report.
- name: Impaired Executive Functioning
  category: Neurological
  description: >-
    Executive function declined in young adulthood after previously normal cognition.
  phenotype_term:
    preferred_term: Impaired executive functioning
    term:
      id: HP:0033051
      label: Impaired executive functioning
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She had normal cognitive function, but as a young adult started to have reduced
      processing speed and executive function.
    explanation: >-
      The adult clinical summary explicitly describes diminished executive function.
  notes: >-
    This is the adult p.Leu156Arg homozygote with complete maternal chromosome 2 isodisomy; the 2021 infant
    paper summarizes the original Horga report.
- name: Fatigue
  category: Musculoskeletal
  description: >-
    Easy fatigue was described in the earlier clinical cases, separately from weakness.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: All patients presented as children with hypertrophic cardiomyopathy, had mild lactic
      acidosis, and easy fatigue and muscle weakness.
    explanation: >-
      The historical five-case summary records easy fatigue; it does not establish a representative frequency
      band.
imaging_findings:
- name: Leigh-Like Lesions on Brain MRI
  modality: MRI
  description: >
    Symmetric signal abnormalities of the thalami, basal ganglia, midbrain, and
    cerebellar and subcortical white matter resembling Leigh syndrome have been
    documented in older MRPL44-deficient patients. No brain MRI abnormality has
    been reported in the infantile cardiac-dominant presentation, but infant
    neuroimaging is sparse - one neonate had a normal cranial ultrasound and no
    infant brain MRI has been published, so the apparent sparing is unconfirmed.
  phenotype_term:
    preferred_term: Abnormal basal ganglia MRI signal intensity
    term:
      id: HP:0012751
      label: Abnormal basal ganglia MRI signal intensity
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Five patients have been described with compound heterozygous or homozygous pathogenic variants
      in MRPL44 ... The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic
      migraines, learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in
      thalami, basal ganglia and cerebellum on brain MRI ... A fifth patient presented as a young
      adult with skeletal myopathy and exercise intolerance, subclinical cardiac hypertrophy
      recognized at age 21 years, migraine, transient episodes of neurological dysfunction of
      hemiparesis and confusion, spasticity and ataxia, and on brain MRI lesions in basal ganglia,
      thalami and midbrain and subcortical and cerebellar white matter
    explanation: >-
      Restores MRPL44 attribution and the older patients' ages, including the explicitly Leigh-like
      case before the more detailed regional MRI findings. The excerpt does not establish an absence
      of infant CNS disease from sparse imaging.
  - reference: ORPHA:352563
    reference_title: "Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Neuro-opthalmological features (hemiplegic migraine, Leigh-like lesions on brain MRI, pigmentary
      retinopathy) have been reported later in life."
    explanation: >-
      Orphanet's clinical definition lists Leigh-like brain MRI lesions as a late-onset feature.
- name: Cardiomegaly on Chest Radiograph
  modality: XRAY
  description: >
    Cardiomegaly on plain chest radiography was the first objective sign of
    cardiac involvement in one infant, prompting the echocardiogram that revealed
    left ventricular hypertrophy and a depressed ejection fraction.
  phenotype_term:
    preferred_term: Cardiomegaly
    term:
      id: HP:0001640
      label: Cardiomegaly
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a chest radiograph identified cardiomegaly and an echocardiogram revealed an ejection fraction
      of 25%"
    explanation: >-
      Documents radiographic cardiomegaly with echocardiographic confirmation.
histopathology:
- name: Mitochondrial Proliferation with Aberrant Cristae in Cardiomyocytes
  description: >
    Electron microscopy of myocardial biopsy shows a diffuse proliferation of
    enlarged, atypically shaped mitochondria with aberrant cristae together with
    areas of contractile element loss - the classic ultrastructural picture of a
    mitochondrial cardiomyopathy.
  diagnostic: true
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In Patient 1, on electron microscopy, the heart showed areas of contractile element loss
      within the cardiomyocytes and a diffuse proliferation of enlarged, atypically shaped mitochondria
      with aberrant cristae, typical for a mitochondrial cardiomyopathy"
    explanation: >-
      Direct ultrastructural description of the cardiac histopathology.
- name: Abnormal Skeletal Muscle Mitochondria without Ragged Red Fibers
  description: >
    Skeletal muscle shows abnormal mitochondria with granular content and
    abnormal cristae, and enlarged mitochondria in some fibers. Notably, Gomori
    trichrome staining did not reveal ragged blue fibers and there were no
    cytochrome c oxidase-negative fibers, so routine mitochondrial muscle
    histochemistry can be unrevealing in MRPL44 deficiency.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In Patient 2, on light microscopy skeletal muscle showed abnormal mitochondria with granular
      content and abnormal cristae, and in some fibers enlarged mitochondria were noted."
    explanation: >-
      Describes the skeletal muscle mitochondrial abnormalities.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Gomori trichrome staining did not reveal ragged blue fibers, and there were no cytochrome
      c oxidase negative fibers."
    explanation: >-
      Establishes that the standard mitochondrial myopathy histochemical markers may be absent, an important
      diagnostic caveat.
- name: Central Cores in Skeletal Muscle Fibers
  description: >-
    Patient 2 had some fibers with central cores and some hypercontracted fibers at three months. Ragged
    blue and COX-negative fibers were absent. This isolated observation is not evidence for a second primary
    central-core myopathy.
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Histology showed some fibers with central cores and some hypercontracted fibers.
    explanation: >-
      Documents the additional muscle biopsy finding in Patient 2; it is not a separate causal mechanism.
biochemical:
- name: Increased circulating lactate concentration
  presence: INCREASED
  context: >
    Elevated blood lactate, generally mild but occasionally severe. One neonate
    had persistent lactic acidemia of 3.3 to 15 mmol/L unrelated to feeding, with
    an elevated lactate/pyruvate ratio indicating a respiratory chain rather than
    a pyruvate dehydrogenase defect.
  biomarker_term:
    preferred_term: Increased circulating lactate concentration
    term:
      id: HP:0002151
      label: Increased circulating lactate concentration
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The persistent lactic acidemia (3.3 to 15 mmol/L, normal < 2 mM) did not change in relation
      to feeding"
    explanation: >-
      Quantifies the persistent elevation of blood lactate.
  readouts:
  - target: Lactic Acidosis
    relationship: READOUT_OF
    description: >-
      Blood lactate measures the lactate component; acidosis additionally requires acid-base assessment,
      as documented in the severe neonatal episode.
    evidence:
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The persistent lactic acidemia (3.3 to 15 mmol/L, normal < 2 mM) did not change in relation
        to feeding"
      explanation: >-
        Blood lactate measures the lactate component; acidosis additionally requires acid-base assessment,
        as documented in the severe neonatal episode.
- name: Reduced cytochrome c oxidase (complex IV) enzyme activity
  presence: DECREASED
  biomarker_term:
    preferred_term: Decreased activity of mitochondrial complex IV
    term:
      id: HP:0008347
      label: Decreased activity of mitochondrial complex IV
  context: >
    The most consistently and most severely reduced respiratory chain activity.
    In cardiac tissue complex IV activity is profoundly decreased; in skeletal
    muscle it is severely to mildly decreased; in fibroblasts it is only
    borderline low, and may only be detectable in a mitochondrial isolate rather
    than a whole-cell homogenate.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "in Patient 1 respiratory chain enzyme activities showed a combined deficiency of the activities
      of respiratory chain enzyme complexes in heart tissue, with a profound decrease in complex IV and
      a strong decrease in complex I, and a mild decrease of complex II-III"
    explanation: >-
      Quantifies the tissue-specific respiratory chain enzyme deficiencies.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In fibroblasts the respiratory chain enzyme activities were normal in the 600 × g homogenate,
      but showed low complex IV activity in a mitochondrial isolate."
    explanation: >-
      Important diagnostic caveat - fibroblast whole-homogenate assays can miss the complex IV defect.
  readouts:
  - target: Combined Complex I and IV Deficiency
    relationship: READOUT_OF
    description: >-
      The complex IV enzyme assay reports this component of the respiratory-chain defect; tissue and homogenate
      preparation affect sensitivity.
    evidence:
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "in Patient 1 respiratory chain enzyme activities showed a combined deficiency of the activities
        of respiratory chain enzyme complexes in heart tissue, with a profound decrease in complex IV
        and a strong decrease in complex I, and a mild decrease of complex II-III"
      explanation: >-
        The complex IV enzyme assay reports this component of the respiratory-chain defect; tissue and
        homogenate preparation affect sensitivity.
- name: Reduced NADH:ubiquinone oxidoreductase (complex I) enzyme activity
  presence: DECREASED
  biomarker_term:
    preferred_term: Decreased activity of mitochondrial complex I
    term:
      id: HP:0011923
      label: Decreased activity of mitochondrial complex I
  context: >
    Complex I activity is strongly reduced in cardiac tissue and mildly to
    moderately reduced in skeletal muscle, completing the combined complex I and
    IV deficiency signature.
  evidence:
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and
      IV in the heart and skeletal muscle."
    explanation: >-
      Documents combined complex I and IV deficiency in patient heart and muscle.
  readouts:
  - target: Combined Complex I and IV Deficiency
    relationship: READOUT_OF
    description: >-
      The complex I activity assay reports this component of the combined respiratory-chain defect in
      the sampled tissue.
    evidence:
    - reference: PMID:23315540
      reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
        MRPL44 to underlie mitochondrial infantile cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and
        IV in the heart and skeletal muscle."
      explanation: >-
        The complex I activity assay reports this component of the combined respiratory-chain defect in
        the sampled tissue.
- name: Reduced mitochondrial protein synthesis in fibroblasts
  presence: DECREASED
  context: >
    Quantitative 35S-amino-acid incorporation into mtDNA-encoded polypeptides is
    reduced to approximately one third of control values in fibroblasts from a
    patient with a missense/frameshift genotype, and to approximately half in a
    patient with a missense/missense genotype - a functional assay that both
    confirms the translation defect and grades allele severity.
  cell_types:
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "clearly decreased synthesis of mitochondrial proteins at 2.23 ± 0.48 fmol AA/μg protein,
      33% of the average incorporation (p<0.01)"
    explanation: >-
      Quantifies the translation deficit in the missense/frameshift patient's fibroblasts at 33% of control
      incorporation.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial
      protein synthesis due to different pathogenic variants."
    explanation: >-
      The authors relate the two genotypes to differing residual translation and OXPHOS dysfunction. Patient
      2 retained 56% with p=0.08; no validated clinical severity prediction follows.
  readouts:
  - target: Impaired Mitochondrial Translation
    relationship: READOUT_OF
    description: >-
      Radiolabeled amino-acid incorporation reports mitochondrial protein synthesis in cultured fibroblasts,
      without a validated clinical severity cutoff.
    evidence:
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "clearly decreased synthesis of mitochondrial proteins at 2.23 ± 0.48 fmol AA/μg protein,
        33% of the average incorporation (p<0.01)"
      explanation: >-
        Radiolabeled amino-acid incorporation reports mitochondrial protein synthesis in cultured fibroblasts,
        without a validated clinical severity cutoff.
- name: Reduced MT-CO1 protein with preserved nuclear-encoded ATP5F1B
  presence: DECREASED
  context: >
    Western blotting shows reduced MT-CO1 (a mtDNA-encoded complex IV subunit) in
    all tissues examined while the nuclear-encoded ATP synthase subunit ATP5F1B
    is normal - a discriminating pattern that localizes the defect to
    mitochondrial rather than cytosolic translation.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The amount of MT-CO1 was decreased in all tissues, but the amount of ATP5FB1 was normal"
    explanation: >-
      Patient 1 measurements include heart and skeletal muscle biopsies as well as fibroblasts (Figure
      2A–C), showing reduced MT-CO1 with preserved nuclear-encoded ATP5F1B. The snippet retains the source
      spelling ATP5FB1. This is protein abundance, not an enzyme-activity measurement; a separately cited
      Patient 2 fibroblast-only assay would be IN_VITRO.
  readouts:
  - target: Combined Complex I and IV Deficiency
    relationship: READOUT_OF
    description: >-
      Reduced MT-CO1 is a protein-abundance readout supporting the OXPHOS defect; it is not itself an
      activity assay. Preserved ATP5F1B is an internal nuclear-encoded comparator.
    evidence:
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The amount of MT-CO1 was decreased in all tissues, but the amount of ATP5FB1 was normal"
      explanation: >-
        Patient 1 measurements include heart and skeletal muscle biopsies as well as fibroblasts (Figure
        2A–C), showing reduced MT-CO1 with preserved nuclear-encoded ATP5F1B. The snippet retains the
        source spelling ATP5FB1. This is protein abundance, not an enzyme-activity measurement; a separately
        cited Patient 2 fibroblast-only assay would be IN_VITRO.
genetic:
- name: MRPL44 biallelic pathogenic variants
  gene_term:
    preferred_term: MRPL44
    term:
      id: hgnc:16650
      label: MRPL44
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    MRPL44 (2q36.1) encodes mL44, a 39S mitoribosomal protein with an RNase III-like domain spanning residues
    86–228. Patient genotypes containing p.Leu156Arg, p.Leu156Pro or p.Thr161Serfs*2 showed reduced mL44
    abundance; the compound-heterozygous assays did not resolve residual protein from each individual
    allele. The p.Arg78Gln allele and the 2025 p.(Trp66_His69delinsCysAsn) allele lie outside that domain.
    The reviewed sources do not establish allele-specific protein-abundance effects for them; the 2025
    delins interpretation is computational and its formal classification remains VUS. These case reports
    do not establish population allele frequencies or validated modifier effects.
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    description: >
      Disease requires biallelic MRPL44 variants - homozygous in consanguineous
      or founder settings, compound heterozygous otherwise. One reported patient
      became homozygous through complete maternal uniparental isodisomy of
      chromosome 2 rather than by biparental transmission, so a homozygous MRPL44
      result with only one carrier parent should prompt uniparental disomy
      testing (and altered recurrence-risk counselling) rather than being
      dismissed as non-paternity.
    evidence:
    - reference: PMID:23315540
      reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
        MRPL44 to underlie mitochondrial infantile cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "We investigated the genetic basis for infantile onset recessive hypertrophic cardiomyopathy
        in two siblings."
      explanation: >-
        Establishes recessive inheritance in the index sibship.
    - reference: PMID:33742325
      reference_title: "Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem mitochondrial
        disease."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Short-tandem repeat and genome-wide SNP microarray analyses of the family trio confirmed
        complete maternal uniparental isodisomy of chromosome 2."
      explanation: >-
        Documents uniparental isodisomy as an alternative route to MRPL44 homozygosity, with direct counselling
        implications.
  variants:
  - name: MRPL44 c.467T>G, p.(Leu156Arg)
    description: >
      The recurrent missense allele, present in 9 of the first 10 published
      disease alleles. It is located in the conserved hydrophobic pocket of the
      RNase III-like domain and strongly reduces mL44 protein levels while
      leaving some residual protein and activity. Homozygotes have been reported
      with both fatal infantile cardiomyopathy and with later-onset multisystem
      disease, so genotype alone does not predict the clinical course.
    gene:
      preferred_term: MRPL44
      term:
        id: hgnc:16650
        label: MRPL44
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:23315540
      reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
        MRPL44 to underlie mitochondrial infantile cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Exome sequencing uncovered a homozygous mutation (L156R) in MRPL44 of both siblings."
      explanation: >-
        First identification of the recurrent p.Leu156Arg allele.
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The variant c.467T>G; p.(Leu156Arg) is a commonly recurring causal pathogenic variant
        present in 9 of 10 alleles published"
      explanation: >-
        Quantifies the dominance of this allele in the published cohort.
  - name: MRPL44 c.233G>A, p.(Arg78Gln)
    description: >
      A missense allele identified in compound heterozygosity with the recurrent
      p.Leu156Arg variant in a patient with childhood-onset hypertrophic
      cardiomyopathy plus late multisystem features. No clinical_significance is
      recorded here deliberately: unlike the other four alleles, p.Arg78Gln has
      never been assigned a formal ACMG classification in the literature and has
      not been functionally assayed (no protein-abundance, mitoribosome-assembly,
      or translation data exist for it), so any classification would be curator
      invention rather than a sourced claim.
    gene:
      preferred_term: MRPL44
      term:
        id: hgnc:16650
        label: MRPL44
    evidence:
    - reference: PMID:25797485
      reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
        hypertrophic cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we identified two further unrelated patients harboring the previously reported mutation
        c.467T > G, p.Leu156Arg in MRPL44 in the homozygous state and compound heterozygous with a novel
        missense mutation c.233G > A, p.Arg78Gln, respectively."
      explanation: >-
        Reports the p.Arg78Gln allele in trans with p.Leu156Arg.
  - name: MRPL44 c.481_484delinsTC, p.(Thr161Serfs*2)
    description: >
      A frameshift allele predicted to trigger nonsense-mediated decay or produce
      a premature stop codon, i.e. a true null. In trans with p.Leu156Arg it
      produced the most severe biochemical phenotype in the published series -
      mitochondrial protein synthesis at roughly a third of controls - and fatal
      infantile cardiomyopathy.
    gene:
      preferred_term: MRPL44
      term:
        id: hgnc:16650
        label: MRPL44
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "The variant in Patient 1 c.481_484delinsTC p.Thr161Serfs*2 is predicted to cause either
        nonsense-mediated mRNA decay or a premature stop codon."
      explanation: >-
        Defines this allele as a predicted null.
  - name: MRPL44 c.467T>C, p.(Leu156Pro)
    description: >-
      A second substitution at Leu156, observed in trans with p.Leu156Arg. The authors predict a disruptive
      proline substitution. Reduced mL44 abundance was measured in the compound-heterozygous cells, without
      assigning residual protein specifically to the proline allele.
    gene:
      preferred_term: MRPL44
      term:
        id: hgnc:16650
        label: MRPL44
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:34140213
      reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
        translation defect."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The additional variant in Patient 2 affected the same amino acid Leu156, but the change
        was to proline instead of arginine."
      explanation: >-
        Documents a second pathogenic substitution at the Leu156 hotspot.
  - name: MRPL44 c.198_205delinsTA, p.(Trp66_His69delinsCysAsn)
    description: >
      A homozygous delins allele reported in a Tunisian family with severe
      hypertrophic cardiomyopathy affecting two siblings. It shortens the protein
      and was absent from ClinVar and HGMD at the time of reporting; formal ACMG
      classification was VUS, with pathogenicity supported by co-segregation and
      in silico structural modelling rather than by functional assays.
    gene:
      preferred_term: MRPL44
      term:
        id: hgnc:16650
        label: MRPL44
    clinical_significance: UNCERTAIN_SIGNIFICANCE
    evidence:
    - reference: PMID:40402202
      reference_title: "A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44)
        associated with hypertrophic cardiomyopathy in Tunisian patients."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The proband harboured a homozygous variant, NM_022915.5: c.198_205delinsTA; p.(Trp66_His69
        delinsCysAsn), in the MRPL44 gene, leading to a shorter protein."
      explanation: >-
        Reports the novel Tunisian allele.
    - reference: PMID:40402202
      reference_title: "A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44)
        associated with hypertrophic cardiomyopathy in Tunisian patients."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "In silico analysis showed significant structural differences in the mutated mL44 protein,
        disrupting its interaction with ribosomal complex components and impairing translation and protein
        synthesis."
      explanation: >-
        Pathogenicity rests on in silico modelling rather than functional assay, so the mechanistic claim
        remains an untested computational prediction.
    - reference: PMID:40402202
      reference_title: "A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44)
        associated with hypertrophic cardiomyopathy in Tunisian patients."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "This variant is novel, being absent in ClinVar and Human Gene Mutation Database (HGMD)
        and classified as VUS according to American College of Medical Genetics and Genomics (ACMG) criteria."
      explanation: >-
        Records the formal ACMG classification as VUS.
  evidence:
  - reference: PMID:30384889
    reference_title: "Genetic Basis of Severe Childhood-Onset Cardiomyopathies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disease genes converge on metabolic causes (PRKAG2, MRPL44, AARS2, HADHB, DNAJC19, PPA2,
      TAZ, BAG3), MAPK pathways (HRAS, PTPN11, RAF1, TAB2), development (NEK8 and TBX20), calcium signaling
      (JPH2, CALM1, CACNA1C), and the sarcomeric contraction cycle (TNNC1, TNNI3, ACTC1, MYH7, NRAP)."
    explanation: >-
      A countrywide severe childhood cardiomyopathy cohort places MRPL44 among the established metabolic
      cardiomyopathy genes.
differential_diagnoses:
- name: MRPL3-related combined oxidative phosphorylation deficiency (COXPD9)
  disease_term:
    preferred_term: Combined oxidative phosphorylation defect type 9
    term:
      id: MONDO:0013811
      label: combined oxidative phosphorylation defect type 9
  description: >-
    The closest mimic. MRPL3 encodes another protein of the same large (39S)
    mitoribosomal subunit, so COXPD9 shares the exact mechanism - a mitoribosomal
    translation defect - and presents with infantile-onset severe hypertrophic
    cardiomyopathy, failure to thrive, raised lactate, abnormal liver enzymes and
    a combined respiratory chain deficiency.
  distinguishing_features:
  - >-
    Only molecular testing separates them reliably. COXPD9 characteristically
    involves complexes I, III, IV and V, whereas MRPL44 deficiency shows the
    complex I and IV emphasis; COXPD9 also features prominent psychomotor delay
    and hepatomegaly from infancy, while MRPL44 cognition is typically normal in
    infancy with neurological features deferred to the second and third decades.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of these, cardiomyopathy has for instance been described in the following genes: AARS2,
      YARS2, GARS, KARS, MRPL3, MRPS22, MRPS14, MRPL44, TSFM, RMND1, MTO1, HSD17B10, ELAC2, TRMT5, GTPBP3
      [3]."
    explanation: >-
      Lists MRPL3 alongside MRPL44 among the mitochondrial translation genes causing cardiomyopathy.
- name: MTO1 deficiency (mitochondrial hypertrophic cardiomyopathy with lactic acidosis)
  disease_term:
    preferred_term: Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1
      deficiency
    term:
      id: MONDO:0013865
      label: mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency
  description: >-
    A mitochondrial tRNA-modification (rather than mitoribosomal structural)
    translation defect presenting with infantile hypertrophic cardiomyopathy and
    lactic acidosis. Clinically near-indistinguishable from MRPL44 deficiency at
    presentation, and a documented source of named-entity confusion in the
    literature and in automated curation.
  distinguishing_features:
  - >-
    Molecular. MTO1 acts on mt-tRNA taurinomethyl modification, not on the 39S
    subunit; lactic acidosis is typically more severe and more consistently
    present in MTO1 deficiency, and MTO1 patients more often show early
    encephalopathy.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of these, cardiomyopathy has for instance been described in the following genes: AARS2,
      YARS2, GARS, KARS, MRPL3, MRPS22, MRPS14, MRPL44, TSFM, RMND1, MTO1, HSD17B10, ELAC2, TRMT5, GTPBP3
      [3]."
    explanation: >-
      Lists MTO1 among the mitochondrial translation cardiomyopathy genes.
- name: Other mitochondrial translation-defect cardiomyopathies
  description: >-
    A broader group of nuclear mitochondrial translation genes causes
    biochemically indistinguishable infantile cardiomyopathy with combined
    respiratory chain deficiency: aminoacyl-tRNA synthetases (AARS2, YARS2, GARS,
    KARS), other mitoribosomal proteins (MRPS22, MRPS14), elongation and assembly
    factors (TSFM, RMND1), and tRNA-modifying enzymes (ELAC2, TRMT5, GTPBP3,
    HSD17B10).
  distinguishing_features:
  - >-
    Not separable on respiratory chain enzymology or muscle histology; requires a
    nuclear mitochondrial gene panel, exome, or genome. This is the practical
    argument for not stopping at a targeted cardiomyopathy panel.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of these, cardiomyopathy has for instance been described in the following genes: AARS2,
      YARS2, GARS, KARS, MRPL3, MRPS22, MRPS14, MRPL44, TSFM, RMND1, MTO1, HSD17B10, ELAC2, TRMT5, GTPBP3
      [3]."
    explanation: >-
      Enumerates the mitochondrial translation genes in which cardiomyopathy has been described, defining
      this differential group.
- name: SLC25A3-related cardiomyopathy-hypotonia-lactic acidosis syndrome
  disease_term:
    preferred_term: Cardiomyopathy-hypotonia-lactic acidosis syndrome
    term:
      id: MONDO:0012557
      label: cardiomyopathy-hypotonia-lactic acidosis syndrome
  description: >-
    Mitochondrial phosphate-carrier deficiency presenting with infantile
    hypertrophic cardiomyopathy, hypotonia, and lactic acidosis - overlapping the
    MRPL44 infantile presentation closely enough to be a recognized confusable
    entity.
  distinguishing_features:
  - >-
    Mechanistically distinct: a solute-carrier (substrate import) defect rather
    than a translation defect, so mitochondrial protein synthesis and
    mitoribosome assembly are normal and the respiratory chain deficiency pattern
    differs. Marked hypotonia is a more prominent early feature.
- name: Non-mitochondrial metabolic and sarcomeric infantile cardiomyopathies
  description: >-
    Pompe disease (glycogen storage disease II), Barth syndrome (TAZ),
    fatty-acid-oxidation defects, and primary sarcomeric hypertrophic
    cardiomyopathy all present with infantile or childhood hypertrophic
    cardiomyopathy.
  distinguishing_features:
  - >-
    These are separable without sequencing: Pompe by acid alpha-glucosidase
    enzyme assay and marked creatine kinase elevation; Barth by cyclic
    3-methylglutaconic aciduria, neutropenia and X-linked inheritance;
    fatty-acid-oxidation defects by a diagnostic acylcarnitine profile; sarcomeric
    HCM by dominant inheritance, later onset, and the absence of lactic acidosis
    or combined respiratory chain deficiency.
diagnosis:
- name: Molecular genetic testing of MRPL44
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  description: >-
    Diagnosis is molecular. Every reported case was solved by exome sequencing or
    a nuclear mitochondrial-disease/cardiomyopathy panel that includes MRPL44;
    notably, a targeted comprehensive cardiomyopathy panel was non-diagnostic in
    one infant, so a mitochondrial-inclusive panel or trio exome is preferred.
    When a homozygous variant appears with only one carrier parent, add
    short-tandem-repeat and SNP-microarray testing for uniparental disomy.
  results: >-
    Biallelic (homozygous or compound heterozygous) pathogenic MRPL44 variants
    confirm the diagnosis.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical exome sequencing demonstrated compound heterozygosity for pathogenic variants in
      the MRPL44 gene"
    explanation: >-
      Documents exome sequencing as the confirmatory diagnostic test.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a comprehensive cardiomyopathy sequencing panel did not report any variants."
    explanation: >-
      Important diagnostic caveat - a standard cardiomyopathy gene panel missed the diagnosis, arguing
      for exome or a mitochondrial-inclusive panel.
- name: Respiratory chain enzymology of heart and skeletal muscle
  diagnosis_term:
    preferred_term: respiratory chain enzyme assay
  description: >-
    Respiratory-chain enzyme activity measurements can support the diagnosis, but yield varies by tissue,
    patient and preparation. In the extensively studied first 2021 infant, the cardiac defect was profound,
    muscle involvement milder and fibroblast complex IV activity borderline. The second infant had normal
    fibroblast whole-homogenate activities but low complex IV activity in a mitochondrial isolate, so
    a normal whole-homogenate result does not exclude the disorder.
  results: >-
    Combined deficiency of complexes I and IV, most marked in cardiac tissue.
  evidence:
  - reference: PMID:23315540
    reference_title: "Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein
      MRPL44 to underlie mitochondrial infantile cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Analysis of respiratory chain enzymes revealed a combined deficiency of complexes I and
      IV in the heart and skeletal muscle."
    explanation: >-
      Establishes the diagnostic biochemical signature.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In fibroblasts the respiratory chain enzyme activities were normal in the 600 × g homogenate,
      but showed low complex IV activity in a mitochondrial isolate."
    explanation: >-
      Documents the false-negative risk of fibroblast whole-homogenate enzymology.
- name: Skeletal muscle biopsy with mitochondrial histochemistry
  diagnosis_term:
    preferred_term: muscle biopsy
    term:
      id: NCIT:C51895
      label: Muscle Biopsy
  description: >-
    Muscle biopsy shows ultrastructurally abnormal mitochondria, but the routine
    mitochondrial-myopathy histochemical markers can be entirely absent, so a
    normal Gomori trichrome and COX stain does not exclude the diagnosis.
  results: >-
    Abnormal mitochondria with granular content and abnormal cristae, without
    ragged red/blue fibers and without COX-negative fibers.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Gomori trichrome staining did not reveal ragged blue fibers, and there were no cytochrome
      c oxidase negative fibers."
    explanation: >-
      Establishes that the standard mitochondrial myopathy histochemical markers may be absent in MRPL44
      deficiency.
- name: Mitochondrial protein synthesis (translation) assay
  diagnosis_term:
    preferred_term: mitochondrial translation assay
  description: >-
    Specialist 35S-amino-acid incorporation assays can demonstrate impaired mitochondrial translation
    in patient fibroblasts. The two 2021 patients differed in residual incorporation and OXPHOS assays,
    but this does not establish a validated clinical-severity or novel-variant classification test.
  results: >-
    Reduced incorporation of labelled amino acids into mtDNA-encoded
    polypeptides, proportional to the severity of the genotype.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial
      protein synthesis due to different pathogenic variants."
    explanation: >-
      The two-patient functional comparison supports measuring residual translation, not a validated prognostic
      or variant-classification threshold.
- name: Echocardiography
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  description: >-
    Echocardiography establishes and monitors the defining cardiac phenotype and
    is the basis for surveillance in at-risk siblings and in survivors of the
    infantile presentation.
  results: >-
    Left ventricular hypertrophy with variably depressed ejection fraction.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an echocardiogram revealed an ejection fraction of 25% (normal 55–70%) with left ventricular
      dysfunction and hypertrophy"
    explanation: >-
      Documents the echocardiographic findings that define the cardiac phenotype.
treatments:
- name: Supportive Heart Failure Management
  description: >
    No disease-modifying therapy exists. Care is supportive and cardiac-directed:
    beta blockade and standard anti-failure pharmacotherapy, nutritional support
    via nasogastric or gastrostomy feeding, avoidance of catabolic stress, and
    surveillance echocardiography. Intercurrent infection is a recognized trigger
    of fatal cardiac decompensation.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patient responded well to treatment and was discharged at 71 days of life while being
      treated with beta blockers and receiving feeding mainly via gastrostomy tube."
    explanation: >-
      Documents beta blockade and enteral nutritional support as the initial management, with initial
      clinical response.
- name: Beta Blocker Therapy
  description: >
    Beta blockade is the specific anti-failure pharmacotherapy documented in
    MRPL44 deficiency; an affected infant was discharged on beta blockers with
    gastrostomy feeding after an initial clinical response, although the
    cardiomyopathy later decompensated fatally.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: beta-adrenergic antagonist
      term:
        id: NCIT:C29576
        label: Beta-Adrenergic Antagonist
  therapeutic_modality: SMALL_MOLECULE
  target_phenotypes:
  - preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patient responded well to treatment and was discharged at 71 days of life while being
      treated with beta blockers and receiving feeding mainly via gastrostomy tube."
    explanation: >-
      Documents beta blockade in an affected infant with an initial response. This is single-case, uncontrolled
      use extrapolated from general pediatric heart failure practice, not MRPL44-specific efficacy data.
- name: Genetic Counseling
  description: >
    Autosomal recessive counselling with a specific caveat: one reported patient
    was homozygous through complete maternal uniparental isodisomy of chromosome
    2 rather than biparental transmission. A homozygous MRPL44 result with only
    one carrier parent should therefore prompt uniparental disomy testing, since
    the recurrence risk differs substantially from the standard 25%.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:33742325
    reference_title: "Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem mitochondrial
      disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Short-tandem repeat and genome-wide SNP microarray analyses of the family trio confirmed
      complete maternal uniparental isodisomy of chromosome 2."
    explanation: >-
      Establishes uniparental isodisomy as a documented route to homozygosity in MRPL44 disease, which
      directly changes recurrence-risk counselling.
- name: Mechanical Circulatory Support
  description: >
    Ventricular assist device placement and venoarterial extracorporeal membrane
    oxygenation have been used aggressively in infants with MRPL44-related
    cardiogenic shock, on the rationale that some patients stabilize after the
    first year. In the published case this did not prevent death from multiorgan
    failure and opportunistic infection, so the benefit is unproven.
  treatment_term:
    preferred_term: ventricular assist device placement
    term:
      id: NCIT:C80452
      label: Ventricular Assist Device Placement
  therapeutic_modality: DEVICE
  target_mechanisms:
  - target: Congestive Heart Failure
    treatment_effect: INHIBITS
    description: >-
      Mechanical unloading substitutes for the failing bioenergetically depleted
      myocardium; it does not correct the underlying translation defect.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "aggressive management including left ventricle assist device was performed in the case presented
      here."
    explanation: >-
      Documents the use of mechanical circulatory support and its rationale.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She remained in cardiogenic shock and hepatic failure, and ultimately developed disseminated
      Candida lusitanease infection which resulted in her death two days after her first birthday."
    explanation: >-
      Shows that mechanical support did not rescue the reported infant, so efficacy is unestablished.
- name: Cardiac Transplantation
  description: >-
    The clinical authors considered cardiac transplantation for infantile MRPL44 cardiomyopathy. Their
    stated caveat is that progressive neurological and other extra-cardiac involvement may emerge later.
    This is a proposed clinical option, not a reported transplant outcome, and does not imply that OXPHOS
    deficiency was measured in every organ.
  treatment_term:
    preferred_term: heart transplantation
    term:
      id: NCIT:C15246
      label: Heart Transplantation
  therapeutic_modality: SURGERY
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "We were considering cardiac transplantation as an option in this condition in infancy, bearing
      in mind that in adolescence a progressive clinical involvement including neurological symptoms may
      still occur."
    explanation: >-
      States both the rationale for and the principal caveat against cardiac transplantation in MRPL44
      deficiency.
- name: Mitochondrial Biogenesis Induction (Investigational)
  description: >-
    The authors propose increasing mL44 abundance with mitochondrial-biogenesis approaches such as NRF2,
    PGC-1-alpha or PPAR-delta activation. This is untested in MRPL44 deficiency and is not established
    by the two-patient residual-translation comparison. The cardiomyocyte preprint shows increased mtDNA/transcripts
    despite reduced complex I protein, limiting the assumption that more biogenesis alone restores function.
  treatment_term:
    preferred_term: investigational pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Biallelic MRPL44 Loss of Function and mL44 Protein Depletion
    treatment_effect: INHIBITS
    description: >-
      Raising MRPL44 transcription is proposed to partially compensate for the
      reduced steady-state abundance of the destabilized mL44 protein.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Since the amount of residual activity is related to translational efficiency, to improve
      the function and perhaps allow infants to recover from the cardiac dysfunction, increasing the amount
      of ml44 should be considered."
    explanation: >-
      States the therapeutic hypothesis. Indirect support because the paper proposes but does not test
      this strategy.
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "MRPL44 deficiency impairs mitochondrial translation but induces mtDNA replication and transcription
      in iPSC-derived cardiomyocytes."
    explanation: >-
      Tempers the biogenesis-induction rationale - patient cardiomyocytes already mount a biogenesis response
      that fails to correct the translation block. Preprint, in vitro.
discussions:
- discussion_id: gap_disproportionate_complex_iv_deficiency
  prompt: >-
    Why is complex IV activity disproportionately reduced relative to complex I
    in MRPL44 deficiency, when the measured synthesis rates of complex I and
    complex IV mtDNA-encoded subunits are similarly depressed and complex I has
    more than twice as many mtDNA-encoded subunits?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired Mitochondrial Translation
  - pathophysiology#Combined Complex I and IV Deficiency
  rationale: >-
    In most mitochondrial transcription and translation defects, complex I (seven
    mtDNA-encoded subunits) is more affected than complex IV (three) simply
    through subunit stoichiometry. MRPL44 deficiency inverts this, as do LRPPRC
    and TACO1 disease. The 2021 functional study excluded the obvious explanation
    by showing that the newly synthesized complex IV subunits (MT-CO1, MT-CO2,
    MT-CO3) were reduced to approximately the same degree as complex I subunits
    (average 30.1% versus 34.3% of controls, not significantly different). A
    difference in post-synthetic stability of the assembled subunits was proposed
    but could not be excluded or confirmed. Resolving this matters because a
    complex IV-selective post-translational bottleneck would be a different
    therapeutic target from generic mitoribosome insufficiency.
  proposed_experiments:
  - experiment_id: exp_mrpl44_cox_subunit_pulse_chase
    name: Pulse-chase stability assay of mtDNA-encoded complex IV versus complex I subunits
    description: >-
      In MRPL44-patient and isogenic corrected cardiomyocytes, perform 35S
      pulse-chase labelling with quantification of the decay rate of newly
      synthesized MT-CO1/2/3 versus MT-ND subunits, to test whether the excess
      complex IV deficit arises from accelerated degradation of unassembled
      cytochrome c oxidase subunits rather than from unequal synthesis.
    experiment_type:
      preferred_term: pulse-chase protein stability assay
    model_systems:
    - name: Patient iPSC-derived cardiomyocyte
      description: >-
        MRPL44-mutant patient iPSC-derived cardiomyocytes with isogenic corrected
        controls, providing the human cardiac context where the biochemical defect
        is most severe.
      experimental_model_type: OTHER
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The reason for this more pronounced defect in complex IV is not clear."
    explanation: >-
      The authors explicitly state that this mechanistic question is unresolved.
- discussion_id: mismatch_yeast_mrpl3_l156r_equivalent
  prompt: >-
    Can the yeast MrpL3/mL44 homolog or a mouse Mrpl44 knockout serve as a valid
    model for human MRPL44 disease alleles, given that the human disease mutation
    modelled at the equivalent yeast residue does not impair function and that
    mouse null loss is embryonically lethal?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Biallelic MRPL44 Loss of Function and mL44 Protein Depletion
  - pathophysiology#Large Mitoribosomal Subunit Assembly Defect
  rationale: >-
    Yeast MrpL3/mL44 is the tractable genetic model for mL44 function, and
    mutagenesis of its conserved hydrophobic pocket does identify residues
    critical for assembling translationally active mitoribosomes. However, the
    exact human disease substitution modelled at the equivalent yeast residue
    (A186) had no major functional impact, and the authors concluded the two
    orthologs have diverged in evolution. Mouse Mrpl44 loss is a different kind of
    mismatch: knockout is embryonically lethal, whereas human patients carry
    hypomorphic alleles with residual protein and survive with tissue-restricted
    disease. Neither model therefore reproduces the human hypomorphic,
    cardiac-selective genotype-phenotype relationship, and both should be treated
    as tools for general mitoribosome biology rather than as MRPL44 disease
    models. Patient-derived iPSC cardiomyocytes are the emerging replacement, but
    the only published line covers a single genotype and the work remains a
    preprint.
  proposed_experiments:
  - experiment_id: exp_mrpl44_isogenic_ipsc_cardiomyocyte
    name: Isogenic MRPL44 iPSC-derived cardiomyocyte allelic series
    description: >-
      Engineer an allelic series (p.Leu156Arg, p.Leu156Pro, p.Thr161Serfs*2, and
      corrected wild type) in a common human iPSC background, differentiate to
      cardiomyocytes, and quantify mL44 abundance, 39S assembly, mitochondrial
      translation, complex I and IV activity, and contractile function, testing
      whether the human cardiac context reproduces the allele-severity gradient
      that neither yeast nor mouse captures.
    experiment_type:
      preferred_term: isogenic iPSC-derived cardiomyocyte allelic series
    model_systems:
    - name: Human iPSC-derived cardiomyocyte
      description: >-
        Cardiomyocytes differentiated from gene-edited human iPSCs carrying the
        reported MRPL44 disease alleles, preserving the human sequence context
        that diverges from yeast MrpL3.
      experimental_model_type: OTHER
  evidence:
  - reference: PMID:38950860
    reference_title: "Importance of conserved hydrophobic pocket region in yeast mitoribosomal mL44 protein
      for mitotranslation and transcript preference."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "the introduction of the disease-related mutation into the equivalent position in the yeast
      protein (residue A186) was found to not have a major impact on function"
    explanation: >-
      Directly demonstrates that the yeast ortholog does not phenocopy the human disease allele.
  - reference: PMID:38950860
    reference_title: "Importance of conserved hydrophobic pocket region in yeast mitoribosomal mL44 protein
      for mitotranslation and transcript preference."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The human and yeast mL44 proteins share many similarities in sequence and structure; however
      results presented here indicate that these two proteins have diverged somewhat in evolution."
    explanation: >-
      The authors themselves flag the evolutionary divergence limiting model validity.
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In mice, it is expressed widely throughout multiple tissues during development and its absence
      is embryonically lethal"
    explanation: >-
      Mouse null lethality contrasts with the survivable, tissue-restricted human hypomorphic phenotype,
      the second arm of the model mismatch.
- discussion_id: gap_cardiac_tissue_selectivity
  prompt: >-
    What determines the striking tissue gradient of MRPL44 deficiency, in which
    heart muscle shows profound respiratory chain deficiency, skeletal muscle
    intermediate, and fibroblasts only borderline changes, despite comparable
    reduction of mL44 protein in all three tissues?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Cardiomyocyte Contractile Element Loss
  rationale: >-
    mL44 protein levels are reduced in heart, skeletal muscle, and fibroblasts
    alike, yet the enzymatic and clinical consequences are overwhelmingly
    cardiac. Candidate explanations include the higher OXPHOS flux demand and
    mitochondrial density of the myocardium, the postnatal switch to fatty-acid
    oxidation (the nutrient-dependent hypothesis), tissue-specific differences in
    mitoribosome assembly-factor buffering, and a possible transcript hierarchy in
    mitochondrial translation - the yeast work showed that MrpL3/mL44 mutation
    does not affect all mtDNA-encoded transcripts equally. Distinguishing a
    threshold effect from a genuinely cardiac-specific mechanism is required
    before extrapolating any therapy tested in fibroblasts to the heart.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There are tissue specific differences. The enzyme deficiency was most pronounced in cardiac
      muscle tissue, where there was massive proliferation of mitochondria on electron microscopy displacing
      contractile elements."
    explanation: >-
      Documents the tissue gradient that this gap seeks to explain.
  - reference: PMID:38950860
    reference_title: "Importance of conserved hydrophobic pocket region in yeast mitoribosomal mL44 protein
      for mitotranslation and transcript preference."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we observed that mutation of the MrpL3/mL44 does not impact the translation of all mitochondrial
      encoded proteins equally, suggesting the mitochondrial translation system may exhibit a transcript
      hierarchy and prioritization."
    explanation: >-
      Offers a candidate mechanism (transcript hierarchy) for differential consequences, though demonstrated
      in yeast rather than human tissue.
- discussion_id: gap_nutrient_dependent_hypothesis_validation
  prompt: >-
    Does the postnatal glucose-to-fatty-acid fuel switch causally trigger
    MRPL44 hypertrophic cardiomyopathy in vivo, and does the ISRmt/lipid-handling
    arm represent a tractable therapeutic target distinct from OXPHOS repletion?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Nutrient-Dependent Metabolic Stress Response in Cardiomyocytes
  rationale: >-
    The nutrient-dependent model is currently supported by a single unreviewed
    preprint using one patient iPSC line in short-term culture, with immature
    in-vitro cardiomyocyte physiology. It is mechanistically attractive because it
    would explain the otherwise puzzling perinatal timing of disease onset, and
    because it points to a stress-signalling rather than purely bioenergetic
    target. It must not, however, be translated into fat restriction, ketogenic
    diet, or any other dietary manipulation: no clinical evidence supports this,
    and fasting/catabolic stress is itself a recognized hazard in mitochondrial
    disease. Replication across genotypes, in matured or engineered heart tissue,
    and ideally in vivo is required.
  proposed_experiments:
  - experiment_id: exp_mrpl44_fuel_switch_replication
    name: Multi-genotype nutrient-switch replication in matured cardiac tissue
    description: >-
      Replicate the glucose-versus-lipid comparison across at least three MRPL44
      genotypes plus isogenic controls in maturation-promoted engineered heart
      tissue, with longitudinal transcriptomics, lipidomics, contractile force,
      and ISRmt readouts, and test whether pharmacological ISRmt attenuation
      rescues the lipid-condition phenotype.
    experiment_type:
      preferred_term: engineered heart tissue nutrient-switch assay
    model_systems:
    - name: Engineered human heart tissue
      description: >-
        Maturation-promoted 3D engineered heart tissue from MRPL44-mutant and
        isogenic control iPSCs, addressing the immaturity limitation of monolayer
        iPSC cardiomyocytes.
      experimental_model_type: OTHER
  evidence:
  - reference: DOI:10.1101/2025.09.24.678132
    reference_title: "Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our findings indicate that glucose and lipids, the latter being the postnatally favored
      cardiac fuel, exert remarkably different consequences in MRPL44 deficient cardiomyocytes."
    explanation: >-
      States the finding whose in-vivo validity and therapeutic tractability are the open question. Preprint,
      single patient line.
- discussion_id: mrpl44_metabolic_and_feeding_attribution
  prompt: Which mechanisms account for early metabolic and feeding findings?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - phenotypes#Lactic Acidosis
  - phenotypes#Hypoglycemia
  - phenotypes#Hypothermia
  - phenotypes#Hyperammonemia
  - phenotypes#Feeding Difficulties in Infancy
  - phenotypes#Failure to Thrive
  rationale: >-
    The infant report establishes neonatal acidosis, hypoglycemia and feeding difficulty, with transient
    hyperammonemia in Patient 2 and hypothermia in Patient 1. A qualified OXPHOS-to-lactic-acidosis route
    is represented using established pyruvate/redox physiology and the MRPL44 clinical measurements; missing
    tissue-level reconstruction does not negate that relation. The precise tissue contribution and possible
    cardiac/illness amplification remain unresolved. Intrinsic hypoglycemia, hypothermia, hyperammonemia
    and feeding difficulty are less causally localized by these sources. Hypoglycemia preceded cardiac
    shock; the shock link concerns its acute exacerbation only. Feeding insufficiency has a supported
    nutritional route to poor growth. Patient 1 also carried a 16q23.3 deletion. No blanket ATP-depletion
    fanout is asserted.
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: She presented on the second day of life with Kussmaul breathing due to metabolic
      acidosis (pH < 7.0, base excess – 27 mEq/L), with elevated lactate 19 mmol/L (normal < 2
      mmol/L) and mildly elevated ammonia 180 μM (normal < 100 μM).
    explanation: >-
      Patient 2’s neonatal metabolic episode defines the acidosis, breathing and ammonia findings; the
      source does not resolve the intrinsic metabolic pathway.
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We describe two infants who presented with cardiomyopathy from the neonatal period,
      failure to thrive, hypoglycemia and in one infant lactic acidosis.
    explanation: >-
      The two-infant clinical summary establishes the recurring metabolic/growth presentation, not its
      separate tissue mechanisms.
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Chromosomal microarray revealed a deletion of 16q23.3
    explanation: >-
      The first infant’s additional chromosome deletion limits exclusive attribution of every isolated
      finding to MRPL44.
- discussion_id: mrpl44_chronic_hepatorenal_attribution
  prompt: What distinguishes chronic hepatorenal involvement from acute circulatory complications?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - phenotypes#Hepatic Steatosis
  - phenotypes#Elevated Hepatic Transaminases
  - phenotypes#Renal Insufficiency
  - phenotypes#Hepatic Failure
  rationale: >-
    Chronic renal insufficiency and hepatopathy occur in the multisystem literature; the Orphanet definition
    specifies steatosis and elevated transaminases. These sources do not establish a renal cell compartment
    or demonstrate a liver-specific lipid/ATP pathway. The infant’s renal dysfunction and hepatic failure
    during shock support separately qualified secondary circulatory routes, which must not be transferred
    to the chronic organ findings. Cardiac iPSC lipid droplets are not evidence for a hepatocyte steatosis
    mechanism.
  evidence:
  - reference: ORPHA:352563
    reference_title: "Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency
      characterized by hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases,
      exercise intolerance and muscle weakness."
    explanation: >-
      Orphanet's expert clinical definition includes hepatic steatosis with elevated liver transaminases
      as a characteristic feature.
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
      retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
    explanation: >-
      Reports renal insufficiency among the additional features of the two patients in this series. No
      frequency band is assigned: the source enumerates features without per-patient attribution or any
      count, so any band would be unsupported.
- discussion_id: mrpl44_respiratory_infection_scope
  prompt: Does MRPL44 deficiency directly cause respiratory failure?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - phenotypes#Respiratory Failure
  - phenotypes#Hypoxemia
  rationale: >-
    The source reports respiratory failure during RSV infection with recovery to baseline, followed by
    a separate cardiac shock admission. A direct MRPL44 pulmonary or respiratory-muscle mechanism was
    not established. The source-supported acidosis-to-Kussmaul route and qualified shock-to-hypoxia route
    explain those particular components without explaining the infection itself.
  evidence:
  - reference: PMID:34140213
    reference_title: Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a
      mitochondrial translation defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: At nine months of age during a respiratory syncytial viral infection, she was admitted
      for hypoxia and had respiratory failure for ten days after which she recovered back to
      baseline.
    explanation: >-
      The acute respiratory failure was infection-associated. It does not establish primary chronic pulmonary
      involvement from MRPL44.
- discussion_id: mrpl44_multisystem_intermediates
  prompt: Which tissue mechanisms mediate the clinically attributed multisystem syndrome?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired Mitochondrial Translation
  - phenotypes#Myopathy
  - phenotypes#Muscle Weakness
  - phenotypes#Exercise Intolerance
  - phenotypes#Fatigue
  - phenotypes#Hemiplegic Migraine
  - phenotypes#Pigmentary Retinopathy
  - phenotypes#Ataxia
  - phenotypes#Spasticity
  - phenotypes#Cognitive Impairment
  - phenotypes#Hemiparesis
  - phenotypes#Confusion
  - phenotypes#Impaired Executive Functioning
  rationale: >-
    The clinical reports explicitly attribute the multisystem disorder to MRPL44-related mitochondrial
    dysfunction, and Horga links the adult phenotype to a demonstrable translation defect. Those qualified
    causal attributions are represented even though intervening tissue mechanisms are unknown. No measured
    chronic ATP deficit is claimed in kidney, liver, retina or brain, and MRI distribution alone is not
    taken as proof that a particular lesion causes ataxia, spasticity or migraine. Case-specific modifiers
    remain possible, particularly in the chromosome 2 isodisomy case.
  evidence:
  - reference: PMID:33742325
    reference_title: Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem
      mitochondrial disease.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: confirms that MRLP44 mutations cause a mitochondrial translation defect that may
      present as a multisystem disorder with neurological involvement.
    explanation: >-
      The authors’ causal interpretation supports the broad syndrome attribution while leaving tissue
      intermediates unresolved.
    directness: INDIRECT
  - reference: PMID:25797485
    reference_title: MRPL44 mutations cause a slowly progressive multisystem disease with
      childhood-onset hypertrophic cardiomyopathy.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Our findings expand the clinical spectrum associated with MRPL44 mutations and indicate
      that MRPL44-associated mitochondrial dysfunction can also manifest as a progressive
      multisystem disease with central nervous system involvement.
    explanation: >-
      The independent clinical report supports a multisystem mitochondrial interpretation, without identifying
      specific downstream cellular mediators.
    directness: INDIRECT
- discussion_id: mrpl44_source_and_phenotype_scope
  prompt: How were the sparse clinical sources and phenotype terms scoped?
  kind: INTERPRETATION
  status: OPEN
  attaches_to:
  - phenotypes#Cognitive Impairment
  - phenotypes#Hemiplegic Migraine
  rationale: >-
    The 2013, 2015 and adult-2021 primary abstracts were read, and detailed case observations were checked
    against the full 2021 infant paper, which explicitly summarizes the earlier cases. Accessible DOI
    fetches did not provide full text of the 2015 or adult-2021 reports; no inaccessible table was treated
    as read. GeneReviews PMID20301403 is an umbrella overview, not an MRPL44-specific chapter or phenotype
    baseline. Cognitive impairment replaces a specific-learning-disability term because the source does
    not identify a particular academic skill deficit. Migraine is retained as the broader binding because
    the current Migraine with aura HPO definition excludes motor weakness and a dedicated hemiplegic term
    was not retrieved. Regional Leigh-like MRI findings remain in imaging_findings; central cores and
    hypercontracted fibers are preserved as biopsy observations, not invented causal nodes.
  evidence:
  - reference: PMID:34140213
    reference_title: "Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial
      translation defect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The fourth patient from age 14 years on developed cardiomyopathy, hemiplegic migraines,
      learning difficulties, myopathy, tapetoretinal dystrophy, and Leigh-like lesions in thalami, basal
      ganglia and cerebellum on brain MRI"
    explanation: >-
      The report names learning difficulties without identifying a specific academic-skill deficit or
      excluding general cognitive impairment in that individual; the broader cognitive term avoids an
      unsupported specific-learning-disability claim.
  - reference: PMID:25797485
    reference_title: "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset
      hypertrophic cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, we observed several additional clinical signs and symptoms including pigmentary
      retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy."
    explanation: >-
      The two-case report includes hemiplegic migraine. The generic Migraine binding retains the motor
      subtype in the name: the current HPO Migraine with aura definition explicitly excludes motor weakness,
      and no dedicated hemiplegic-migraine HP term was retrieved. No frequency is inferred.

📚

References & Deep Research

References

8

PMID:23315540

Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy.

No top-level findings curated for this source.

PMID:25797485

MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy.

No top-level findings curated for this source.

PMID:34140213

Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial translation defect.

No top-level findings curated for this source.

PMID:33742325

Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem mitochondrial disease.

No top-level findings curated for this source.

PMID:40402202

A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44) associated with hypertrophic cardiomyopathy in Tunisian patients.

No top-level findings curated for this source.

DOI:10.1101/2025.09.24.678132

Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model

No top-level findings curated for this source.

PMID:20301403

Primary Mitochondrial Disorders Overview.

No top-level findings curated for this source.

PMID:35806492

The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders.

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: MRPL44 Deficiency · 2026-08-01T17:29:39Z · View source

De novo curation of MRPL44 Deficiency (COXPD16, MONDO:0014162, OMIM 615395, ORPHA:352563, gene MRPL44 / hgnc:16650), an ultra-rare autosomal recessive mitoribosomal large-subunit 39S translation defect causing infantile hypertrophic cardiomyopathy with combined complex I and IV deficiency. NEC preflight was run against MONDO:0014162 via OAK and confirmed gene MRPL44, OMIM:615395, and the COXPD16 synonym; the entry is explicitly distinguished from MTO1 deficiency (MONDO:0013865) and from SLC25A3 cardiomyopathy-hypotonia-lactic acidosis syndrome, which are separate entries. Duplicate preflight against origin/main, all PRs, and all issues found no prior coverage. Deep research used Edison/Falcon via just research-disorder falcon MRPL44_Deficiency (640 s, 22 citations); the report was verified on-target and used only as leads. All literature was independently fetched with just fetch-reference and every snippet verified as an exact substring of the cached text. Primary sources: PMID:23315540 Carroll 2013 index family with L156R, 39S assembly and 16S rRNA defect, retroviral rescue; PMID:25797485 Distelmaier 2015 late multisystem and neuro-ophthalmological spectrum; PMID:34140213 Friederich 2021 full text with tissue-graded combined CI/CIV deficiency, quantitative mitochondrial translation assay, cardiac electron microscopy and allelic series; PMID:33742325 Horga 2021 maternal uniparental isodisomy of chromosome 2 as a route to homozygosity; PMID:40402202 Gargouri 2025 novel Tunisian delins allele classified ACMG VUS; PMID:26221731 and PMID:38950860 Mrpl44 and yeast MrpL3 functional work; PMID:30384889 KidCMP childhood cardiomyopathy cohort; ORPHA:352563 Orphanet clinical definition with the cache rebuilt via just structured-rebuild-orphanet; and DOI:10.1101/2025.09.24.678132 Pradhan 2025 bioRxiv preprint on patient iPSC-cardiomyocyte nutrient-dependent pathology. An eight-node pathograph was curated running from biallelic MRPL44 loss through 39S assembly failure, impaired mitochondrial translation, failed compensatory mtDNA replication, combined CI/CIV deficiency, cardiomyocyte bioenergetic failure, progressive heart failure, and late multisystem involvement, plus an EMERGING mechanistic_hypotheses entry nutrient_dependent_postnatal_manifestation tagging the preprint-supported ISRmt and lipid arm. Added 16 phenotypes, 2 imaging findings, 2 histopathology findings, 5 biochemical markers, 5 variants with an autosomal recessive inheritance block flagging uniparental disomy, 4 treatments, and 4 discussions comprising 3 KNOWLEDGE_GAP and 1 HUMAN_MODEL_MISMATCH covering the yeast and mouse model divergence. No GeneReviews article exists for MRPL44; the PubMed search returned zero hits and this was documented rather than substituted. Validation: just validate, just validate-references and just validate-terms all pass. 75 of 82 snippets were machine-verified; the 7 DOI-prefixed snippets are skipped by validator config and were verified manually as exact substrings. validate-graphs shows no MRPL44 issues and compliance is 87.3 percent.

Falcon ▸

MRPL44 Deficiency: Disease-Characteristics Research Report

Edison Scientific Literature 22 citations 2026-08-01T17:15:45.233192

MRPL44 Deficiency: Disease-Characteristics Research Report

Executive summary

MRPL44 deficiency is an ultra-rare, autosomal-recessive nuclear mitochondrial disorder caused by biallelic pathogenic variants in MRPL44, which encodes a protein of the mitochondrial large ribosomal subunit. Its best-established presentation is neonatal or infantile hypertrophic cardiomyopathy, although subsequent reports support a broader, slowly progressive multisystem phenotype involving skeletal muscle, liver, kidney, and central nervous system. The molecular lesion destabilizes MRPL44 and the large mitoribosomal subunit, impairs 16S mitochondrial rRNA stability and mitochondrial protein synthesis/assembly, and causes combined oxidative-phosphorylation dysfunction, particularly involving complex IV. Evidence remains limited to very few families, patient-derived cells, and recent iPSC-cardiomyocyte work; prevalence, penetrance, formal diagnostic criteria, prospective natural history, and disease-specific treatment outcomes are unavailable. (boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)

Topic	Key finding	Evidence level	Notes / unknowns
Disease identity / identifier	MRPL44-related disease is a nuclear-encoded mitochondrial translation disorder described as infantile mitochondrial/hypertrophic cardiomyopathy and as part of combined oxidative phosphorylation deficiency; Open Targets lists MONDO:0014162 “infantile hypertrophic cardiomyopathy due to MRPL44 deficiency” and association to broader combined oxidative phosphorylation deficiency (MONDO:0000732) (OpenTargets Search: MRPL44 deficiency-MRPL44, boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13)	Review/database + direct literature linkage	A disease-specific OMIM/Orphanet identifier was not directly available in retrieved source text; avoid asserting one without primary confirmation.
Causal gene and inheritance	Causal gene: MRPL44 (mitochondrial ribosomal protein L44), a component of the mitochondrial large ribosomal subunit; reported disease mechanism is biallelic/homozygous pathogenic variation, consistent with autosomal recessive inheritance (wang2021mitochondrialproteintranslation pages 12-13, pradhan2025nutrientdependentpathologyin pages 8-11)	Direct human + review	Direct segregation details for all published families were not accessible in full text here; AR inference is supported by homozygous cases and review summaries.
Established variants	Directly retrieved variant from iPSC/model study: c.467T>G, p.Leu156Arg (p.L156R) in homozygous state (pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 14-17). Reviews also summarize a homozygous p.Leu156Arg MRPL44 mutation uncovered by exome sequencing in affected siblings (wang2021mitochondrialproteintranslation pages 12-13).	Direct human + iPSC preprint + review	Additional MRPL44 variants were mentioned in unavailable or secondary sources, but should be treated as unconfirmed here because the primary full text was not available in retrieved context.
Core phenotypes	Core phenotype is neonatal/infantile hypertrophic cardiomyopathy; broader spectrum may include slowly progressive multisystem disease involving skeletal muscle, liver, kidney, and central nervous system in later reports/review summaries (boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13, pradhan2025nutrientdependentpathologyin pages 11-14)	Direct human + review	Detailed per-patient frequencies, sex ratio, and full HPO-level breakdown were not available from accessible primary text.
Molecular defect	MRPL44 deficiency causes impaired mitochondrial translation, defective large mitoribosomal subunit assembly/stability, reduced 16S rRNA stability, and OXPHOS deficiency with particular impact on complex IV; in cardiomyocytes, complex I protein reduction, increased mtDNA copy number, and stress-response activation were observed (wang2021mitochondrialproteintranslation pages 12-13, pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 11-14)	Patient-cell + iPSC preprint + review	The exact hierarchy of complex defects across tissues remains incompletely resolved from accessible primary evidence.
Diagnosis	Diagnostic approaches reported or implied include exome sequencing/genomic sequencing for MRPL44, functional follow-up in patient fibroblasts or iPSC-derived cardiomyocytes, and mitochondrial disease workup focused on respiratory chain/OXPHOS defects and cardiomyopathy assessment (wang2021mitochondrialproteintranslation pages 12-13, pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 1-5)	Direct human + patient-cell + iPSC preprint	No disease-specific standardized diagnostic criteria, biomarker threshold, or screening algorithm was identified in retrieved sources.
Treatment / trials	No MRPL44-specific disease-modifying therapy or interventional clinical trial was identified; management appears supportive and phenotype-directed as for mitochondrial cardiomyopathy. A review of severe childhood cardiomyopathies noted that cardiac findings in some mitochondrial cardiomyopathies including MRPL44 may stabilize in a minority who survive early childhood (vasilescu2018geneticbasisof pages 8-9, pradhan2025nutrientdependentpathologyin pages 11-14)	Review/contextual clinical evidence	No MRPL44-targeted pharmacotherapy, gene therapy, or registered MRPL44-specific trial was found in retrieved evidence.
Epidemiology	Ultra-rare disorder with only a small number of published families/cases implied across foundational and later reports; no prevalence or incidence estimate was retrieved (wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)	Review/database	Population prevalence, carrier frequency, founder effects, and sex distribution are unknown from accessible evidence.
Models	Patient fibroblasts: reduced MRPL44 levels and mitoribosome/OXPHOS defects summarized in reviews; patient-derived iPSC-cardiomyocytes with homozygous p.L156R show nutrient-dependent pathology, increased mtDNA copy number, reduced complex I protein, ISRmt/ER stress, and lipid droplet accumulation in fatty-acid conditions (wang2021mitochondrialproteintranslation pages 12-13, pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 11-14, pradhan2025nutrientdependentpathologyin pages 14-17)	Patient-cell + iPSC preprint	No dedicated animal model of MRPL44 deficiency was directly retrieved in accessible evidence; broader mouse-model reviews discuss mitochondrial translation disease generally, not a specific MRPL44 animal model here.

Table: This table condenses the most reliable disease-specific findings currently retrievable for MRPL44 deficiency, separating direct human and cellular evidence from review/database support. It also highlights where identifiers, epidemiology, and treatment data remain unknown or insufficiently documented.

Evidence scope and limitations

The foundational report is Carroll et al., Journal of Medical Genetics, published online January 2013, “Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy” (PMID 23315540; DOI 10.1136/jmedgenet-2012-101375). A later multisystem report is indexed under PMID 34140213. Open Targets links these publications and ClinVar records RCV000054810 and RCV000791065 to MRPL44-associated disease. Some foundational full text was not retrievable during this review; consequently, unsupported patient-level numbers, laboratory values, and variant frequencies are not reconstructed from secondary summaries. (OpenTargets Search: MRPL44 deficiency-MRPL44)

A 2025 bioRxiv preprint—outside the requested 2023–2024 priority window but currently the newest disease-specific mechanistic study—uses patient-derived iPSC cardiomyocytes. Its findings should be considered pre-peer-review evidence rather than established clinical guidance. (pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 1-5)

1. Disease information

Definition and identifiers

MRPL44 deficiency is a nuclear-encoded mitochondrial translation disorder in which deficient mitochondrial ribosomal protein L44 causes defective synthesis or stabilization of mtDNA-encoded oxidative-phosphorylation proteins. The cardinal recognized phenotype is infantile mitochondrial hypertrophic cardiomyopathy. Open Targets records the specific disease as MONDO:0014162, infantile hypertrophic cardiomyopathy due to MRPL44 deficiency, and also associates MRPL44 with MONDO:0000732, combined oxidative phosphorylation deficiency. MRPL44 OMIM gene entry: 611849; this number is a gene identifier, not necessarily a distinct disease-entry number. (boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, OpenTargets Search: MRPL44 deficiency-MRPL44)

Common names include:

MRPL44 deficiency;
MRPL44-related mitochondrial disease;
infantile hypertrophic cardiomyopathy due to MRPL44 deficiency;
mitochondrial infantile cardiomyopathy due to MRPL44 mutation;
MRPL44-related combined oxidative phosphorylation deficiency;
MRPL44-related multisystem mitochondrial disease.

No disease-specific ICD-10, ICD-11, or MeSH code was established in the retrieved evidence. Coding would ordinarily use broader mitochondrial-metabolism and cardiomyopathy categories. A definitive Orphanet identifier was likewise not verified.

The evidence base is aggregated from published disease-level resources but ultimately derived from a very small number of individual patients and families, not population-scale EHR data. (wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)

2. Etiology

Cause and genetic risk

The primary cause is a germline biallelic pathogenic MRPL44 variant, producing autosomal-recessive loss of normal protein function. The best-established allele is homozygous NM_022915-related c.467T>G, p.(Leu156Arg), also abbreviated p.L156R. Exome sequencing identified this allele in affected siblings, and the same patient-derived genotype was used in the recent iPSC-cardiomyocyte model. (pradhan2025nutrientdependentpathologyin pages 8-11, wang2021mitochondrialproteintranslation pages 12-13)

The disease mechanism is functional loss/hypomorphism rather than gain of function: p.Leu156Arg reduces MRPL44 protein stability and abundance in heart, skeletal muscle, and fibroblasts. Maternal uniparental isodisomy of chromosome 2 has also been reported as a route to homozygosity for MRPL44-related disease, demonstrating that recessive disease can occasionally arise without parental consanguinity. Open Targets links the multisystem report through PMID 34140213. (wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)

Other risk, protective, and gene–environment factors

No validated susceptibility loci, modifier genes, protective alleles, environmental causes, toxins, infectious triggers, sex effect, or lifestyle risk factors have been established. Family history and parental carrier status are relevant because of recessive inheritance.

The strongest gene–environment observation is experimental: lipid-enriched medium, intended to approximate the postnatal cardiac fuel environment, worsened mitochondrial and ER stress and lipid dysregulation in MRPL44-mutant cardiomyocytes compared with glucose-rich conditions. This is mechanistic evidence for nutrient-dependent expression, not evidence that dietary fat causes the disease or that clinical fat restriction is beneficial. (pradhan2025nutrientdependentpathologyin pages 1-5, pradhan2025nutrientdependentpathologyin pages 11-14)

3. Phenotypes

Because the number of documented patients is extremely small, percentages should not be assigned. “Core,” “reported,” and “possible” are more defensible frequency labels.

Phenotype	Type and temporal pattern	Evidence/frequency	Suggested HPO term
Hypertrophic cardiomyopathy	Clinical sign; neonatal/infantile onset; potentially severe and progressive	Core defining phenotype	HP:0001639 Hypertrophic cardiomyopathy
Cardiac hypertrophy/ventricular-wall thickening	Imaging/pathology manifestation	Core, accompanying HCM	HP:0001712 Left ventricular hypertrophy
Heart failure/contractile dysfunction	Symptom/sign; potentially life-threatening	Expected complication of severe infantile HCM; patient-level frequency unavailable	HP:0001635 Congestive heart failure; HP:0001645 Myocardial dysfunction
Combined respiratory-chain deficiency	Biochemical abnormality; tissue dependent	Established disease mechanism	HP:0011923 Abnormal activity of mitochondrial respiratory chain
Complex IV deficiency	Biochemical abnormality	Particularly prominent in patient-cell evidence	HP:0008347 Decreased activity of cytochrome-c oxidase
Skeletal-muscle involvement/myopathy	Clinical sign	Reported in expanded multisystem spectrum	HP:0003198 Myopathy; HP:0001324 Muscle weakness
Liver dysfunction	Clinical/laboratory abnormality	Reported in expanded spectrum	HP:0001410 Decreased liver function
Renal dysfunction	Clinical/laboratory abnormality	Reported in expanded spectrum	HP:0000083 Renal insufficiency
CNS/neurologic involvement	Neurologic signs, variably progressive	Reported in expanded spectrum; exact manifestations/frequency unresolved	Use patient-specific terms rather than a generic inferred annotation
Cardiac lipid accumulation	Histopathologic/metabolic manifestation	Reported in autopsy context and reproduced as lipid-droplet accumulation in iPSC cardiomyocytes	HP:0006565 Hepatic steatosis is not appropriate; retain as free-text cardiac lipid accumulation pending an exact HPO term

Reviews classify onset as neonatal, while newer work describes infantile-onset or early-childhood HCM. Some mitochondrial cardiomyopathy survivors, including patients in MRPL44-associated groups, may stabilize around ages 5–6 years, but the proportion and predictors are unknown. (pradhan2025nutrientdependentpathologyin pages 11-14, boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13)

No MRPL44-specific EQ-5D, SF-36, PROMIS, developmental, or caregiver-burden studies exist. Severe heart failure, weakness, and neurologic or multiorgan dysfunction would predict substantial effects on feeding, exercise tolerance, development, hospitalization burden, and daily functioning, but these impacts have not been quantified.

4. Genetic and molecular information

Gene: MRPL44, mitochondrial ribosomal protein L44; Ensembl ENSG00000135900; OMIM 611849. MRPL44 is nuclear encoded and imported into mitochondria, where it forms part of the 39S large mitoribosomal subunit. It is among mammalian mitoribosomal proteins without a direct bacterial homolog and is positioned near the polypeptide-exit region. (boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)

Pathogenic variants

c.467T>G, p.(Leu156Arg), homozygous: established disease-associated missense allele; germline; functional consequence is destabilization/reduced abundance of MRPL44 and defective large-subunit function. It was identified by WES in affected siblings and used in patient-derived fibroblast/iPSC studies. (pradhan2025nutrientdependentpathologyin pages 8-11, wang2021mitochondrialproteintranslation pages 12-13)
Other disease-associated records exist in ClinVar, including RCV000054810 and RCV000791065, but exact HGVS descriptions and current ACMG classifications were not recoverable from the retrieved texts and should be imported directly from current ClinVar rather than inferred. (OpenTargets Search: MRPL44 deficiency-MRPL44)

No reliable gnomAD/1000 Genomes/TOPMed allele frequencies were retrieved. No somatic MRPL44 disease mechanism, recurrent chromosomal deletion, structural rearrangement, repeat expansion, or disease-specific epigenetic lesion is established. No validated modifier gene has been identified.

5. Environmental information

No toxin, radiation, pollution, occupational exposure, smoking, alcohol, infection, or other external cause is known. MRPL44 deficiency is not infectious or transmissible.

The postnatal metabolic switch is a plausible physiologic modifier. Fetal myocardium relies more heavily on glucose and lactate, whereas postnatal heart maturation increases fatty-acid oxidation. MRPL44-mutant cardiomyocytes maintained better homeostasis in glucose but developed stronger stress responses and lipid accumulation under palmitate/oleate exposure. This observation may explain postnatal manifestation, but it does not justify an untested therapeutic diet. (pradhan2025nutrientdependentpathologyin pages 1-5, pradhan2025nutrientdependentpathologyin pages 11-14)

6. Mechanism and pathophysiology

Core causal chain

Biallelic MRPL44 variant → reduced/stable-defective MRPL44 protein → impaired assembly/stability of the 39S mitoribosomal large subunit and reduced 16S mt-rRNA stability → defective synthesis, maturation, or assembly of mtDNA-encoded OXPHOS subunits → respiratory-chain deficiency, especially complex IV and in cardiomyocytes complex I protein loss → impaired oxidative ATP generation and maladaptive metabolic signaling → preferential injury of high-energy tissues, particularly myocardium → infantile hypertrophy, myocardial dysfunction, and possible multisystem disease. (wang2021mitochondrialproteintranslation pages 12-13)

The foundational patient-cell work found that reduced MRPL44 did not uniformly abolish measured de novo mitochondrial translation; instead, it markedly disturbed large-subunit assembly, 16S rRNA stability, and stabilization/assembly of nascent proteins such as COX1. This nuance suggests a defect in ribosome integrity and cotranslational OXPHOS assembly rather than a simple complete translation shutdown. (wang2021mitochondrialproteintranslation pages 12-13)

Recent molecular profiling

In p.Leu156Arg iPSC-derived cardiomyocytes, glucose conditions produced a 2.5-fold increase in mtDNA copy number, increased mitochondrial transcripts and mitochondrial content, but markedly reduced steady-state complex-I protein. Thus, increased mtDNA replication/transcription failed to compensate for defective translation. (pradhan2025nutrientdependentpathologyin pages 8-11)

Fatty-acid conditions activated the mitochondrial integrated stress response and partial ER stress, including ATF5, TRIB3, ASNS, MTHFD2, GDF15, DDIT3, PSAT1, PSPH, CEBPG, HERPUD1, NUPR1, XBP1, CHAC1, and HSPA5. FGF21 induction was absent. Mutant cells showed increased lipid droplets, lipid uptake and cholesterol-pathway genes—including CD36, LDLR, ACSL1, HMGCR, HMGCS1, FDFT1 and SQLE—and reduced effective lipid utilization. The authors propose persistent ISRmt/mTORC1-linked anabolic signaling, oxidative stress, and possible ferroptotic vulnerability as downstream contributors to hypertrophic growth. These results come from one patient line and require replication. (pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 11-14)

Ontology suggestions

GO biological process: mitochondrial translation (GO:0032543); mitochondrial ribosome assembly (GO:0061668); oxidative phosphorylation (GO:0006119); respiratory electron transport chain (GO:0022904); cellular response to oxidative stress (GO:0034599); fatty-acid beta-oxidation (GO:0006635).
GO cellular component: mitochondrion (GO:0005739); mitochondrial matrix (GO:0005759); mitochondrial large ribosomal subunit (GO:0005762); mitochondrial inner membrane (GO:0005743); respiratory-chain complex IV (GO:0045277).
Cell Ontology: cardiomyocyte (CL:0000746); skeletal-muscle cell/myocyte (CL:0000187); neuron (CL:0000540); hepatocyte (CL:0000182); kidney epithelial cell—use the specific renal lineage when known.

Immune dysregulation is not an established primary mechanism. Inflammation, autophagy, apoptosis, methylation changes, single-cell heterogeneity, spatial transcriptomics, lipidomics, and proteomics have not been characterized directly at disease-cohort scale.

7. Anatomical structures affected

The heart, especially ventricular myocardium and cardiomyocytes, is the best-established primary target. Suggested annotation: heart (UBERON:0000948), myocardium (UBERON:0002349), cardiac ventricle (UBERON:0002082), and cardiomyocyte (CL:0000746). Cardiac disease is generally bilateral/systemic rather than a lateralized lesion. (boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13)

Potential secondary targets in multisystem disease include skeletal muscle, liver, kidney, and CNS. At the subcellular level, the primary compartment is the mitochondrial matrix/large ribosomal subunit, with downstream dysfunction at the inner mitochondrial membrane OXPHOS complexes. (wang2021mitochondrialproteintranslation pages 12-13)

8. Temporal development

Typical onset is congenital, neonatal, or within infancy. The course can be rapidly severe in infantile cardiomyopathy, but later reports broaden the phenotype to slowly progressive multisystem disease. Some surviving children with mitochondrial cardiomyopathy may undergo cardiac stabilization by approximately 5–6 years, although this is neither predictable nor equivalent to molecular remission. (pradhan2025nutrientdependentpathologyin pages 11-14, boczonadi2014mitochondriaimpairedmitochondrial pages 4-5, wang2021mitochondrialproteintranslation pages 12-13)

A proposed critical period is the perinatal shift from glucose/lactate metabolism to fatty-acid oxidation. In vitro, this transition uncovered strong MRPL44-mutant stress and lipid-storage phenotypes, making early postnatal cardiac maturation a plausible window of vulnerability. There are no formally defined stages, remission criteria, or validated intervention windows. (pradhan2025nutrientdependentpathologyin pages 1-5, pradhan2025nutrientdependentpathologyin pages 11-14)

9. Inheritance and population

Inheritance is autosomal recessive. For two confirmed carrier parents, each pregnancy has the standard Mendelian probabilities of 25% affected, 50% carrier, and 25% unaffected/non-carrier, subject to confirmation of parental genotypes. Uniparental isodisomy can create homozygosity and changes recurrence counseling because the mechanism may not be two-parent carrier transmission. (wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)

Penetrance has not been quantified; severe biallelic disease appears highly penetrant, but expressivity is variable between cardiomyopathy-dominant and multisystem presentations. There is no evidence for anticipation. Germline mosaicism, founder effects, carrier frequency, ethnic enrichment, geographic clustering, sex ratio, incidence, and prevalence remain unknown. Published evidence supports designation as ultra-rare, not a numerical prevalence estimate.

10. Diagnostics

Clinical and biochemical workup

Suspect MRPL44 deficiency in neonatal/infantile HCM—especially when accompanied by lactic acidosis, muscle, neurologic, hepatic, renal, or combined respiratory-chain abnormalities—or in otherwise unexplained mitochondrial multisystem disease with cardiomyopathy.

Recommended evaluation, extrapolated from mitochondrial-disease practice, includes:

Echocardiography and ECG, with cardiac MRI where clinically appropriate.
Plasma/CSF lactate and pyruvate, blood gas, glucose, liver and renal profiles, creatine kinase, amino acids, acylcarnitines, and urine organic acids. None is MRPL44-specific.
Respiratory-chain enzymology, oxygen-consumption studies, blue-native PAGE, or immunoblotting in fibroblasts or muscle when genomic findings require functional confirmation.
Large-mitoribosomal protein/16S-rRNA assessment and mitochondrial translation assays in specialist laboratories. Patient evidence supports reduced MRPL44, disturbed 39S assembly, reduced 16S-rRNA stability, and complex-IV deficiency as useful functional signatures. (wang2021mitochondrialproteintranslation pages 12-13)

Genetic testing

A comprehensive nuclear mitochondrial-disease/cardiomyopathy panel that includes MRPL44, trio WES, or WGS is preferred. WES identified the original p.Leu156Arg allele. WGS may add value for intronic, copy-number, structural, and uniparental-disomy detection. Segregation analysis and parental SNP/haplotype testing are important when homozygosity occurs unexpectedly. (pradhan2025nutrientdependentpathologyin pages 8-11, wang2021mitochondrialproteintranslation pages 12-13)

CMA and karyotyping are not first-line tests for a single-nucleotide MRPL44 disorder but may detect large copy-number changes or suggest UPD. mtDNA sequencing is useful in the differential diagnosis but will not detect a nuclear MRPL44 variant. FISH and repeat-expansion testing have no routine role.

RNA sequencing, quantitative proteomics, and patient-derived cellular assays may resolve splice variants or demonstrate mitoribosomal/OXPHOS signatures in unsolved cases; however, no validated MRPL44-specific omics diagnostic threshold exists.

Differential diagnosis and screening

Differential diagnoses include other mitochondrial-translation cardiomyopathies involving MRPL3, TSFM, TUFM, ELAC2, MTO1, GTPBP3, TRMT5, AARS2, mtDNA disorders, primary sarcomeric HCM, Pompe disease, fatty-acid oxidation defects, Barth syndrome, and other metabolic cardiomyopathies. MRPL3 and MRPL44 are both recognized causes of infantile HCM due to mitoribosomal dysfunction. (pradhan2025nutrientdependentpathologyin pages 1-5, boczonadi2014mitochondriaimpairedmitochondrial pages 4-5)

No standardized clinical diagnostic criteria or population/newborn biochemical screen exists. Targeted familial testing and cascade carrier testing are appropriate after a molecular diagnosis.

11. Outcome and prognosis

No 5-year survival, median life expectancy, mortality rate, or validated prognostic model is available. Severe infantile cardiomyopathy can be life-threatening, while surviving patients may stabilize cardiac function during childhood; broader multisystem disease can remain slowly progressive. (pradhan2025nutrientdependentpathologyin pages 11-14, wang2021mitochondrialproteintranslation pages 12-13)

Potential morbidity includes chronic heart failure, arrhythmia risk, impaired exercise tolerance, muscle weakness, neurodevelopmental or neurologic disability, and liver or kidney dysfunction. Prognosis should therefore be based on serial cardiac function, rhythm, growth, lactate/metabolic status, neurologic development, and hepatic/renal involvement rather than genotype alone. No validated prognostic biomarker has been established. GDF15 was induced in mutant cardiomyocytes under experimental conditions, but it is not validated as an MRPL44-specific clinical predictor. (pradhan2025nutrientdependentpathologyin pages 8-11)

12. Treatment

There is no approved MRPL44-specific disease-modifying therapy, gene therapy, RNA therapy, or clinical-trial intervention. The ClinicalTrials.gov search retrieved no relevant MRPL44-specific study.

Current care is supportive and multidisciplinary:

guideline-directed pediatric cardiomyopathy/heart-failure therapy and arrhythmia surveillance;
consideration of mechanical support or transplantation for refractory end-stage cardiac failure, evaluated individually because multisystem mitochondrial disease can affect candidacy;
nutritional support and avoidance of prolonged fasting/catabolic stress;
prompt treatment of infection, dehydration, and metabolic decompensation;
physical, occupational, speech, and developmental therapy as indicated;
monitoring and treatment of hepatic, renal, neurologic, hearing, vision, and endocrine complications.

Potential NCIt annotations include Supportive Care (NCIT:C15747), physical therapy, occupational therapy, cardiac transplantation, mechanical circulatory support, and genetic counseling; exact NCIt identifiers should be verified against the current terminology release.

The iPSC finding that fatty acids exacerbate cellular pathology is hypothesis-generating only. It should not be translated into ketogenic therapy, fat restriction, or another major dietary manipulation outside specialist supervision and research protocols. (pradhan2025nutrientdependentpathologyin pages 1-5, pradhan2025nutrientdependentpathologyin pages 11-14)

13. Prevention

The molecular disease cannot presently be prevented after conception by lifestyle change or immunization. Primary reproductive prevention options after identifying familial variants include carrier testing, cascade testing, preimplantation genetic testing for monogenic disease, chorionic-villus sampling, amniocentesis, donor gametes, or other family-planning choices. UPD-mediated cases require individualized recurrence assessment.

Secondary prevention consists of early molecular diagnosis and cardiac surveillance in at-risk siblings. Tertiary prevention focuses on avoiding fasting and catabolic stress, maintaining vaccination and infection prevention, monitoring organ function, and treating cardiac or metabolic deterioration promptly. MRPL44 deficiency is not currently an established population newborn-screening target; the absence of a specific, proven early treatment is a major limitation.

14. Other species and natural disease

No naturally occurring MRPL44-deficiency syndrome in companion animals, livestock, or wildlife was identified. There is no zoonotic potential or cross-species transmission. Orthologs are evolutionarily conserved across mammals, but exact NCBI Gene and NCBI Taxonomy identifiers should be imported from current organism databases rather than inferred here.

15. Model organisms and experimental systems

Patient fibroblasts

Patient fibroblasts provided the foundational functional model. They demonstrated reduced MRPL44 abundance, impaired large-mitoribosomal-subunit assembly, destabilized 16S rRNA, and complex-IV/OXPHOS abnormalities. Their limitation is that fibroblasts do not reproduce the mature myocardium’s high energy and fatty-acid demands. (wang2021mitochondrialproteintranslation pages 12-13)

Patient-derived iPSC cardiomyocytes

The principal disease-relevant model is the homozygous c.467T>G, p.Leu156Arg patient iPSC line differentiated into cardiomyocytes. More than 80–90% of differentiated cells expressed cardiac troponin T. The model reproduced mitochondrial compensation, reduced complex-I protein, nutrient-dependent ISRmt/ER stress, and lipid-droplet accumulation. It is useful for studying cardiac maturation, metabolic stress, biomarkers, and candidate interventions. Limitations include one patient genotype, immature in-vitro cardiomyocyte physiology, short exposure, and preprint status. (pradhan2025nutrientdependentpathologyin pages 8-11, pradhan2025nutrientdependentpathologyin pages 5-8)

Animal models

No dedicated MRPL44 knock-in or conditional-knockout animal model with a published, well-characterized human-disease phenotype was established in the retrieved evidence. Recent reviews emphasize that mouse models of mitochondrial translation are valuable because constitutive loss of essential translation machinery can be embryonically lethal and tissue-specific models reveal organ vulnerability; however, these general observations should not be represented as direct MRPL44 animal evidence. (hughes2024illuminatingmitochondrialtranslation pages 6-7)

Recent developments and expert interpretation

A 2024 review of defective mitochondrial protein synthesis emphasized that these diseases preferentially affect high-energy tissues and remain mechanistically heterogeneous despite advances in NGS and cryo-EM (published May 2024; DOI 10.3389/fcell.2024.1410245). A 2024 mouse-model review likewise concluded that impaired mitochondrial translation produces severe, diverse disease and that tissue-specific models are essential for therapeutic development (published May/August 2024; DOI 10.1093/hmg/ddae020). (hughes2024illuminatingmitochondrialtranslation pages 6-7, antolinezfernandez2024molecularpathwaysin pages 12-14)

The newest MRPL44-specific work proposes that OXPHOS failure alone is insufficient to explain hypertrophy. Its key abstract conclusion is that lipid-enriched conditions elicited “robust activation of metabolic stress responses” and lipid accumulation, providing a mechanistic link between the postnatal fuel transition and infantile disease manifestation. This is an important shift from a purely ATP-deficiency model toward a combined model of mitochondrial translation failure, maladaptive stress signaling, and lipid-metabolic remodeling. It remains experimental and awaits peer review, replication across genotypes, and validation in vivo. (pradhan2025nutrientdependentpathologyin pages 1-5, pradhan2025nutrientdependentpathologyin pages 11-14)

Key knowledge gaps

Exact worldwide case count, prevalence, incidence, carrier frequency, and population distribution.
Complete variant spectrum with harmonized ACMG classification and gnomAD frequencies.
Prospective natural history, survival, quality of life, and genotype–phenotype correlations.
Standardized biochemical diagnostic thresholds and validated prognostic biomarkers.
Dedicated animal models and replicated patient-specific cardiac models.
Evidence for pharmacologic, dietary, gene-replacement, RNA, or editing therapies.
Single-cell, spatial, longitudinal proteomic, metabolomic, and lipidomic studies.

Accordingly, MRPL44 deficiency should be represented in a knowledge base as a well-supported gene–disease association with a strong mechanistic basis but a very limited clinical evidence set, and unknown fields should remain explicitly null rather than be populated from broader mitochondrial-disease assumptions. (wang2021mitochondrialproteintranslation pages 12-13, OpenTargets Search: MRPL44 deficiency-MRPL44)

References

(boczonadi2014mitochondriaimpairedmitochondrial pages 4-5): Veronika Boczonadi and Rita Horvath. Mitochondria: impaired mitochondrial translation in human disease. The International Journal of Biochemistry & Cell Biology, 48:77-84, Mar 2014. URL: https://doi.org/10.1016/j.biocel.2013.12.011, doi:10.1016/j.biocel.2013.12.011. This article has 156 citations.
(wang2021mitochondrialproteintranslation pages 12-13): Fei Wang, Deyu Zhang, Dejiu Zhang, Peifeng Li, and Yanyan Gao. Mitochondrial protein translation: emerging roles and clinical significance in disease. Frontiers in Cell and Developmental Biology, Jul 2021. URL: https://doi.org/10.3389/fcell.2021.675465, doi:10.3389/fcell.2021.675465. This article has 145 citations.
(OpenTargets Search: MRPL44 deficiency-MRPL44): Open Targets Query (MRPL44 deficiency-MRPL44, 3 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(pradhan2025nutrientdependentpathologyin pages 8-11): Swagat Pradhan, Nahid A Khan, Tuula Manninen, Aleksandra Zhaivoron, and Anu Suomalainen. Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.24.678132, doi:10.1101/2025.09.24.678132. This article has 0 citations.
(pradhan2025nutrientdependentpathologyin pages 14-17): Swagat Pradhan, Nahid A Khan, Tuula Manninen, Aleksandra Zhaivoron, and Anu Suomalainen. Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.24.678132, doi:10.1101/2025.09.24.678132. This article has 0 citations.
(pradhan2025nutrientdependentpathologyin pages 11-14): Swagat Pradhan, Nahid A Khan, Tuula Manninen, Aleksandra Zhaivoron, and Anu Suomalainen. Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.24.678132, doi:10.1101/2025.09.24.678132. This article has 0 citations.
(pradhan2025nutrientdependentpathologyin pages 1-5): Swagat Pradhan, Nahid A Khan, Tuula Manninen, Aleksandra Zhaivoron, and Anu Suomalainen. Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.24.678132, doi:10.1101/2025.09.24.678132. This article has 0 citations.
(vasilescu2018geneticbasisof pages 8-9): Catalina Vasilescu, Tiina H. Ojala, Virginia Brilhante, Simo Ojanen, Helena M. Hinterding, Eino Palin, Tero-Pekka Alastalo, Juha Koskenvuo, Anita Hiippala, Eero Jokinen, Timo Jahnukainen, Jouko Lohi, Jaana Pihkala, Tiina A. Tyni, Christopher J. Carroll, and Anu Suomalainen. Genetic basis of severe childhood-onset cardiomyopathies. Journal of the American College of Cardiology, 72 19:2324-2338, Nov 2018. URL: https://doi.org/10.1016/j.jacc.2018.08.2171, doi:10.1016/j.jacc.2018.08.2171. This article has 170 citations and is from a highest quality peer-reviewed journal.
(pradhan2025nutrientdependentpathologyin pages 5-8): Swagat Pradhan, Nahid A Khan, Tuula Manninen, Aleksandra Zhaivoron, and Anu Suomalainen. Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.24.678132, doi:10.1101/2025.09.24.678132. This article has 0 citations.
(hughes2024illuminatingmitochondrialtranslation pages 6-7): Laetitia A Hughes, Oliver Rackham, and Aleksandra Filipovska. Illuminating mitochondrial translation through mouse models. Human Molecular Genetics, 33:R61-R79, May 2024. URL: https://doi.org/10.1093/hmg/ddae020, doi:10.1093/hmg/ddae020. This article has 4 citations and is from a domain leading peer-reviewed journal.
(antolinezfernandez2024molecularpathwaysin pages 12-14): Álvaro Antolínez-Fernández, Paula Esteban-Ramos, Miguel Ángel Fernández-Moreno, and Paula Clemente. Molecular pathways in mitochondrial disorders due to a defective mitochondrial protein synthesis. Frontiers in Cell and Developmental Biology, May 2024. URL: https://doi.org/10.3389/fcell.2024.1410245, doi:10.3389/fcell.2024.1410245. This article has 16 citations.

Artifacts

Edison artifact artifact-00

Ask OpenScientist

OpenScientist Report

Classifications

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Histopathology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Biochemical Markers

Diagnosis

Imaging Findings

Progression

Prevalence

Differential Diagnoses

Source YAML

References & Deep Research

References

Deep Research

MRPL44 Deficiency: Disease-Characteristics Research Report

Executive summary

Evidence scope and limitations

1. Disease information

Definition and identifiers

2. Etiology

Cause and genetic risk

Other risk, protective, and gene–environment factors

3. Phenotypes

4. Genetic and molecular information

Pathogenic variants

5. Environmental information

6. Mechanism and pathophysiology

Core causal chain

Recent molecular profiling

Ontology suggestions

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

10. Diagnostics

Clinical and biochemical workup

Genetic testing

Differential diagnosis and screening

11. Outcome and prognosis

12. Treatment

13. Prevention

14. Other species and natural disease

15. Model organisms and experimental systems

Patient fibroblasts

Patient-derived iPSC cardiomyocytes

Animal models

Recent developments and expert interpretation

Key knowledge gaps

Artifacts